cepia

Clinical Epidemiology and Ageing

  1. A propos
  2. Nos publications

Nos publications

Retrouvez l'ensemble de nos publications originales parues dans des revues internationales à comité de lecture

2024

  1. Orcel V, Banh L, Bastuji-Garin S, Renard V, Boutin E, Gouja A, Caillet P, Paillaud E, Audureau E, Ferrat E. Effectiveness of comprehensive geriatric assessment adapted to primary care when provided by a nurse or a general practitioner: the CEpiA cluster-randomised trial. BMC Med. 2024;22(1):414.
  2. Broussier A, Paugam M, Liu N, Oghina S, Kharoubi M, Lafont C, Zaroui A, Galat A, Hittinger L, Teiger E, David JPhilippe, Bastuji-Garin S, Damy T. Frailty in heart failure according to the presence or absence of wild-type transthyretin cardiac amyloidosis. ESC Heart Fail. 2024.
  3. Grenon S, Guibert V, Engels C, Wolkenstein P, Chabroux-Vinson S, Barau C. [Bridging the gap between the first year of the Health Sciences bachelor's degree and the second year at Ifsi]. Soins. 2024;69(888):8-13.
  4. Mirat W, Moscova L, Lustman M, Dawidowicz S, Picot G, Lebel A, Cittée J, Ferrat E. Interprofessional follow-up of patients with cancer in France (the SINPATIC study): a preliminary, qualitative study of the patient's perspective. Fam Pract. 2024.
  5. Ferrat E, Mirat W, Boutin E, Maroto E, Brossier S, Hoonakker J-D, Audureau E, Phan T-T, Bastuji-Garin S. COVID-19 profiles in general practice: a latent class analysis. BMJ Open. 2024;14(6):e080393.
  6. Tamisier R, Damy T, Bailly S, Goutorbe F, Davy J-M, Lavergne F, Palot A, Verbraecken JA, d'Ortho M-P, Pépin J-L, d'Ortho M-P, Pépin J-L, Davy J-M, Damy T, Tamisier R. FACE study: 2-year follow-up of adaptive servo-ventilation for sleep-disordered breathing in a chronic heart failure cohort. Sleep Med. 2024;113:412-421.
  7. Teiger E, Eschalier R, Amabile N, Rioufol G, Ducrocq G, Garot P, Lepillier A, Bille J, Elbaz M, Defaye P, Audureau E, Le Corvoisier P. Left atrial appendage closure in very elderly patients in the French National Registry. Heart. 2024;110(4):245-253.
  8. Valter R, Paillaud E, Boudou-Rouquette P, Oubaya N, Arégui A, Lorisson E, Brain E, de Lempdes GRochette, Histe A, Laurent M, Canoui-Poitrine F, Caillet P, Broussier A, Martinez-Tapia C. Comparison of the prognostic value of eight nutrition-related tools in older patients with cancer: A prospective study. J Nutr Health Aging. 2024;28(4):100188.
  9. Lafont C, Paillaud E, Bertolus C, Baron M, Caillet P, Bouvard E, Laurent M, Salvan D, Chaumette L, de Decker L, Piot B, Barry B, Raynaud-Simon A, Sauvaget E, Minard A, Anota A, Panjo H, Brugel L, Canoui-Poitrine F. Geriatric assessment and quality of life for 2 years in older patients with head and neck cancer. J Natl Cancer Inst. 2024.
  10. Hagege M, Bringuier M, Martinez-Tapia C, Chouaid C, Helissey C, Brain E, Lempdes GRochette, Dubot C, Bello-Roufai D, Geiss R, Kempf E, Gourden A, Elgharbi H, Garrigou S, Gregoire L, Derbez B, Canoui-Poitrine F. Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach. Age Ageing. 2024;53(2).

2023

  1. Delbarre M-A, Girardon F, Roquette L, Blanc-Durand P, Hubaut M-A, Hachulla E, Semah F, Huglo D, Garcelon N, Marchal E, Esper IEl, Tribouilloy C, Lamblin N, Duhaut P, Schmidt J, Itti E, Damy T. Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2023;16(8):1085-1095.
  2. Lasvergnas J, Fallet V, Duchemann B, Jouveshomme S, Cadranel J, Chouaid C. PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors. Respir Med Res. 2023;84:101018.
  3. Hoonakker J-D, Adeline-Duflot F, Orcel V, Grudzinski M-L, Cognet M, Renard V. Use of visual aids in general practice consultations: A questionnaire-based survey. PEC Innov. 2023;2:100159.
  4. García-Pavía P, Siepen FAus dem, Donal E, Lairez O, van der Meer P, Kristen AV, Mercuri MF, Michalon A, Frost RJA, Grimm J, Nitsch RM, Hock C, Kahr PC, Damy T. Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid. N Engl J Med. 2023;389(3):239-250.
  5. Leemans M, Cuzuel V, Bauër P, Aissa HBaba, Cournelle G, Baelde A, Thuleau A, Cognon G, Pouget N, Guillot E, Fromantin I, Audureau E. Screening of Breast Cancer from Sweat Samples Analyzed by 2-Dimensional Gas Chromatography-Mass Spectrometry: A Preliminary Study. Cancers (Basel). 2023;15(11).
  6. Chouaid C, Monnet I, Auliac J-B. First-line management of advanced non-small-cell lung cancer: can we do better?. Transl Lung Cancer Res. 2023;12(7):1643-1648.
  7. Bizos A, Hostalrich A, Chaufour X, Desgranges P, Layese R, Cochennec F, Canoui-Poitrine F. Comparison of Fenestrated Stentgrafts and Open Repair for Juxtarenal Aortic Aneurysms Using a Propensity Score Matching. Ann Vasc Surg. 2023;95:50-61.
  8. Ladner J, Madi F, Jayasundera R, Saba J, Audureau E. Phone contacts and treatment discontinuation predict survival cancer patients in a subsidized drug access program. J Comp Eff Res. 2023;12(7):e220210.
  9. Babey H, Jamme P, Curcio H, Assié JBaptiste, Veillon R, Doubre H, Perol M, Guisier F, Huchot E, Decroisette C, Falchero L, Corre R, Cortot A, Chouaid C, Descourt R. Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study. Target Oncol. 2023;18(4):585-591.
  10. Barbe C, Boiteux-Chabrier M, Bouazzi L, El-Adib O, Pham B-N, Lourdelle A, Hurtaud A. Does the use of color coding facilitate parents' understanding of body mass index curves?. Arch Pediatr. 2023;30(7):458-465.
  11. Tian Y, Hirsch G, Skayem C, Thomas E, Hua C, David J-P, Chosidow O, Duong T-A. Evolution and challenges of store-and-forward teledermatology for skin diseases of elderly in long-term care facilities: Results of a 5-year analysis. J Eur Acad Dermatol Venereol. 2023;37(10):e1242-e1244.
  12. Albenque G, Bezard M, Kharoubi M, Odouard S, Lunati A, Poullot E, Zaroui A, Teiger E, Hittinger L, Audard V, Karoui KEl, Funalot B, Fanen P, Damy T, Oghina S. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study. Amyloid. 2023;30(4):407-415.
  13. Frasca M, Jonveaux T, Lhuaire Q, Bidegain-Sabas A, Chanteclair A, Francis-Oliviero F, Burucoa B. Sedation practices in palliative care services across France: a nationwide point-prevalence analysis. BMJ Support Palliat Care. 2023;13(e3):e1326-34.
  14. Feredj E, Wiedemann A, Krief C, Maitre B, Derumeaux G, Chouaid C, Le Corvoisier P, Lacabaratz C, Gallien S, Lelièvre JD, Boyer L. Immune response to pertussis vaccine in COPD patients. Sci Rep. 2023;13(1):11654.
  15. Galvin A, Amadéo B, Frasca M, Soubeyran P, Rondeau V, Delva F, Pérès K, Coureau G, Helmer C, Mathoulin-Pelissier S. Association between pre-diagnosis geriatric syndromes and overall survival in older adults with cancer (the INCAPAC study). J Geriatr Oncol. 2023;14(6):101539.
  16. Zolnowski-Kolp V, Din NUm, Havreng-Théry C, Pariel S, Veyron J-H, Lafuente-Lafuente C, Belmin J. Assessment of Frailty by the French Version of the Vulnerable Elders Survey-13 on Digital Tablet: Validation Study. J Med Internet Res. 2023;25:e42017.
  17. Nicol M, Vergaro G, Damy T, Kharoubi M, Baudet M, Canuti ESofia, Aimo A, Castiglione V, Emdin M, Royer B, Harel S, Cohen-Solal A, Arnulf B, Logeart D. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study. Front Cardiovasc Med. 2023;10:1179968.
  18. Damy T, Zaroui A, de Tournemire M, Kharoubi M, Gounot R, Galat A, Guendouz S, Funalot B, Itti E, Roulin L, Audard V, Fanen P, Leroy V, Poulot E, Belhadj K, Mallet S, Chadah GDeep Singh, Planté-Bordeneuve V, Gendre T, Chevalier X, Guignard S, Béquignon E, Bartier S, Folliguet T, Lemonier F, Audureau E, Tixier D, Canoui-Poitrine F, Lefaucheur J-P, Souvannanorath S, Authier F-J, Maupou S, Hittinger L, Molinier-Frenkel V, David J-P, Broussier A, Oghina S, Teiger E. Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France. Arch Cardiovasc Dis. 2023;116(10):433-446.
  19. Huon J-F, Nizet P, Caillet P, Lecompte H, Victorri-Vigneau C, Fournier J-P. Evaluation of the effectiveness of a joint general practitioner-pharmacist intervention on the implementation of benzodiazepine deprescribing in older adults (BESTOPH-MG trial): protocol for a cluster-randomized controlled trial. Front Med (Lausanne). 2023;10:1228883.
  20. Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C, Cappelli F. Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study. Front Cardiovasc Med. 2023;10:1238843.
  21. Buckinx F, Bonnefoy M, Raynaud A, Jeandel C, Lahaye C, Paillaud E, Haine M, Berrut G, Sanchez M, Guerin O, Rolland Y, Aquino J-P, Bruyère O. [Knowledge and application of the HAS recommendations concerning the diagnosis of undernutrition in people aged 70 and above: an international online survey among members of the "Société Française de Gériatrie et de Gérontologie"]. Geriatr Psychol Neuropsychiatr Vieil. 2023;21(3):307-318.
  22. Gouverneur A, Favary C, Jové J, Rouyer M, Bignon E, Salvo F, Tchalla A, Paillaud E, Aparicio T, Noize P. Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer. Target Oncol. 2023;18(5):717-726.
  23. Wardhere A, Bampatsias D, Fine N, García-Pavía P, Grogan M, Kristen AV, Damy T, Sekijima Y, Maurer MS. Heterogeneous worldwide access and pricing of Tafamidis. Amyloid. 2023:1-3.
  24. Assié J-B, Grumberg V, Reynaud D, Gaudin A-F, Batisse A, Jolivel R, Jouaneton B, Cotté F-E, Chouaid C. Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis. Respir Med Res. 2023;84:101051.
  25. Decroisette C, Greillier L, Curcio H, Perol M, Ricordel C, Auliac J-B, Falchero L, Veillon R, Vieillot S, Guisier F, Marcq M, Justeau G, Bigay-Gamé L, Bernardi M, Doubre H, Pinsolle J, Amrane K, Chouaid C, Descourt R. Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study). J Immunother. 2023.
  26. Benderra M-A, Serrano AG, Paillaud E, Tapia CM, Cudennec T, Chouaid C, Lorisson E, De la Taille A, Laurent M, Brain E, Bringuier M, Gligorov J, Caillet P, Canoui-Poitrine F. Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study. ESMO Open. 2023;8(5):101831.
  27. Mohty D, Omer MH, Ahmad O, Alayary I, Alzahrani T, Damy T, Fadel B. Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications. Front Cardiovasc Med. 2023;10:1265681.
  28. Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHWilson, Yu W-C, Obici L, Simões M, Fernandes F, Poulsen SHvitfeldt, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. N Engl J Med. 2023;389(17):1553-1565.
  29. Maidodou L, Clarot I, Leemans M, Fromantin I, Marchioni E, Steyer D. Unraveling the potential of breath and sweat VOC capture devices for human disease detection: a systematic-like review of canine olfaction and GC-MS analysis. Front Chem. 2023;11:1282450.
  30. Damy T, Bourel G, Slama M, Algalarrondo V, Lairez O, Fournier P, Costa J, Pelcot F, Farrugia A, Zaleski IDurand, Lilliu H, Rault C, Bartoli M, Fievez S, Granghaud A, Rudant J, Coste A, Cosson CNoirot, Squara P-A, Narbeburu M, De Neuville B, Charron P. Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases. Orphanet J Rare Dis. 2023;18(1):345.
  31. Assouan D, Paillaud E, Caillet P, Broussier A, Kempf E, Frelaut M, Brain E, Lorisson E, Chambraud C, Bastuji-Garin S, Hanon O, Canoui-Poitrine F, Laurent M, Martinez-Tapia C. Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA-19). Cancer Med. 2023;12(22):20940-20952.
  32. Dhamelincourt E, Descourt R, Rousseau-Bussac G, Doubre H, Decroisette C, Demontrond P, Le Garff G, Falchero L, Huchot E, Vieillot S, Corre R, Kazulinski L, Bizieux A, Bigay-Gamé L, Morel H, Molinier O, Chouaid C, Guisier F. Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study). Target Oncol. 2023;18(6):905-914.
  33. Hild S, Teigné D, Fairier D, Ruelle Y, Aubin-Auger I, Sidorkiewicz S, Citrini M, Gocko X, Cerisey C, Ferrat E, Rat C. Development and evaluation of a decision aid for women eligible for organized breast cancer screening according to international standards: A multi-method study. Breast. 2023;73:103613.
  34. Boyer L, Zebachi S, Gallien S, Margarit L, Baptista BRibeiro, Lopez-Zaragoza J-L, d'Humières T, Zerah F, Hue S, Derumeaux G, Adnot S, Audureau E, Lelièvre J-D. Combined effects of smoking and HIV infection on the occurrence of aging-related manifestations. Sci Rep. 2023;13(1):21745.
  35. Vaillant-Ciszewicz A-J, Couturier B, Segaux L, Canoui-Poitrine F, Guerin O, Bonin-Guillaume S. National cross-sectional survey on psychological impact on French nursing homes of the first lockdown during the COVID-19 pandemic as observed by psychologists, psychomotor, and occupational therapists. Front Public Health. 2023;11:1290594.
  36. Moreels T, Cruyt E, De Baets S, Andries L, Arts-Tielemans M, Rodriguez-Bailon M, Bergström A, Boete K, Bormans I, Costa U, Declercq H, Dekelver S, Dekyvere V, Delooz E, Engels C, Helderweirt S, Jarrey M, Lenaerts A, Leyman A, Lim KHean, Meynen L, Satink T, Schoenmakers F, Senn D, Slembrouck L, Van Meensel E, Vangenechten D, Van Paepeghem B, De Vriendt P, Van de Velde D. Self-Management Analysis in Chronic Conditions (SMACC) checklist: an international consensus-based tool to develop, compare and evaluate self-management support programmes. BMJ Open. 2023;13(12):e075676.
  37. Engels C, Segaux L, Ibanez A, Canoui-Poitrine F, Lafont C. Which Occupations Did People Engage in during Lockdown? A European Cross-Sectional Descriptive Survey by Generation. Occup Ther Int. 2023;2023:3979298.
  38. Lafuente-Lafuente C, Truong C, Recto C, Lafont C, Canoui-Poitrine F, Belmin J. Author Response: Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials. Neurology. 2023;100(15):737-738.
  39. Mebarki S, Pamoukdjian F, Pierro M, Poisson J, Baldini C, Taieb J, Fabre E, Canoui-Poitrine F, Oudard S, Paillaud E. Safety and efficacy of immunotherapy according to the age threshold of 80 years. Bull Cancer. 2023;110(5):570-580.
  40. Vergnenègre A, Monnet I, Ricordel C, Bizieux A, Curcio H, Bernardi M, Corre R, Guisier F, Hominal S, Le Garff G, Bylicki O, Locher C, Geier M, Chouaid C, Robinet G. Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung Cancer. 2023;178:191-197.
  41. Secretan P-H, Vieillard V, Thirion O, Annereau M, Yayé HSadou, Astier A, Paul M, Damy T, Do B. 3D-Printed, Liquid-Filled Capsules of Concentrated and Stabilized Polyphenol Epigallocatechin Gallate, Developed in a Clinical Trial. Antioxidants (Basel). 2023;12(2).
  42. Kharoubi M, Bezard M, Broussier A, Galat A, Gounot R, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Itti E, Lemonnier F, Chadha GDeep Sing, Guendouz S, Mallet S, Zaroui A, Audard V, Audureau E, Le Corvoisier P, Hittinger L, Bordeneuve VPlanté, Lefaucheur J-P, Amiot A, Béquignon E, Bartier S, Leroy V, Teiger E, Oghina S, Damy T. Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis. Front Cardiovasc Med. 2023;10:1124660.
  43. Logeart D, Damy T, Doublet M, Salvat M, Tribouilloy C, Bauer F, Eicher J-C, Picard F, Roul G, Trochu J-N, De Groote P, Bihry N, Berthelot E, Jondeau G, Seronde M-F, Roubille F, Isnard R. Feasibility and accuracy of linking a heart failure registry to the national claims database using indirect identifiers. Arch Cardiovasc Dis. 2023;116(1):18-24.
  44. Lund LH, Zeymer U, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Kalus S, Ferber PC, Koch C, Maggioni AP. Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry. Int J Cardiol. 2023;370:279-286.
  45. Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, T Hiltermann JN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B. Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study. J Thorac Oncol. 2023;18(2):181-193.
  46. Girerd N, Leclercq C, Hanon O, Bayes-Génis A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F. Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts. Rev Esp Cardiol (Engl Ed). 2023.
  47. Grambow-Velilla J, Seban R-D, Chouahnia K, Assié J-B, Champion L, Girard N, Bonardel G, Matton L, Soussan M, Chouaid C, Duchemann B. Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy. Cancers (Basel). 2023;15(8).
  48. Dang J, Ferlicot S, Misrahi M, Mussini C, Kounis I, Remy P, Samuel D, Planté-Bordeneuve V, Adams D, Funalot B, Snanoudj R, Damy T, Moktefi A, Audard V, Zaidan M. Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study. Nephrol Dial Transplant. 2023;38(9):2019-2030.
  49. Descourt R, Greillier L, Perol M, Ricordel C, Auliac J-B, Falchero L, Gervais R, Veillon R, Vieillot S, Guisier F, Marcq M, Justeau G, Bigay-Gamé L, Bernardi M, Fournel P, Doubre H, Pinsolle J, Amrane K, Chouaid C, Decroisette C. First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study). Cancer Immunol Immunother. 2023;72(1):91-99.
  50. Fauvel C, Bonnet G, Mullens W, Giraldo CInes Salda, Mežnar AZupan, Barasa A, Tokmakova M, Shchendrygina A, Costa FMoscoso, Mapelli M, Zemrak F, Tops LF, Jakus N, Sultan A, Bahouth F, Hadjseyd C-E, Salvat M, Anselmino M, Messroghli D, Weberndörfer V, Giverts I, Bochaton T, Courand PYves, Berthelot E, Legallois D, Beauvais F, Bauer F, Lamblin N, Damy T, Girerd N, Sebbag L, Pezel T, Cohen-Solal A, Rosano G, Roubille F, Mewton N. Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey. Eur J Heart Fail. 2023;25(2):213-222.
  51. Bylicki O, Tomasini P, Radj G, Guisier F, Monnet I, Ricordel C, Bigay-Gamé L, Geier M, Chouaid C, Daniel C, Swalduz A, Toffart A-C, Doubre H, Peloni J-M, Moreau D, Subtil F, Grellard J-M, Castera M, Clarisse B, Martins-Lavinas P-H, Decroisette C, Greillier L. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-. Eur J Cancer. 2023;183:38-48.
  52. Bezard M, Kharoubi M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Abulizi M, Deux J-F, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Itti E, Hittinger L, Teiger E, Oghina S, Damy T. Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis. Mayo Clin Proc. 2023;98(1):48-59.
  53. Soubeyran P, Bellera C, Paillaud E. Achieving harmony in oncological geriatric assessment - Should we agree on a best set of tools?. J Geriatr Oncol. 2023;14(7):101482.
  54. Aparicio T, Layese R, Hemery F, Tournigand C, Paillaud E, de Angelis N, Quero L, Ganne N, Prat F, Pachev A, Galula G, Benderra M-A, Canoui-Poitrine F. The 10-month mortality rate among older patients treated for digestive system cancer during the first wave of the COVID-19 pandemic: The CADIGCOVAGE multicentre cohort study. J Geriatr Oncol. 2023;14(2):101443.
  55. Gendarme S, Zebachi S, Corre R, Greillier L, Justeau G, Bylicki O, Decroisette C, Auliac J-B, Guisier F, Geier M, Ricordel C, Frelaut M, Paillaud E, Chouaid C, Canoui-Poitrine F. Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study. J Geriatr Oncol. 2023:101506.
  56. Labbe V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Préau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit J-F, Picos SAlberto, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Dessap AMekontso. Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial. JAMA Intern Med. 2023;183(6):520-531.
  57. Halimi F, Sabouret P, Huberman JP, Ouazana L, Guedj D, Djouadi K, Dhanjal TS, Goette A, Lafont C, Lellouche N. Atrial fibrillation detection with long-term continuous Holter ECG recording in patients with high cardiovascular risk and clinical palpitations: the prospective after study. Clin Res Cardiol. 2023;112(6):807-814.
  58. Guillet S, Loustau V, Boutin E, Zarour A, Comont T, Souchaud-Debouverie O, Chalumeau NCostedoat, Pan-Petesch B, Gobert D, Cheze S, Viallard JFrancois, Morin A-S, Sauvetre G, Cliquennois M, Royer B, Masseau A, Terriou L, Fieschi C, Lambotte O, Girault S, Lioger B, Audia S, Sacre K, Lega JChristophe, Langlois V, Benachi A, Orvain C, Devidas A, Humbert S, Gambier N, Ruivard M, Zarrouk V, Ebbo M, Willems L, Segaux L, Mahévas M, Haddad B, Michel M, Canoui-Poitrine F, Godeau B. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study. Blood. 2023;141(1):11-21.
  59. Lopinto J, Arrestier R, Peiffer B, Gaillet A, Voiriot G, Urbina T, Luyt C-E, Bellaïche R, Pham T, Ait-Hamou Z, Roux D, Clere-Jehl R, Azoulay E, Gaudry S, Mayaux J, Dessap AMekontso, Canoui-Poitrine F, de Prost N. High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study. Crit Care Med. 2023;51(10):1306-1317.
  60. Schlemmer F, Valentin S, Boyer L, Guillaumot A, Chabot F, Dupin C, Le Guen P, Lorillon G, Bergeron A, Basille D, Delomez J, Andrejak C, Bonnefoy V, Goussault H, Assié J-B, Choinier P, Ruppert A-M, Cadranel J, Mennitti MChiara, Roumila M, Colin C, Günther S, Sanchez O, Gille T, Sésé L, Uzunhan Y, Faure M, Patout M, Morelot-Panzini C, Laveneziana P, Zysman M, Blanchard E, Raherison-Semjen C, Giraud V, Giroux-Leprieur E, Habib S, Roche N, Dinh-Xuan ATuan, Sifaoui I, Brillet P-Y, Jung C, Boutin E, Layese R, Canoui-Poitrine F, Maitre B. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. Eur Respir J. 2023;61(4).
  61. Phan T-T, Mirat W, Brossier S, Boutin E, Fabre J, Hoonakker J-D, Bastuji-Garin S, Renard V, Ferrat E. Initial characteristics and course of disease in patients with suspected COVID-19 managed in general practice: a prospective, multicentre cohort study. BMJ Open. 2023;13(5):e068424.
  62. Frelaut M, Paillaud E, Beinse G, Scain A-L, Culine S, Tournigand C, Poisson J, Bastuji-Garin S, Canoui-Poitrine F, Caillet P. External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort. Oncologist. 2023;28(6):e341-e349.
  63. Dreyfus J, Bohbot Y, Coisne A, Lavie-Badie Y, Flagiello M, Bazire B, Eggenspieler F, Viau F, Riant E, Mbaki Y, Eyharts D, Senage T, Modine T, Nicol M, Doguet F, Le Tourneau T, Tribouilloy C, Donal E, Tomasi J, Habib G, Selton-Suty C, Radu C, Lim P, Raffoul R, Iung B, Obadia J-F, Audureau E, Messika-Zeitoun D. Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery. Heart. 2023;109(12):951-958.
  64. Damy T. [The taboo of the impact of end of life and death on caregivers]. Soins. 2023;68(874):18-24.
  65. Hild S, Teigné D, Ferrat E, Banaszuk A-S, Berquet K, Lebon A, Bataille E, Nanin F, Gaultier A, Rat C. Breast cancer: a randomized controlled trial assessing the effect of a decision aid on mammography screening uptake: study protocol. Front Oncol. 2023;13:1128467.
  66. Ramond-Roquin A, Gautier S, Le Breton J, Bourgueil Y, Bouchez T. French General Practitioners' Adaptations for Patients with Suspected COVID-19 in May 2020. Int J Environ Res Public Health. 2023;20(3).
  67. Depotte L, Caroux M, Gligorov J, Canoui-Poitrine F, Belkacemi Y, de la Taille A, Tournigand C, Kempf E. Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review. Health Qual Life Outcomes. 2023;21(1):11.
  68. Couderc A-L, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Montégut C, Mebarki S, Geiss R, Thomas ZAp, Noret A, Pierro M, Baldini C, Paillaud E, Pamoukdjian F. Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment. Nutrients. 2023;15(5).
  69. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz J-F, Paillaud E, Lièvre A, Boulahssass R, Vitellius C, Bengrine L, Canoui-Poitrine F, Manfredi S. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer. 2023;23(1):17.
  70. Pezel T, Dreyfus J, Mouhat B, Thébaut C, Audureau E, Bernard A, Badie YLavie, Bohbot Y, Fard D, Nguyen LS, Monteil C, Bière L, Le Ven F, Canu M, Ribeyrolles S, Mion B, Bazire B, Fauvel C, Cautela J, Cambet T, Le Tourneau T, Donal E, Lafitte S, Magne J, Mansencal N, Coisne A. Effectiveness of Simulation-Based Training on Transesophageal Echocardiography Learning: The SIMULATOR Randomized Clinical Trial. JAMA Cardiol. 2023;8(3):248-256.
  71. Serrano AGonzález, Laurent M, Barnay T, Martinez-Tapia C, Audureau E, Boudou-Rouquette P, Aparicio T, Rollot-Trad F, Soubeyran P, Bellera C, Caillet P, Paillaud E, Canoui-Poitrine F. A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis. J Clin Oncol. 2023;41(4):826-834.
  72. Torres MJ, Coste J, Canoui-Poitrine F, Pouchot J, Rachas A, Carcaillon-Bentata L. Impact of the First COVID-19 Pandemic Wave on Hospitalizations and Deaths Caused by Geriatric Syndromes in France: A Nationwide Study. J Gerontol A Biol Sci Med Sci. 2023;78(9):1612-1626.
  73. Guillet S, Crickx E, Azzaoui I, Chappert P, Boutin E, Viallard J-F, Rivière E, Gobert D, Galicier L, Malphettes M, Cheze S, Lefrère F, Audia S, Bonnotte B, Lambotte O, Noel N, Fain O, Moulis G, Hamidou M, Gerfaud-Valentin M, Marolleau J-P, Terriou L, Martis N, Morin A-S, Perlat A, Le Gallou T, Roy-Peaud F, Robbins A, Lega J-C, Puyade M, Comont T, Limal N, Languille L, Zarrour A, Luka M, Menager M, Belmondo T, Hue S, Canoui-Poitrine F, Michel M, Godeau B, Mahévas M. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study. Blood. 2023;141(23):2867-2877.
  74. Le Goff E, Blanc-Durand P, Roulin L, Lafont C, Loyaux R, MBoumbae D-L, Benmaad I, Claudel A, Poullot E, Robe C, Gricourt G, Aissat A, Copie-Bergman C, Lemonnier F, Gaulard P, Itti E, Haioun C, Delfau-Larue M-H. Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort. Br J Haematol. 2023;202(1):54-64.
  75. Feredj E, Audureau E, Boueilh A, Fihman V, Fourati S, Lelièvre J-D, Gallien S, Grimbert P, Matignon M, Melica G. Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 Recipients. Pathogens. 2023;12(1).
  76. Celante H, Oubaya N, Fourati S, Beaune S, Khellaf M, Casalino E, Ricard J-D, Vieillard-Baron A, Heming N, Dessap AMekontso, de Montmollin E, Benghanem S, Epaillard N, Layese R, de Prost N. Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study. Clin Microbiol Infect. 2023;29(7):943.e1-943.e8.
  77. Segaux L, Oubaya N, Leissing-Desprez C, de Langavant LCleret, Broussier A, Naga H, Fromantin I, David J-P, Bastuji-Garin S. More than a third of middle-aged adults (50-65) have understated executive dysfunction. Aging Ment Health. 2023;27(4):708-713.
  78. Jenvrin A, Galletto-Pregliasco A, Audureau E, Pujals A, Favre L, Luciani A, Calderaro J, Sommacale D, Chatellier G, Tournigand C, Laurent A, Kempf E. Intentional R1 resection of liver metastases: A new treatment paradigm for patients with advanced colorectal cancer based on a propensity score-Matched case-control analysis. Clin Res Hepatol Gastroenterol. 2023;47(4):102097.
  79. Melica G, Bartolucci P, Audureau E, Le Corvoisier P, Habibi A, Gellen J, Selmane D, Michel M, Lacabaratz C, Levy Y. Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial. Clin Infect Dis. 2023;76(11):1949-1958.
  80. Dang J, Segaux L, Moktefi A, Stehlé T, Kharoubi M, Karoui KEl, Remy P, Grimbert P, Planté-Bordeneuve V, Guendouz S, Galat A, Mallet S, Oghina S, Chadha GDeep Singh, Zaroui A, Fanen P, Canoui-Poitrine F, Damy T, Audard V. Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study. Amyloid. 2023;30(1):38-48.
  81. Assié J-B, Chouaid C, Nunes H, Reynaud D, Gaudin A-F, Grumberg V, Jolivel R, Jouaneton B, Cotté F-E, Duchemann B. Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting. Ther Adv Med Oncol. 2023;15:17588359231152847.
  82. Berthelot E, Broussier A, Hittinger L, Donadio C, Rovani X, Salengro E, Megbemado R, Godreuil C, Belmin J, David JPhilippe, Genet B, Damy T. Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure. ESC Heart Fail. 2023;10(3):2042-2050.
  83. Bastuji-Garin S, Brouard L, Bourgeon-Ghittori I, Zebachi S, Boutin E, Hemery F, Fourreau F, Oubaya N, De Roux Q, Mongardon N, Fourati S, Decousser J-W. The Relative Contributions of Occupational and Community Risk Factors for COVID-19 among Hospital Workers: The HOP-COVID Cohort Study. J Clin Med. 2023;12(3).
  84. Chouaid C, Bosquet L, Girard N, Kron A, Scheffler M, Griesinger F, Sebastian M, Trigo J, Viteri S, Knott C, Rodrigues B, Rahhali N, Cabrieto J, Diels J, Perualila NJ, Schioppa CA, Sermon J, Toueg R, Erdmann N, Mielke J, Nematian-Samani M, Martin-Fernandez C, Pfaira I, Li T, Mahadevia P, Wolf J. An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Adv Ther. 2023;40(3):1187-1203.
  85. Martinez-Tapia C, Rougette K, Fossey-Diaz V, Cudennec T, Taleb C, Balardy L, Mertens C, Mitha N, Bringuier M, Maley K, Estivin S, Quipourt V, Canoui-Poitrine F, Baldini C, Poisson J, Paillaud E. Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort Study. Nutrients. 2023;15(6).
  86. Chouaid C, Gendarme S, Auliac J-B. Artificial intelligence to finally enable precision medicine for the management of resected non-small-cell lung cancer. Ann Oncol. 2023;34(7):565-566.

2022

  1. Gendarme S, Bylicki O, Chouaid C, Guisier F. Fusions in Non-Small-Cell Lung Cancer: Evidence to Date. Curr Oncol. 2022;29(2):641-658.
  2. Paillaud E, Caillet P, Conti C, Mebarki S. [Specificities of supportive care in geriatric oncology]. Bull Cancer. 2022;109(5):568-578.
  3. Zeymer U, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Lund LH, Kalus S, Ferber PC, Hussain RI, Koch C, Maggioni AP. Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry. Eur Heart J Qual Care Clin Outcomes. 2022;8(4):469-477.
  4. Hacil A, Genet B, Assayag P, Jourdain P, Motiejunaite J, David JPhilippe, Verny C, Hanon O, Berthelot E. Management and prognosis of older patients with acute heart failure hospitalized in geriatrics and cardiology departments: The GERDICA study. J Am Geriatr Soc. 2022;70(4):1282-1284.
  5. Odouard S, Abulizi M, Kharoubi M, Oghina S, Guendouz S, Zaroui A, Teiger E, Itti E, Damy T, Galat A. Tafamidis Decreases Cardiac Uptake of Tc-HMDP in Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2022;15(12):2149-2151.
  6. Touboul O, Algalarrondo V, Oghina S, Elbaz N, Rouffiac S, Hamon D, Extramiana F, Gandjbakhch E, d'Humières T, Marijon E, Dhanjal TS, Teiger E, Damy T, Lellouche N. Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants. ESC Heart Fail. 2022;9(5):3556-3564.
  7. Van Sanden S, Murton M, Bobrowska A, Rahhali N, Sermon J, Rodrigues B, Goff-Leggett D, Chouaid C, Sebastian M, Greystoke A. Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis. Target Oncol. 2022;17(2):153-166.
  8. Moulin T, Hamon D, Djouadi K, d'Humières T, Elbaz N, Boukantar M, Zerbib C, Rouffiac S, Dhanjal TS, Ernande L, Derumeaux G, Teiger E, Damy T, Lellouche N. Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real-world experience. ESC Heart Fail. 2022;9(5):3101-3112.
  9. Nguyen-Michel V-H, Houot M, Delorme C, Sangaré A, Gales A, Frazzini V, Hanin A, Aissani D, Trân T, Oquendo B, Ketz F, Lafuente-Lafuente C, Oasi C, Kinugawa K, Ouvrard G, Ursu R, Degos B, Rohaut B, Demeret S, Lambrecq V, Navarro V, Fournier E, Corvol J-C, Borden A. Older patients with COVID-19 and neuropsychiatric conditions: A study of risk factors for mortality. Brain Behav. 2022;12(12):e2787.
  10. Paleiron N, Gervais R, Rousseau-Bussac G, Game LBigay, Chiappa AMarie, Lamy R, Guisier F, Le Caer H, Robinet G, Bizieux A, Chouaid C. Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study. J Cancer Res Ther. 2022;18(Supplement):S160-S164.
  11. Pasteur-Rousseau A, Odouard S, Souibri K, Sebag FA, Deux J-F, Damy T. [Cardiac imaging in infiltrative cardiomyopathies. What cardiovascular imaging modalities to propose in hypertrophic cardiomyopathies ?]. Ann Cardiol Angeiol (Paris). 2022;71(2):63-74.
  12. Hourqueig M, Bouzille G, Mirabel M, Huttin O, Damy T, Labombarda F, Eicher J-C, Charron P, Habib G, Réant P, Hagège A, Donal E. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY). Clin Res Cardiol. 2022;111(2):163-174.
  13. Jobbé-Duval A, Bezard M, Moutereau S, Kharoubi M, Oghina S, Zaroui A, Galat A, Chalard C, Hugon-Vallet E, Lemonnier F, Eyharts D, Poulot E, Fanen P, Funalot B, Molinier-Frenkel V, Audard V, Hittinger L, Delbarre MAntoine, Teiger E, Damy T. Prevalence and determinants of iron deficiency in cardiac amyloidosis. ESC Heart Fail. 2022;9(2):1314-1327.
  14. Justeau G, Huchot E, Simonneau Y, Roa M, Le Treut J, Le Garff G, Bylicki O, Schott R, Bravard A-S, Tiercin M, Lamy R, De Chabot G, Marty A, Moreau D, Locher C, Bernier C, Chouaid C, Descourt R. Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy. Lung Cancer. 2022;174:45-49.
  15. Kharoubi M, Bodez D, Bezard M, Zaroui A, Galat A, Guendouz S, Gendre T, Hittinger L, Attias D, Mohty D, Bergoend E, Itti E, Lebras F, Hamon D, Poullot E, Molinier-Frenkel V, Lellouche N, Deux J-F, Funalot B, Fannen P, Oghina S, Arrouasse R, Lecorvoisier P, Souvannanorath S, Amiot A, Teiger E, Bougouin W, Damy T. Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival. Amyloid. 2022;29(2):79-91.
  16. Landre T, Justeau G, Assié J-B, Chouahnia K, Davoine C, Taleb C, Chouaid C, Duchemann B. Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials. Cancer Immunol Immunother. 2022;71(3):719-726.
  17. Law S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, Ogunbiyi O, Kharoubi M, Ganeshananthan S, Ganeshananthan S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Damy T, Fontana M, Gillmore JD. Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. Eur Heart J. 2022;43(27):2622-2632.
  18. Maggioni AP, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Lund LH, Kalus S, Ferber PC, Hussain RI, Koch C, Zeymer U. Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry. ESC Heart Fail. 2022;9(6):4209-4218.
  19. Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, García-Pavía P. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC CardioOncol. 2022;4(4):442-454.
  20. Goussault H, Gendarme S, Assié J-B, Jung C, Epaud S, Algans C, Salaün-Penquer N, Rousseau M, Lazatti A, Chouaid C. Risk factors for early mortality of lung cancer patients in France: A nationwide analysis. Cancer Med. 2022;11(24):5025-5034.
  21. Gendarme S, Pairon J-C, Andujar P, Laurent F, Brochard P, Delva F, Clin B, Gislard A, Paris C, Thaon I, Goussault H, Canoui-Poitrine F, Chouaid C. Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects. Cancers (Basel). 2022;14(17).
  22. Damy T, Adams D, Bridoux F, Grateau G, Planté-Bordeneuve V, Ghiron Y, Farrugia A, Pelcot F, Taieb C, Labeyrie C, Jaccard A, Georgin-Lavialle S. Amyloidosis from the patient perspective: the French daily impact of amyloidosis study. Amyloid. 2022;29(3):165-174.
  23. Descourt R, Perol M, Rousseau-Bussac G, Planchard D, Mennecier B, Wislez M, Cadranel J, Cortot ABenjamin, Guisier F, Galland L, Do P, Schott R, Dansin E, Arrondeau J, Auliac J-B, Geier M, Chouaid C. Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study. Cancers (Basel). 2022;14(7).
  24. Edelman MJ, Dvorkin M, Laktionov K, Navarro A, Juan-Vidal O, Kozlov V, Golden G, Jordan O, Deng CQ, Bentsion D, Chouaid C, Dechev H, Dowlati A, Núñez NFernández, Ivashchuk O, Kiladze I, Kortua T, Leighl N, Luft A, Makharadze T, Min YJ, Quantin X. Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. Lung Cancer. 2022;166:135-142.
  25. Fischer K, Lellouche N, Damy T, Martins R, Clementy N, Bisson A, Lesaffre F, Espinosa M, Garcia R, Degand B, Serzian G, Jourda F, Huttin O, Guichard J-B, Devilliers H, Eicher J-C, Laurent G, Guenancia C. Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis. ESC Heart Fail. 2022;9(1):740-750.
  26. Garassino MC, Mazières J, Reck M, Chouaid C, Bischoff H, Reinmuth N, Cove-Smith L, Mansy T, Cortinovis D, Migliorino MR, Delmonte A, Sánchez JGarcia, Velarde LEnrique Ch, Bernabe R, Paz-Ares L, Perez IDiaz, Trunova N, Foroutanpour K, Faivre-Finn C. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial. J Thorac Oncol. 2022;17(12):1415-1427.
  27. Boureau A-S, Annweiler C, Belmin J, Bouleti C, Chacornac M, Chuzeville M, David J-P, Jourdain P, Krolak-Salmon P, Lamblin N, Paccalin M, Sebbag L, Hanon O. Practical management of frailty in older patients with heart failure: Statement from a panel of multidisciplinary experts on behalf the Heart Failure Working Group of the French Society of Cardiology and on behalf French Society of Geriatrics and Gerontol. ESC Heart Fail. 2022;9(6):4053-4063.
  28. Colombat M, Gaspard M, Camus M, Dalloux-Chioccioli J, Delas A, Poullot E, Moktefi A, François A, Moreau A, Gibier J-B, Raynaud P, Huart A, Piedrafita A, Gilhodes J, Lairez O, Grateau G, Georgin-Lavialle S, Maisonneuve H, Moreau P, Jaccard A, Bridoux F, Planté-Bordeneuve V, Damy T, Mal H, Brousset P, Valleix S, Burlet-Schiltz O. Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort. Haematologica. 2022;107(12):2983-2987.
  29. Assié J-B, Crépin F, Grolleau E, Canellas A, Geier M, Grébert-Manuardi A, Akkache N, Renault A, Hauss P-A, Sabatini M, Bonnefoy V, Cortot A, Wislez M, Gauvain C, Chouaid C, Scherpereel A, Monnet I. Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers (Basel). 2022;14(6).
  30. Benson MD, Berk JL, Dispenzieri A, Damy T, Gillmore JD, Hazenberg BP, Lavatelli F, Picken MM, Röcken C, Schönland S, Ueda M, Westermark P. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid. 2022;29(1):8-13.
  31. Abroud H, Beldi-Ferchiou A, Audard V, Lemonnier F, Le Bras F, Belhadj K, Moktefi A, Poullot E, Karoui KEl, Dupuis J, Maarek A, Roulin L, Delfau-Larue M-H, Oghina S, Kharoubi M, Bezard M, Zaroui A, Damy T, Molinier-Frenkel V. Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis. EJHaem. 2022;3(3):828-837.
  32. Ladner J, Alshurafa S, Madi F, Nofal A, Jayasundera R, Saba J, Audureau E. Factors impacting self-management ability in patients with chronic diseases in the United Arab Emirates, 2019. J Comp Eff Res. 2022;11(3):179-192.
  33. Paillaud E, Poisson J, Granier C, Ginguay A, Plonquet A, Conti C, Broussier A, Raynaud-Simon A, Bastuji-Garin S. Serum Leptin Levels, Nutritional Status, and the Risk of Healthcare-Associated Infections in Hospitalized Older Adults. Nutrients. 2022;14(1).
  34. Aparicio T, Layese R, Hemery F, Tournigand C, Paillaud E, de Angelis N, Quero L, Ganne N, Prat F, Pachev A, Galula G, Benderra M-A, Canoui-Poitrine F. Effect of lockdown on digestive system cancer care amongst older patients during the first wave of COVID-19: The CADIGCOVAGE multicentre cohort study. Dig Liver Dis. 2022;54(1):10-18.
  35. Boudou-Rouquette P, de Moura A, Martinez-Tapia C, Serrano AGonzalez, Chahwakilian A, Jouinot A, Ulmann G, Orvoën G, Chambraud C, Durand J-P, Caillet P, Goldwasser F, Paillaud E, Canoui-Poitrine F. Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: The ELCAPA-25 prospective cohort survey. Clin Nutr. 2022;41(5):1073-1082.
  36. Esser R, Oufkir M, Tall F, David J-P. [Screening and management of peripheral arterial obstructive disease in the lower limb wounds amongst diabetic elderly patients]. Geriatr Psychol Neuropsychiatr Vieil. 2022;20(4):473-480.
  37. Jung C, Excoffier J-B, Raphaël-Rousseau M, Salaün-Penquer N, Ortala M, Chouaid C. Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysis. PLoS One. 2022;17(2):e0263266.
  38. Damy T, Benedyga V, Pezel T, Berthelot E, Gauthier J, Habib G, Iliou M-C, Aupetit J-F, Baudry G, De Groote P, Logeart D, Chaufourier L, Ciobotaru V, Pousset F, Beauvais F, Bauer F, Zores F, Lairez O, Richard K, Hittinger L, Teiger E, Taieb C, Audureau E. Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory. Nutrients. 2022;14(2).
  39. Yana J, Moscova L, Le Breton J, Boutin E, Siess T, Clerc P, Bastuji-Garin S, Ferrat E. Prescription of benzodiazepines and Z-drugs among older patients in primary care: a French, national, cohort study. Fam Pract. 2022.
  40. Paillaud E, Brugel L, Bertolus C, Baron M, Béquignon E, Caillet P, Schouman T, Guily JLacau Sain, Périé S, Bouvard E, Laurent M, Salvan D, Chaumette L, de Decker L, Piot B, Barry B, Raynaud-Simon A, Sauvaget E, Bach C, Bizard A, Bounar A, Minard A, Aziz B, Chevalier E, Chevalier D, Gaxatte C, Malard O, Liuu E, Lacour S, Gregoire L, Lafont C, Canoui-Poitrine F. Effectiveness of Geriatric Assessment-Driven Interventions on Survival and Functional and Nutritional Status in Older Patients with Head and Neck Cancer: A Randomized Controlled Trial (EGeSOR). Cancers (Basel). 2022;14(13).
  41. Moreno ASuarez, Nguyen J-P, Calmelet A, Le Saout E, Damier P, de Decker L, Malineau C, Nizard J, Canoui-Poitrine F, Lefaucheur J-P. Multi-site rTMS with cognitive training improves apathy in the long term in Alzheimer's disease: A 4-year chart review. Clin Neurophysiol. 2022;137:75-83.
  42. Avrillon V, Daniel C, Boisselier P, Le Péchoux C, Chouaid C. Nationwide Real-Life Safety and Treatment Exposure Data on Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III, Locally Advanced, Non-small Cell Lung Cancer: Analysis of Patients Enrolled in the French Early Access Program. Lung. 2022;200(1):95-105.
  43. Belmin J, Lafuente-Lafuente C. [Not Available]. Geriatr Psychol Neuropsychiatr Vieil. 2022;20(1):5-7.
  44. Tuppin P, Lesuffleur T, Constantinou P, Atramont A, Coatsaliou C, Ferrat E, Canoui-Poitrine F, Debeugny G, Rachas A. Underuse of primary healthcare in France during the COVID-19 epidemic in 2020 according to individual characteristics: a national observational study. BMC Prim Care. 2022;23(1):200.
  45. Bencheikh L, Nguyen K-A, Chadebech P, Kiger L, Bodivit G, Jouard A, Pakdaman S, Adypagavane S, Audureau E, Tebbakha K, Bocquet T, Mignen B, Hebert N, Seguin M, Pirenne F, Sowemimo-Coker S, Dunham A, Bartolucci P. Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease. Haematologica. 2022;107(8):1944-1949.
  46. Boisteau E, Francois E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P, Ataz DLopez-Trab, Tougeron D, Dourthe L-M, Guimbaud R, Samalin E, Moreau M, Louvet C, Lepage C, Lièvre A. SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer. Dig Liver Dis. 2022;54(6):747-754.
  47. Labbe V, Contou D, Heming N, Megarbane B, Ait-Oufella H, Boissier F, Carreira S, Robert A, Vivier E, Fejjal M, Doyen D, Monchi M, Préau S, Noel-Savina E, Souweine B, Zucman N, Picos SAlberto, Dres M, Juguet W, Mariotte E, Timsit J-F, Turpin M, Razazi K, Gendreau S, Baloul S, Voiriot G, Fartoukh M, Audureau E, Dessap AMekontso. Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial. BMJ Open. 2022;12(4):e059383.
  48. Bouchez T, Gautier S, Le Breton J, Bourgueil Y, Ramond-Roquin A. The challenge for general practitioners to keep in touch with vulnerable patients during the COVID-19 lockdown: an observational study in France. BMC Prim Care. 2022;23(1):82.
  49. [Primary healthcare and COVID-19 in France: contributions of a research network including practitioners and researchers]. Sante Publique. 2022;Vol. 33(6):923-934.
  50. Oghina S, Delbarre MA, Poullot E, Belhadj K, Fanen P, Damy T. [Cardiac amyloidosis: State of art in 2022]. Rev Med Interne. 2022;43(9):537-544.
  51. C Quarta C, Fontana M, Damy T, Catini J, Simoneau D, Mercuri M, García-Pavía P, Maurer MS, Palladini G. Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. Front Cardiovasc Med. 2022;9:1073503.
  52. Sabouret P, Attias D, Beauvais C, Berthelot E, Bouleti C, G Genty G, Galat A, Hanon O, Hulot JS, Isnard R, Jourdain P, Lamblin N, Lebreton G, Lellouche N, Logeart D, Meune C, Pezel T, Damy T. Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance. Ann Cardiol Angeiol (Paris). 2022;71(1):41-52.
  53. Bourdon E, Havreng-Théry C, Lafuente C, Belmin J. Effect of the Physical Environment on Health and Well-Being of Nursing Homes Residents: A Scoping Review. J Am Med Dir Assoc. 2022;23(11):1826.e1-1826.e20.
  54. Hagege M, Ali-Hamadi A, Oddou S, Serhal R, Isocarma T, Klass M, Khettab M. Health, illness and cancer in Mayotte: Multicultural experiences in a medically underserved French Territory. Bull Cancer. 2022;109(2):241-245.
  55. Hagege M, Chirpaz E, Khettab M. Health, illness and cancer in Reunion Island: Health services in a diverse but aging French territory. Bull Cancer. 2022;109(2):226-231.
  56. Vincent Y-M, Frachon A, Allaire A, Boussageon R, Pouchain D, Ferrat E, Rat C. Development of a patient decision aid for COVID-19 vaccination with the Comirnaty vaccine. Fam Pract. 2022;39(3):486-492.
  57. Amélie A-E, Ruelle Y, Frèche B, Houllemare M, Bonillo A, Bouaziz L, Rat C, Gocko X, Cerisey C, Aubin-Auger I, Ferrat E. What do women and healthcare professionals expect of decision aids for breast cancer screening? A qualitative study in France. BMJ Open. 2022;12(3):e058879.
  58. Girerd N, Mewton N, Tartiere J-M, Guijarro D, Jourdain P, Damy T, Lamblin N, Bayes-Génis A, Pellicori P, Januzzi JL, Rossignol P, Roubille F. Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail. 2022;24(5):750-761.
  59. Miller EJ, Campisi R, Shah NR, McMahon S, Cuddy S, Gallegos-Kattan C, Maurer MS, Damy T, Slart RHJA, Bhatia K, Einstein AJ. Radiopharmaceutical supply disruptions and the use of Tc-hydroxymethylene diphosphonate as an alternative to Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement. J Nucl Cardiol. 2022;29(5):2748-2760.
  60. Bauër P, Leemans M, Audureau E, Gilbert C, Armal C, Fromantin I. Remote Medical Scent Detection of Cancer and Infectious Diseases With Dogs and Rats: A Systematic Review. Integr Cancer Ther. 2022;21:15347354221140516.
  61. Greillier L, Gauvrit M, Paillaud E, Girard N, Montégut C, Boulahssass R, Wislez M, Pamoukdjian F, Corre R, Cabart M, Caillet P, Belaroussi Y, Frasca M, Noize P, Wang P, Mebarki S, Mathoulin-Pelissier S, Couderc A-L. Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF). Cancers (Basel). 2022;14(3).
  62. Maurice C, Engels C, Canoui-Poitrine F, Lemogne C, Fromantin I, Poitrine E. Dog ownership and mental health among community-dwelling older adults: A systematic review. Int J Geriatr Psychiatry. 2022;37(11).
  63. Leemans M, Bauër P, Cuzuel V, Audureau E, Fromantin I. Volatile Organic Compounds Analysis as a Potential Novel Screening Tool for Breast Cancer: A Systematic Review. Biomark Insights. 2022;17:11772719221100709.
  64. Boussageon M, Swalduz A, Chouaid C, Bylicki O. First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data. BioDrugs. 2022;36(2):137-151.
  65. Juarez-Garcia A, Sharma R, Hunger M, Kayaniyil S, Penrod JR, Chouaid C. Real-world effectiveness of immunotherapies in pre-treated, advanced non-small cell lung cancer Patients: A systematic literature review. Lung Cancer. 2022;166:205-220.
  66. Griesinger F, Perol M, Girard N, Durand-Zaleski I, Zacharias S, Bosquet L, Jänicke M, Quantin X, Groth A, Fleitz A, Calleja A, Patel S, Lacoin L, Daumont MJ, Penrod JR, Carroll R, Waldenberger D, Reynaud D, Thomas M, Chouaid C. Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany. Lung Cancer. 2022;172:65-74.
  67. Grumberg V, Chouaid C, Cotté F-E, Jouaneton B, Jolivel R, Gaudin A-F, Reynaud D, Assié J-B, Borget I. Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France. J Med Econ. 2022;25(1):691-699.
  68. Guendouz S, Grimbert P, Radu C, Cherqui D, Salloum C, Mongardon N, Maghrebi S, Belhadj K, Le Bras F, Teiger E, Couetil J-P, Balan A, Kharoubi M, Bezard M, Oghina S, Bodez D, Hittinger L, Audard V, Planté-Bordeneuve V, de la Taille A, Bergoend E, Frenkel V, Fanen P, Leroy V, Duvoux C, Carmagnat M, Folliguet T, Damy T. Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis. Transplant Direct. 2022;8(7):e1323.
  69. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Sultan MB, Maurer MS. Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary. Future Cardiol. 2022;18(3):165-172.
  70. Minssen L, Dao THa, Quang AVo, Martin L, Andureau E, Luciani A, Meyblum E, Derumeaux G, Deux J-F. Breast arterial calcifications on mammography: a new marker of cardiovascular risk in asymptomatic middle age women?. Eur Radiol. 2022;32(7):4889-4897.
  71. Touma J, Couture T, Davaine J-M, de Boissieu P, Oubaya N, Michel C, Cochennec F, Chiche L, Desgranges P. Mycotic/Infective Native Aortic Aneurysms: Results After Preferential Use of Open Surgery and Arterial Allografts. Eur J Vasc Endovasc Surg. 2022;63(3):475-483.
  72. Lemercier P, de Langavant LCleret, Bagnou JHamet, Youssov K, Lemoine L, Audureau E, Massart R, Bachoud-Lévi A-C. Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington's Disease. J Pers Med. 2022;12(2).
  73. Grimaldi D, Legriel S, Pichon N, Colardelle P, Leblanc S, Canoui-Poitrine F, O Salem BHadj, Muller G, de Prost N, Herrmann S, Marque S, Baron A, Sauneuf B, Messika J, Dior M, Creteur J, Bedos JP, Boutin E, Cariou A. Ischemic injury of the upper gastrointestinal tract after out-of-hospital cardiac arrest: a prospective, multicenter study. Crit Care. 2022;26(1):59.
  74. Truong C, Recto C, Lafont C, Canoui-Poitrine F, Belmin JBelmin, Lafuente-Lafuente C. Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials. Neurology. 2022.
  75. Morel A, Ouamri Y, Canoui-Poitrine F, Mulé S, Champy CMaud, Ingels A, Audard V, Luciani A, Grimbert P, Matignon M, Pigneur F, Stehlé T. Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study. J Cachexia Sarcopenia Muscle. 2022;13(1):386-396.
  76. Sebti M, Petit-Hoang C, Chami B, Audureau E, Cordonnier-Jourdin C, Paul M, Pourcine F, Grimbert P, Ourghanlian C, Matignon M. ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation. Front Immunol. 2022;13:1045580.
  77. Beaudart C, Bonnefoy M, Gilbert T, Paillaud E, Raynaud-Simon A, Guerin O, Jeandel C, Le Sourd B, Haine M, Ferry M, Rolland Y, Berrut G, Reginster J-Y, Bruyère O. Quality of life and sarcopenic patients. Geriatr Psychol Neuropsychiatr Vieil. 2022.
  78. Dreyfus J, Audureau E, Bohbot Y, Coisne A, Lavie-Badie Y, Bouchery M, Flagiello M, Bazire B, Eggenspieler F, Viau F, Riant E, Mbaki Y, Eyharts D, Senage T, Modine T, Nicol M, Doguet F, Nguyen V, Le Tourneau T, Tribouilloy C, Donal E, Tomasi J, Habib G, Selton-Suty C, Raffoul R, Iung B, Obadia J-F, Messika-Zeitoun D. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J. 2022;43(7):654-662.
  79. Youssov K, Audureau E, Vandendriessche H, Morgado G, Layese R, Goizet C, Verny C, Bourhis M-L, Bachoud-Lévi A-C. The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs. Parkinsonism Relat Disord. 2022;103:77-84.
  80. Hanon O, Vidal J-S, Lehmann S, Bombois S, Allinquant B, Baret-Rose C, Tréluyer J-M, Abdoul H, Gelé P, Delmaire C, Blanc F, Mangin J-F, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P, Godefroy O, Camus V, Belmin J, Vandel P, Novella J-L, Duron E, Rigaud A-S, Schraen-Maschke S, Gabelle A. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study. Alzheimers Dement. 2022;18(12):2537-2550.
  81. Canoui-Poitrine F, Segaux L, Benderra M-A, About F, Tournigand C, Laurent M, Caillet P, Audureau E, Ferrat E, Lagrange J-L, Paillaud E, Bastuji-Garin S. The Prognostic Value of Eight Comorbidity Indices in Older Patients with Cancer: The ELCAPA Cohort Study. Cancers (Basel). 2022;14(9).
  82. Baptista BRibeiro, d'Humières T, Schlemmer F, Bendib I, Justeau G, Al-Assaad L, Hachem M, Codiat R, Bardel B, Chakra LAbou, Belmondo T, Audureau E, Hue S, Mekontso-Dessap A, Derumeaux G, Boyer L. Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort. Respir Res. 2022;23(1):68.
  83. Lidou-Renault V, Baudouin É, Courtois-Amiot P, Bianco C, Esnault H, Rouet A, Baque M, Toméo C, Rainone A, Thietart S, Veber R, Ayache C, Pépin M, Lafuente-Lafuente C, Duron E, Cailleaux P-E, Haguenauer D, Lemarié N, Paillaud E, Raynaud-Simon A, Thomas C, Boddaert J, Zerah L, Vallet H. Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study. J Gerontol A Biol Sci Med Sci. 2022;77(7):1352-1360.
  84. Oubaya N, Pombet T, Delestrain C, Remus N, Douvry B, Grenet D, Corvol H, Thouvenin G, Prulière-Escabasse V, Mounir H, Argoud D, Fretigne C, Costes L, Mackiewicz M-P, Jung C, Ahamada L, Lanone S, Maitre B, Bégot A-C, Epaud R. Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN). Front Public Health. 2022;10:978627.
  85. Canoui-Poitrine F, Martinez-Tapia C, Paillaud E, Mathoulin-Pelissier S, Pamoukdjian F, Frasca M, Tolppanen A-M, Bringuier M, Brain E, Broussier A, Bastuji-Garin S, Laurent M, Audureau E. Geriatric impairments were directly and indirectly associated with mortality in older patients with cancer: a structural equation analysis. J Clin Epidemiol. 2022;148:17-26.
  86. Excoffier J-B, Salaün-Penquer N, Ortala M, Raphaël-Rousseau M, Chouaid C, Jung C. Analysis of COVID-19 inpatients in France during first lockdown of 2020 using explainability methods. Med Biol Eng Comput. 2022;60(6):1647-1658.
  87. Jakubowicz D, Dariane C, Correas J-M, Audenet F, Caillet P, Méjean A, Timsit M-O. Disease Progression in Older Patients With Renal Tumor Assigned to an Active Surveillance Protocol. Clin Genitourin Cancer. 2022;20(1):e53-e60.
  88. Poucineau J, Delory T, Lapidus N, Hejblum G, Chouaid C, Le Cœur S, Khlat M. Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France. Front Med (Lausanne). 2022;9:995016.
  89. Conti C, Pamoukdjian F, Aparicio T, Mebarki S, Poisson J, Manceau G, Taieb J, Rance B, Katsahian S, Charles-Nelson A, Paillaud E. Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database. Cancers (Basel). 2022;14(5).
  90. Chouaid C, Grumberg V, Batisse A, Corre R, Levra MGiaj, Gaudin A-F, Prodel M, Lortet-Tieulent J, Assié J-B, Cotté F-E. Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab. JCO Clin Cancer Inform. 2022;6:e2100108.
  91. Chouaid C, Thomas M, Debieuvre D, Durand-Zaleski I, Zacharias S, Bosquet L, Groth A, Fleitz A, Calleja A, Patel S, Lacoin L, Daumont MJ, Penrod JR, Carroll R, Waldenberger D, Cotté F-E, Audigier-Valette C, Griesinger F. Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts. Cancers (Basel). 2022;14(24).
  92. Lafuente-Lafuente C, Rainone A, Guerin O, Drunat O, Jeandel C, Hanon O, Belmin J. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents. Gerontology. 2022;68(12):1384-1392.
  93. Paillaud E, Hamaker ME, Soubeyran P. Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer. Cancers (Basel). 2022;14(17).
  94. Seknazi L, Jamelot M, Canoui-Poitrine F, Gligorov J, Benderra M-A. COVID-19 mortality: are comorbidities, socio-economic status and ethnicity more important than cancer?. Ann Transl Med. 2022;10(24):1302.
  95. Damy T, Zaroui A, Oghina S. The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response. Eur Heart J. 2022;43(45):4736-4738.
  96. Martinez-Tapia C, Laurent M, Paillaud E, Caillet P, Ferrat E, Lagrange J-L, Rwabihama J-P, Allain M, Chahwakilian A, Boudou-Rouquette P, Bastuji-Garin S, Audureau E. Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions-ELCAPA Cohort. Cancers (Basel). 2022;14(1).

2021

  1. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart FailEur J Heart FailEur J Heart Fail. 2021;23:512-526.
  2. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart JEur Heart JEur Heart J. 2021;42:1554-1568.
  3. Abdellatif A, Bouaud J, Lafuente-Lafuente C, Belmin J, Séroussi B. Computerized Decision Support Systems for Nursing Homes: A Scoping Review. J Am Med Dir Assoc. 2021;22(5):984-994.
  4. Elena P, Demetris S, Christina M, Marios P. Differences Between Exergaming Rehabilitation and Conventional Physiotherapy on Quality of Life in Parkinson's Disease: A Systematic Review and Meta-Analysis. Front Neurol. 2021;12:683385.
  5. Lebreton C, Cantarel C, Toulza E, Desgrippes R, Bozec L, Saada E, Ducoulombier A, Tardy M, Paillaud E, Lalet C, Bellera C, Italiano A. Incidence and prognostic factors of clinically meaningful toxicities of kinase inhibitors in older patients with cancer: The PreToxE study. J Geriatr Oncol. 2021;12(4):668-671.
  6. Damy T, Sultan MB, Witteles R. Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'. Eur J Heart Fail. 2021;23(6):1057-1058.
  7. Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment. Leuk Lymphoma. 2021;62(4):979-983.
  8. Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F. Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis. Br J Haematol. 2021;193(3):674-677.
  9. Moulin T, Landes R, Ouazana V, Abehsira G, Lim P, Huguet R, Damy T, Teiger E, Lellouche N, Hamon D. Severe Heart Failure Associated With Tachycardia-Induced Cardiomyopathy Due to Incessant Atrioventricular Re-Entrant Tachycardia. JACC Case Rep. 2021;3(3):479-483.
  10. Poullot E, Oghina S, Kalsoum S, Damy T. [Cardiac amyloidosis]. Ann Pathol. 2021;41(1):25-37.
  11. Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT. JACC Heart Fail. 2021;9(2):115-123.
  12. Roncalli J, Roubille F, Lamblin N, Girerd N, Mouquet F, Chapet N, Roubille C, Berthelot E, Galois K, Battistella P, Jondeau G, Tartiere J-M, Aguilhon S, Gueffet J-P, Salvat M, Damy T, Galinier M. Coronavirus disease vaccination in heart failure: No time to waste. Arch Cardiovasc Dis. 2021;114(5):434-438.
  13. Scotte F, Simon H, Laplaige P, Antoine E-C, Spasojevic C, Texier N, Gouhier K, Chouaid C. Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment. BMJ Support Palliat Care. 2021.
  14. Secretan P-H, Thirion O, Yayé HSadou, Damy T, Astier A, Paul M, Do B. Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations. Pharmaceuticals (Basel). 2021;14(12).
  15. Nicol M, Deney A, Lairez O, Vergaro G, Emdin M, Carecci A, Inamo J, Montfort A, Neviere R, Damy T, Harel S, Royer B, Baudet M, Cohen-Solal A, Arnulf B, Logeart D. Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis. Eur J Heart Fail. 2021;23(2):231-239.
  16. Oghina S, Bougouin W, Kharoubi M, Bonnefous L, Galat A, Guendouz S, Bezard M, Le Bras F, Deux J-F, Itti E, Moktefi A, Fanen P, Teiger E, Mohty D, Damy T, Bodez D. Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation. J Clin Med. 2021;10(21).
  17. Oghina S, Josse C, Bezard M, Kharoubi M, Delbarre M-A, Eyharts D, Zaroui A, Guendouz S, Galat A, Hittinger L, Fanen P, Teiger E, Mouri N, Montestruc F, Damy T. Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment. J Clin Med. 2021;10(21).
  18. Martel-Lafay I, Monnet I, Lardy-Cleaud A, Danhier S, Salem N, Gallocher O, Fournel P, Chouaid C, Bylicki O. Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14). Curr Oncol. 2021;28(5):3804-3811.
  19. Matrat M, Gain M, Haioun C, Le Bras F, Nisse C, Morschhauser F, Clin B, Baldi I, Verdun-Esquer C, Garnier R, Laborde-Castérot H, Hérin F, Esquirol Y, Andujar P, Belacel M, Chouaid C, Chauvet C, Lasfargues G, Pairon J-C. Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study. Int J Environ Res Public Health. 2021;18(8).
  20. Michalon A, Hagenbuch A, Huy C, Varela E, Combaluzier B, Damy T, Suhr OB, Saraiva MJ, Hock C, Nitsch RM. A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells. Nat Commun. 2021;12(1):3142.
  21. Monnet I, Vergnenègre A, Robinet G, Bérard H, Lamy R, Falchero L, Vieillot S, Schott R, Ricordel C, Chouabe S, Thomas P, Gervais R, Madroszyk A, Abdiche S, Chiappa AMarie, Greillier L, Decroisette C, Auliac JBernard, Chouaid C. Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis. Ther Adv Med Oncol. 2021;13:17588359211006983.
  22. Kharoubi M, Bezard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur J-P, Abulizi M, Deux J-F, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Béquignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis. ESC Heart Fail. 2021;8(6):5501-5512.
  23. Lamy T, Cabarrou B, Planchard D, Quantin X, Schneider S, Bringuier M, Besse B, Girard N, Chouaid C, Filleron T, Simon G, Baldini C. Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience. Cancers (Basel). 2021;14(1).
  24. Girard N, Perol M, Simon G, Valette CAudigier, Gervais R, Debieuvre D, Schott R, Quantin X, Coudert B, Lena H, Carton M, Robain M, Filleron T, Chouaid C. Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort. Lung Cancer. 2021;162:119-127.
  25. Gounant V, Duruisseaux M, Soussi G, Van Hulst S, Bylicki O, Cadranel J, Wislez M, Trédaniel J, Spano J-P, Helissey C, Chouaid C, Molinier O, Dhalluin X, Doucet L, Hureaux J, Cazes A, Zalcman G. Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients. Cancers (Basel). 2021;13(5).
  26. Damy T, García-Pavía P, Hanna M, Judge DP, Merlini G, Gundapaneni B, Patterson TA, Riley S, Schwartz JH, Sultan MB, Witteles R. Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study. Eur J Heart Fail. 2021;23(2):277-285.
  27. Bezard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T. Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement. PLoS One. 2021;16(9):e0257189.
  28. Brannagan TH, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL. ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis. 2021;16(1):204.
  29. Auliac J-B, Monnet I, Bizieux A, Greillier L, Geier M, Falchero L, Le Garff G, Lamy R, Guisier F, Ricordel C, Chouaid C, Vergnenègre A. Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study). Lung Cancer. 2021;161:122-127.
  30. Beauvais F, Tartière L, Pezel T, Motet C, Aumont M-C, Baudry G, Eicher J-C, Galinier M, Gellen B, Guihaire J, Legallois D, Lequeux B, Mika D, Mouquet F, Salvat M, Taieb C, Zores F, Berthelot E, Damy T. First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology. Clin Cardiol. 2021;44(8):1144-1150.
  31. Belmin J, Georges S, Franke F, Daniau C, Cochet A, Durand C, Noury U, Santo MEugênia G, Fonteneau L, Pariel S, Lafuente-Lafuente C, Danis K. Coronavirus Disease 2019 in French Residential Care Facilities: A Nationwide Study. J Am Med Dir Assoc. 2021;22(6):1142-1145.
  32. Berthelot E, Flécher E, Roubille F, Damy T, Lamblin N. [Impact de la pandémie de COVID-19 sur la charge des patients atteints d'insuffisance cardiaque chronique en France]. Ann Cardiol Angeiol (Paris). 2021;70(4):191-195.
  33. Abulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Israël J-M, Emsen B, Bodez D, Monnet A, Didierlaurent D, Tacher V, Luciani A, Damy T, Deux J-F, Itti E. F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol. 2021;28(4):1586-1595.
  34. Bonnefous L, Kharoubi M, Bezard M, Oghina S, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Deux J-F, Audard V, Itti E, Damy T, Audureau E. Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis. J Am Coll Cardiol. 2021;78(22):2177-2192.
  35. Hanon O, Vidal J-S, Pisica-Donose G, Orvoën G, David J-P, Chaussade E, Caillard L, de Jong LW, Boulloche N, Vinsonneau U, Bouée S, Krolak-Salmon P, Fauchier L, Jouanny P, Sacco G, Bellarbre F, Belmin J, Puisieux F, Lilamand M, Paillaud E, Boureau ASophie. Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation. Heart. 2021;107(17):1376-1382.
  36. Belmin J, Lafuente-Lafuente C. The challenge of asymptomatic SARS-CoV-2 transmission in care homes. Lancet Reg Health Eur. 2021;3:100051.
  37. Belmin J, Din NUm, Pariel S, Lafuente-Lafuente C. [How staff members of 17 French nursing homes protected their residents from Covid-19]. Geriatr Psychol Neuropsychiatr Vieil. 2021;19(3):243-244.
  38. Serrano AGonzález, Tapia CMartínez, de la Taille A, Mongiat-Artus P, Irani J, Bex A, Paillaud E, Audureau E, Barnay T, Laurent M, Canoui-Poitrine F. Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study. Cancers (Basel). 2021;13(18).
  39. Ganne-Carrié N, Nahon P, Chaffaut C, N'Kontchou G, Layese R, Audureau E, Chevret S. Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance. JHEP Rep. 2021;3(3):100285.
  40. Oghina S, Bougouin W, Bezard M, Kharoubi M, Komajda M, Cohen-Solal A, Mebazaa A, Damy T, Bodez D. The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. JACC Heart Fail. 2021;9(3):169-178.
  41. Khettab M, Hagege M, Ah-Pine F, Zunic P, Kassir R, Bay J-O. [Oncology in French overseas territories]. Bull Cancer. 2021;108(12):1067-1068.
  42. Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, Lamblin N, Gueffet J-P, Damy T, Galinier M, Tartiere J-M, Janssen C, Berthelot E, Aguilhon S, Escamilla R, Roubille F. Vaccination for Respiratory Infections in Patients with Heart Failure. J Clin Med. 2021;10(19).
  43. Goussault H, Gendarme S, Assié JBaptiste, Bylicki O, Chouaid C. Factors associated with early lung cancer mortality: a systematic review. Expert Rev Anticancer Ther. 2021;21(10):1125-1133.
  44. Gendarme S, Goussault H, Assié J-B, Taleb C, Chouaid C, Landre T. Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis. Cancers (Basel). 2021;13(7).
  45. Granier C, Gey A, Roncelin S, Weiss L, Paillaud E, Tartour E. Immunotherapy in older patients with cancer. Biomed J. 2021;44(3):260-271.
  46. Vergnenègre A, Chouaid C. Economic analyses of immune-checkpoint inhibitors to treat lung cancer. Expert Rev Pharmacoecon Outcomes Res. 2021;21(3):365-371.
  47. Adam RDaniel, Coriu D, Jercan A, Bădeliţă S, Popescu BA, Damy T, Jurcuţ R. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Fail. 2021;8(4):2380-2396.
  48. Damy T, Chouihed T, Delarche N, Berrut G, Cacoub P, Henry P, Lamblin N, Andrès E, Hanon O. Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper. J Clin Med. 2021;10(16).
  49. Damy T, Conceição I, García-Pavía P, Gillmore J, Jandhyala R, Sabbat J, Wixner J, Coelho T. A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosis. Amyloid. 2021;28(3):189-198.
  50. García-Pavía P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, Nativi-Nicolau J, Obici L, Rapezzi C, Sekijima Y, Elliott PM. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2021;23(6):895-905.
  51. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). Am J Cardiol. 2021;141:98-105.
  52. Geiss R, Sebaste L, Valter R, Poisson J, Mebarki S, Conti C, Vordos D, Bringuier M, Méjean A, Mongiat-Artus P, Cudennec T, Canoui-Poitrine F, Caillet P, Paillaud E. Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study. Cancers (Basel). 2021;13(23).
  53. Wind P, Thomas ZAp, Laurent M, Aparicio T, Siebert M, Audureau E, Paillaud E, Bousquet G, Pamoukdjian F. The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers (Basel). 2021;14(1).
  54. Gamé X, Piollet-Calmette I, Descazeaud A, Hermieu J-F, Fatton B, Paillaud E, Bellessort A, Coloby P. [Mirror survey of patients with urge urinary incontinence and healthcare professionals]. Prog Urol. 2021;31(12):747-754.
  55. Beaudart C, Bonnefoy M, Gilbert T, Paillaud E, Raynaud-Simon A, Guerin O, Jeandel C, Le Sourd B, Haine M, Ferry M, Rolland Y, Berrut G, Reginster J-Y, Bruyère O. [Which quality of life for the sarcopenic patient?]. Geriatr Psychol Neuropsychiatr Vieil. 2021;19(3):245-252.
  56. Burgassi F, Paillaud E, Poisson J, Bousquet G, Pamoukdjian F. Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer. Cancers (Basel). 2021;13(22).
  57. Benderra M-A, Aparicio A, Leblanc J, Wassermann D, Kempf E, Galula G, Bernaux M, Canellas A, Moreau T, Bellamine A, Spano J-P, Daniel C, Champ J, Canoui-Poitrine F, Gligorov J. Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study. Cancers (Basel). 2021;13(19).
  58. Oubaya N, Soubeyran P, Reinald N, Fonck M, Allain M, Zebachi S, Heitz D, Laurent M, Delattre C, Caillet P, Dauba J, Bastuji-Garin S, Albrand G, Bringuier M, Rainfray M, Brain E, Grellety T, Paillaud E, Mathoulin-Pelissier S, Bellera C, Canoui-Poitrine F. Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts. Cancers (Basel). 2021;13(24).
  59. Burugorri-Pierre C, Lafuente-Lafuente C, Oasi C, Lecorche E, Pariel S, Donadio C, Belmin J. Investigation of an Outbreak of COVID-19 in a French Nursing Home With Most Residents Vaccinated. JAMA Netw Open. 2021;4(9):e2125294.
  60. Descourt R, Chouaid C, Perol M, Besse B, Greillier L, Bylicki O, Ricordel C, Guisier F, Gervais R, Schott R, Auliac J-B, Robinet G, Decroisette C. First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50. Future Oncol. 2021;17(23):3007-3016.
  61. de Climens FRoborel, Chouaid C, Poulet C, Leroy V, Stoven L, Cortot ABenjamin, Dhalluin X, Gauvain C. Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC. JTO Clin Res Rep. 2021;2(5):100147.
  62. Seban R-D, Assié J-B, Giroux-Leprieur E, Massiani M-A, Bonardel G, Chouaid C, Deleval N, Richard C, Mezquita L, Girard N, Champion L. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer. 2021;159:45-55.
  63. Chouaid C, Filleron T, Debieuvre D, Perol M, Girard N, Dansin E, Lena H, Gervais R, Cousin S, Otto J, Schott R, Planchard D, Madroszyk A, Kaderbhai C, Dubray-Longeras P, Hiret S, Pichon E, Clément-Duchêne C, Chenuc G, Simon G, Bosquet L, Quantin X. A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes. Target Oncol. 2021;16(6):801-811.
  64. Lafuente-Lafuente C, Nghiem QDuy, Keravec H, Oukbir-Ferrag S, Magri M, Oquendo B, Donadio C, Rainone A, Belmin J. Chronology of COVID-19 Symptoms in Very Old Patients: Study of a Hospital Outbreak. J Clin Med. 2021;10(13).
  65. Rollot-Trad F, Chéron M, Bonhomme S, Fromantin I, Engels C. [Needs and feelings of caregivers in oncogeriatrics, usefulness of a serious game]. Soins Gerontol. 2021;26(152):31-36.
  66. Teiger E, Thambo J-B, Defaye P, Hermida J-S, Abbey S, Klug D, Juliard J-M, Spaulding C, Armero S, Champagnac D, Bhugaloo H, Ternacle J, Lellouche N, Audureau E, Le Corvoisier P. Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry. Catheter Cardiovasc Interv. 2021;98(4):788-799.
  67. Nahon P, Layese R, Cagnot C, Asselah T, Guyader D, Pol S, Pageaux G-P, De Lédinghen V, Ouzan D, Zoulim F, Audureau E. HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management. Cancer Prev Res (Phila). 2021;14(5):581-592.
  68. Salmon-Céron D, Slama D, De Broucker T, Karmochkine M, Pavie J, Sorbets E, Etienne N, Batisse D, Spiridon G, Le Baut V, Meritet J-F, Pichard E, Canoui-Poitrine F. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study. J Infect. 2021;82(2):e1-e4.
  69. d'Humières T, Savale L, Inamo J, Deux J-F, Deswarte S, Lionnet F, Loko G, Chantalat C, Damy T, Guillet H, d'Orengiani ALaure Pham, Galactéros F, Audureau E, Maitre B, Humbert M, Derumeaux G, Bartolucci P. Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography-based cluster analysis. Am J Hematol. 2021;96(9):1166-1175.
  70. Deux J-F, Nouri R, Tacher V, Zaroui A, Derbel H, Sifaoui I, Chevance V, Ridouani F, Galat A, Kharoubi M, Oghina S, Guendouz S, Audureau E, Teiger E, Kobeiter H, Damy T. Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac Amyloidosis. Radiology. 2021;300(2):326-335.
  71. Kempf E, Lamé G, Layese R, Priou S, Chatellier G, Chaieb H, Benderra M-A, Bellamine A, Bey R, Bréant S, Galula G, Taright N, Tannier X, Guyet T, Salamanca E, Audureau E, Daniel C, Tournigand C. New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown. Eur J Cancer. 2021;150:260-267.
  72. Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault J-C, Nahon P, Audureau E, Ratziu V, Castera L, Pagan J-CGarcia, Ganne-Carrié N, Rautou P-E. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. Hepatology. 2021;74(1):364-378.
  73. Benjdir M, Audureau E, Beresniak A, Coll P, Epaud R, Fiedler K, Jacquemin B, Niddam L, Pandis SN, Pohlmann G, Sandanger TM, Simmons K, Sørensen M, Wagner P, Lanone S. Assessing the impact of exposome on the course of chronic obstructive pulmonary disease and cystc fibrosis: The REMEDIA European Project Approach. Environ Epidemiol. 2021;5(4):e165.
  74. Pezel T, Audureau E, Mansourati J, Baudry G, Ben Driss A, Durup F, Fertin M, Godreuil C, Jeanneteau J, Kloeckner M, Koukoui F, Kesri-Tartière L, Laperche T, Roubille F, Cohen-Solal A, Damy T. Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group. ESC Heart Fail. 2021;8(2):1509-1521.
  75. Fourati S, Langendorf C, Audureau E, Challine D, Michel J, Soulier A, Ahnou N, Désveaux I, Picard O, Ortonne V, Gourgeon A, Mills C, Hemery F, Rieux C, Pawlotsky J-M, Malou N, Chevaliez S. Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use. J Clin Virol. 2021;142:104930.
  76. Runyo F, Matignon M, Audureau E, Vindrios W, Boueilh A, Gomart C, Grimbert P, Gallien S, Melica G. Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study. Transpl Infect Dis. 2021;23(4):e13607.
  77. Afach S, Evrenoglou T, Oubaya N, Le Cleach L, Sbidian E. Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments. J Clin Epidemiol. 2021;133:72-79.
  78. Schlemmer F, Zysman M, Baptista BRibeiro, Audureau E, Noroc ACovali, Ridoux A, Derumeaux G, Adnot S, Maitre B, Le Corvoisier P, Lanone S, Boczkowski J, Boyer L. Beclin-1 increases with obstructive sleep apnea severity. Sleep Med. 2021;81:474-476.
  79. Verliere A, Clariot S, Pascual-Jouani C, Audureau E, Langeron O, Levesque E. Outcome of asymptomatic patients with positive SARS-CoV-2 viral RNA reverse transcriptase-PCR undergoing surgery: A matched cohort study. Eur J Anaesthesiol. 2021;38(4):442-444.
  80. Ghosn M, Derbel H, Kharrat R, Oubaya N, Mulé S, Chalaye J, Regnault H, Amaddeo G, Itti E, Luciani A, Kobeiter H, Tacher V. Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Diagn Interv Imaging. 2021;102(1):35-44.
  81. Pezel T, Bernard A, Badie YLavie, Dreyfus J, Audureau E, Bohbot Y, Fard D, Hubert A, Nguyen LS, Monteil C, Bière L, Le Ven F, Canu M, Ribeyrolles S, Mion B, Mouhat B, Bazire B, Fauvel C, Ternacle J, Cautela J, Cambet T, Le Tourneau T, Donal E, Lafitte S, Mansencal N, Coisne A. Rational and Design of the SIMULATOR Study: A Multicentre Randomized Study to Assess the Impact of SIMULation-bAsed Training on Transoesophageal echocardiOgraphy leaRning for Cardiology Residents. Front Cardiovasc Med. 2021;8:661355.
  82. Lunven M, Bagnou JHamet, Youssov K, Gabadinho A, Fliss R, Montillot J, Audureau E, Bapst B, Morgado G, Reilmann R, Schubert R, Busse M, Craufurd D, Massart R, Rosser A, Bachoud-Lévi A-C. Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT). PLoS One. 2021;16(8):e0253064.
  83. Schlemmer F, Hamzaoui A, Zebachi S, Le Thuaut A, Mangiapan G, Monnet I, Boudjema A, Jabot L, Housset B, Bastuji-Garin S, Bassinet L, Maitre B. Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic Fibrosis. J Clin Med. 2021;10(16).
  84. Broussier A, David JPhilippe, Kharoubi M, Oghina S, Segaux L, Teiger E, Laurent M, Fromantin I, Bastuji-Garin S, Damy T. Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg. J Clin Med. 2021;10(15).
  85. Segaux L, Broussier A, Oubaya N, Leissing-Desprez C, Laurent M, Naga H, Fromantin I, David J-P, Bastuji-Garin S. Several frailty parameters highly prevalent in middle age (50-65) are independent predictors of adverse events. Sci Rep. 2021;11(1):8774.
  86. Ferrat E, Fabre J, Galletout P, Boutin E, Le Breton J, Renard V, Frappé P, Bastuji-Garin S. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care. Br J Gen Pract. 2021;71(703):e134-e139.
  87. Nicodème M, Chéron M, Labedade É, Fromantin I, Lefort H. [Management of patients with haemorrhage malignant wounds]. Rev Infirm. 2021;70(273):27-30.
  88. Nicodème M, Dureau S, Chéron M, Kriegel I, Trenchand M, Bauër P, Fromantin I. Frequency and Management of Hemorrhagic Malignant Wounds: A Retrospective, Single-Center, Observational Study. J Pain Symptom Manage. 2021;62(1):134-140.
  89. Rodriguez C, de Prost N, Fourati S, Lamoureux C, Gricourt G, N'debi M, Canoui-Poitrine F, Désveaux I, Picard O, Demontant V, Trawinski E, Lepeule R, Surgers L, Vindrios W, Lelièvre J-D, Mongardon N, Langeron O, Cohen JL, Mekontso-Dessap A, Woerther P-L, Pawlotsky J-M. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19. PLoS Pathog. 2021;17(3):e1009416.
  90. de'Angelis N, Baldini C, Brustia R, Pessaux P, Sommacale D, Laurent A, Le Roy B, Tacher V, Kobeiter H, Luciani A, Paillaud E, Aparicio T, Canoui-Poitrine F, Liuu E. Correction: Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis. PLoS One. 2021;16(4):e0251005.
  91. Contou D, Colin G, Travert B, Jochmans S, Conrad M, Lascarrou J-B, Painvin B, Ferré A, Schnell D, La Combe B, Coudroy R, Ehrmann S, Rambaud J, Wiedemann A, Asfar P, Kalfon P, Guérot E, Préau S, Argaud L, Daviet F, Dellamonica J, Dupont A, Fartoukh M, Kamel T, Béduneau G, Canoui-Poitrine F, Boutin E, Lina G, Dessap AMekontso, Tristant A, de Prost N. Menstrual toxic shock syndrome: a French nationwide multicenter retrospective study. Clin Infect Dis. 2021.
  92. Canoui-Poitrine F, Rachas A, Thomas M, Carcaillon-Bentata L, Fontaine R, Gavazzi G, Laurent M, Robine J-M. Magnitude, change over time, demographic characteristics and geographic distribution of excess deaths among nursing home residents during the first wave of COVID-19 in France: a nationwide cohort study. Age Ageing. 2021;50(5):1473-1481.
  93. Boudhabhay I, Boutin E, Bartolucci P, Bornes M-I, Habibi A, Lionnet F, Hertig A, Grimbert P, Stehlé T, Karoui KEl, Sahali D, Fois E, Remy P, Galactéros F, Haddad B, Canoui-Poitrine F, Lecarpentier E, Audard V. Impact of pre-eclampsia on renal outcome in sickle cell disease patients. Br J Haematol. 2021;194(6):1053-1062.
  94. Urbina T, Canoui-Poitrine F, Hua C, Layese R, Alves A, Ouedraogo R, Bosc R, Sbidian E, Chosidow O, Dessap AMekontso, de Prost N. Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study. Ann Intensive Care. 2021;11(1):102.
  95. Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc A-L, Boulahssass R, Liuu E, Boudou-Rouquette P, Wakilian AChah, Gaxatte C, Pamoukdjian F, de Decker L, Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PAndré, Canoui-Poitrine F, Laurent M, Paillaud E. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021;12(6):1477-1488.
  96. Kharoubi M, Roche F, Bezard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur J-P, Damy T. Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis. ESC Heart Fail. 2021;8(2):1656-1665.
  97. Mézière A, Oubaya N, Michel-Pellegrino V, Boudin B, Neau M, Robert H, Cara I, Sanchez LSalgado, Baloul S, Piette F, Pautas É, Picou Y, Curtis V, Schonheit C, Canoui-Poitrine F, Moreau C. Exercise Interventions With Trained Home Helpers for Preventing Loss of Autonomy and Falls in Community-Dwelling Older Adults Receiving Home Heath Physical Therapy T4H: A Randomized Controlled Pilot Study. J Geriatr Phys Ther. 2021;44(3):E138-E149.
  98. Lafont C, Wakilian AChah, Lemogne C, Gouraud C, Fossey-Diaz V, Orvoën G, Lhuillier N, Paillaud E, Bastuji-Garin S, Zebachi S, Hanon O, Goldwasser F, Boudou-Rouquette P, Canoui-Poitrine F. Diagnostic Performance of the 4-Item Geriatric Depression Scale for Depression Screening in Older Patients with Cancer: The ELCAPA Cohort Study. Oncologist. 2021;26(6):e983-e991.
  99. Zerah L, Baudouin É, Pépin M, Mary M, Krypciak S, Bianco C, Roux S, Gross A, Toméo C, Lemarié N, Dureau A, Bastiani S, Ketz F, Boully C, de Villelongue C, Romdhani M, Desoutter M-A, Duron E, David J-P, Thomas C, Paillaud E, de Malglaive P, Bouvard E, Lacrampe M, Mercadier E, Monti A, Hanon O, Fossey-Diaz V, Bourdonnec L, Riou B, Vallet H, Boddaert J. Clinical Characteristics and Outcomes of 821 Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards. J Gerontol A Biol Sci Med Sci. 2021;76(3):e4-e12.
  100. Berthelot E, Broussier A, Damy T, Donadio C, Cosson S, Rovani X, Salengro E, Billebeau G, Megbemado R, Rekik N, Godreuil C, Richard K, Shourick J, Assayag P, Belmin J, David JPhilippe, Hittinger L. Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experience. BMC Geriatr. 2021;21(1):288.
  101. Hagege M, Canoui-Poitrine F, Derbez B. Including older patients in cancer trials: A qualitative study of collaboration between geriatricians and oncologists. J Geriatr Oncol. 2021;12(6):945-951.
  102. Engels C, Bairet R, Canoui-Poitrine F, Laurent M. Leisure and Productivity in Older Adults with Cancer: A Systematic Review. Occup Ther Int. 2021;2021:8886193.
  103. Bezard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur J-P, Abulizi M, Deux J-F, Gendre T, Audard V, Karoui KEl, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T. Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis. Eur J Heart Fail. 2021;23(2):264-274.
  104. Mahévas M, Azzaoui I, Crickx E, Canoui-Poitrine F, Gobert D, Languille L, Limal N, Guillaud C, Croisille L, Jeljeli M, Batteux F, Baloul S, Fain O, Pirenne F, Weill J-C, Reynaud C-A, Godeau B, Michel M. Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial. Haematologica. 2021;106(9):2449-2457.
  105. Bylicki O, Rivière F, Tournier C, Canoui-Poitrine F, Grassin F, Margery J, Prodel M, Vainchtock A, Assié J-B, Chouaid C. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care. Clin Lung Cancer. 2021;22(3):e320-e328.
  106. Jourdi G, Lobies S, Kosmider O, Duchemin J, Audureau E, Conard J, Mazoyer E, Horellou M-H, Gouin-Thibault I, Flaujac C, Fontenay M. Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases. Thromb Haemost. 2021;121(2):246-249.
  107. Oniszczuk J, Beldi-Ferchiou A, Audureau E, Azzaoui I, Molinier-Frenkel V, Frontera V, Karras A, Moktefi A, Pillebout E, Zaidan M, Karoui KEl, Delfau-Larue M-H, Hénique C, Ollero M, Sahali D, Mahévas M, Audard V. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults. Nephrol Dial Transplant. 2021;36(4):609-617.
  108. Hamon D, Courty B, Leenhardt A, Lim P, Elbaz N, Rouffiac S, Varlet E, Algalarrondo V, Messali A, Audureau E, Extramiana F, Lellouche N. Predictive value of premature atrial complex characteristics in pulmonary vein isolation for patients with paroxysmal atrial fibrillation. Arch Cardiovasc Dis. 2021;114(2):122-131.
  109. Pezel T, Berthelot E, Gauthier J, Chong-Nguyen C, Iliou MC, Juillière Y, Galinier MC, De Groote P, Beauvais F, Bauer F, Vergeylen U, Gellen B, Raphael P, Bezard M, Ricci J-E, Boiteux M-C, Bonnefous L, Bodez D, Audureau E, Damy T. Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study). Arch Cardiovasc Dis. 2021;114(1):51-58.
  110. Derbez B, Z Haffaf E, Galactéros F, de Montgolfier S. [Prevention of genetic diseases : the return of the family practitioner ?]. Rev Epidemiol Sante Publique. 2021;69(1):30-38.

2020

  1. Gertz M, Adams D, Ando Y, Beirão JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam PractBMC Fam PractBMC Fam Pract. 2020;21:198.
  2. Heliö T, Elliott P, Koskenvuo JW, Gimeno JR, Tavazzi L, Tendera M, Kaski JP, Mansencal N, Bilińska Z, Carr-White G, Damy T, Frustaci A, Kindermann I, Ripoll-Vera T, Čelutkienė J, Axelsson A, Lorenzini M, Saad A, Maggioni AP, Laroche C, Caforio ALP, Charron P. ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients. ESC Heart FailESC Heart FailESC Heart Fail. 2020;7:3013-3021.
  3. Mottet N, Ribal MJ, Boyle H, De Santis M, Caillet P, Choudhury A, Garg T, Nielsen M, Wüthrich P, Gust KM, Shariat SF, Gakis G. Management of bladder cancer in older patients: Position paper of a SIOG Task Force. J Geriatr OncolJ Geriatr OncolJ Geriatr Oncol. 2020;11:1043-1053.
  4. Abdellatif A, Bouaud J, Nghiem D, Lafuente-Lafuente C, Belmin J, Séroussi B. Clinical Decision Support Systems in Nursing Homes: A Scoping Review. Stud Health Technol Inform. 2020;270:542-546.
  5. de'Angelis N, Baldini C, Brustia R, Pessaux P, Sommacale D, Laurent A, Le Roy B, Tacher V, Kobeiter H, Luciani A, Paillaud E, Aparicio T, Canuï-Poitrine F, Liuu E. Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis. PLoS One. 2020;15(4):e0230914.
  6. Zeymer U, Clark AL, Barrios V, Damy T, Drożdż J, Fonseca C, Lund LH, Di Comite G, Hupfer S, Maggioni AP. Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry. ESC Heart Fail. 2020;7(2):727-736.
  7. Chouaid C, Monnet I, Baize N. Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer - Authors' reply. Lancet Oncol. 2020;21(12):e546.
  8. Mourey L, Falandry C, de Decker L, Boulahssass R, Carola E, Lefevre LBengrine, Cudennec T, Brain E, Paillaud E, Soubeyran P. Taking care of older patients with cancer in the context of COVID-19 pandemic. Lancet Oncol. 2020;21(5):e236.
  9. Aouate D, Menet A, Bellevre D, Damy T, Marechaux S. Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy. Eur Heart J Case Rep. 2020;4(3):1-5.
  10. Sanchis-Borja M, Ricordel C, Chiappa AMarie, Hureaux J, Odier L, Jeannin G, Descourt R, Gervais R, Monnet I, Auliac J-B, Chouaid C. Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. Lung Cancer. 2020;143:36-39.
  11. Seban R-D, Assié J-B, Giroux-Leprieur E, Massiani M-A, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Girard N, Champion L. FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer. Ann Nucl Med. 2020;34(12):968-974.
  12. Seban R-D, Assié J-B, Giroux-Leprieur E, Massiani M-A, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Mezquita L, Girard N, Champion L. Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab. Cancers (Basel). 2020;12(8).
  13. Tamisier R, Damy T, Davy J-M, Verbraecken JA, Bailly S, Lavergne F, Palot A, Goutorbe F, Pépin J-L, d'Ortho M-P. Cohort profile: FACE, prospective follow-up of chronic heart failure patients with sleep-disordered breathing indicated for adaptive servo ventilation. BMJ Open. 2020;10(7):e038403.
  14. Vergnenègre A, Monnet I, Bizieux A, Bernardi M, Chiapa AMarie, Lena H, Chouaid C, Robinet G. Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC 04-2017). Future Oncol. 2020;16(4):5-10.
  15. Owonikoko TK, Niu H, Nackaerts K, Csoszi T, Ostoros G, Mark Z, Baik C, Joy AAbraham, Chouaid C, Jaime JCorral, Kolek V, Majem M, Roubec J, Santos ES, Chiang AC, Speranza G, Belani CP, Chiappori A, Patel MR, Czebe K, Byers L, Bahamon B, Li C, Sheldon-Waniga E, Kong EF, Williams M, Badola S, Shin H, Bedford L, Ecsedy JA, Bryant M, Jones S, Simmons J, E Leonard J, Ullmann CDansky, Spigel DR. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses. J Thorac Oncol. 2020;15(2):274-287.
  16. Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur J-P, Blanc-Durand P, Deux J-F, Audard V, Bodez D, Itti E, Damy T. Extracardiac soft tissue uptake, evidenced on early Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020;47(10):2396-2406.
  17. Mayenga M, Assié J-B, Monnet I, Massiani M-A, Tabeze L, Friard S, Fraboulet S, Métivier A-C, Chouaid C, Zemoura L, Longchampt E, Callens C, Melaabi S, Couderc L-J, Doubre H. Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases. Lung Cancer. 2020;150:21-25.
  18. Levra MGiaj, Cotté F-E, Corre R, Calvet C, Gaudin A-F, Penrod JR, Grumberg V, Jouaneton B, Jolivel R, Assié J-B, Chouaid C. Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis. Lung Cancer. 2020;140:99-106.
  19. Gibiot Q, Monnet I, Levy P, Brun A-L, Antoine M, Chouaid C, Cadranel J, Naccache J-M. Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study. J Clin Med. 2020;9(3).
  20. Perot JGiner, Jarzebowski W, Lafuente-Lafuente C, Crozet C, Belmin J. Aging-simulation experience: impact on health professionals' social representations. BMC Geriatr. 2020;20(1):14.
  21. Girard N, Moro-Sibilot D, Bouée S, Emery C, Torreton E, Le Lay K, Luciani L, Maritaz C, Chouaid C. Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in -mutated non-small-cell lung cancer: a real life study. Future Oncol. 2020;16(16):1115-1124.
  22. Geier M, Descourt R, Corre R, Léveiller G, Lamy R, Goarant E, Bizec J-L, Bernier C, Quere G, Amrane K, Gaye E, Lucia F, Burte E, Chouaid C, Robinet G. Duration of nivolumab for pretreated, advanced non-small-cell lung cancer. Cancer Med. 2020;9(19):6923-6932.
  23. Gadby F, Descourt R, Robinet G, Quere G, Gouva S, Roge C, Couturaud F, Chouaid C. [Evolution of the costs and management of lung cancer between 2004 and 2014]. Rev Mal Respir. 2020;37(1):1-7.
  24. Garassino MChiara, Cho B-C, Kim J-H, Mazières J, Vansteenkiste J, Lena H, Jaime JCorral, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Poole L, Wadsworth C, Dennis PA, Rizvi NA. Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study. Lung Cancer. 2020;147:137-142.
  25. Bocciarelli C, Cohen J, Pelletier R, Van Nhieu JTran, Derman J, Favre L, Bourgogne A, Monnet I, Chouaid C, Pujals A. Evaluation of the Idylla system to detect the EGFR mutation using extracted DNA. Pathol Res Pract. 2020;216(1):152773.
  26. Breton M, Costemale-Lacoste J-F, Li Z, Lafuente-Lafuente C, Belmin J, Mericskay M. Blood NAD levels are reduced in very old patients hospitalized for heart failure. Exp Gerontol. 2020;139:111051.
  27. Bylicki O, Guisier F, Monnet I, Doubre H, Gervais R, Janicot H, Perol M, Fournel P, Lamy R, Auliac J-B, Chouaid C. Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma. Medicine (Baltimore). 2020;99(3):e18726.
  28. Auliac J-B, Bayle S, Do P, Le Garff G, Roa M, Falchero L, Huchot E, Quere G, Jeannin G, Métivier A-C, Hobeika J, Guisier F, Chouaid C. Efficacy of Dabrafenib Plus Trametinib Combination in Patients with V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019. Cancers (Basel). 2020;12(12).
  29. Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenègre A, Crequit J, Lamy R, Auliac J-B, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault P-A, Le Garff G, Falchero L, Bérard H, Schott R, Saulnier P, Chouaid C. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2020;21(9):1224-1233.
  30. Belmin J, Khellaf L, Pariel S, Jarzebowski W, Valembois L, Zeisel J, Lafuente-Lafuente C. Validation of the French version of the Vulnerable Elders Survey-13 (VES-13). BMC Med Res Methodol. 2020;20(1):21.
  31. Belmin J, Um-Din N, Donadio C, Magri M, Nghiem QDuy, Oquendo B, Pariel S, Lafuente-Lafuente C. Coronavirus Disease 2019 Outcomes in French Nursing Homes That Implemented Staff Confinement With Residents. JAMA Netw Open. 2020;3(8):e2017533.
  32. Bennouna J, Girard N, Audigier-Valette C, Le Thuaut A, Gervais R, Masson P, Marcq M, Molinier O, Cortot A, Debieuvre D, Cadranel J, Lena H, Moro-Sibilot D, Chouaid C, Mennecier B, Urban T, Sagan C, Perrier L, Barlesi F, Denis MG. Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial. Clin Lung Cancer. 2020;21(1):e10-e14.
  33. Berthelot E, Jourdain P, Bailly MTam, Bouchachi A, Gellen B, Rouquette A, Damy T, Hervé P, Chemla D, Assayag P. Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Heart Failure With Preserved Ejection Fraction: Usefulness of Inferior Vena Cava Measurements and 2016 EACVI/ASE Recommendations. J Card Fail. 2020;26(6):507-514.
  34. Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard A-C, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano ALuisa, Zalcman G, Aparicio T. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). Eur J Cancer. 2020;141:62-81.
  35. Akinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS. DISCOVERY: prevalence of transthyretin () mutations in a US-centric patient population suspected of having cardiac amyloidosis. Amyloid. 2020;27(4):223-230.
  36. Amrane K, Geier M, Corre R, Lena H, Léveiller G, Gadby F, Lamy R, Bizec J-L, Goarant E, Robinet G, Gouva S, Quere G, Abgral R, Schick U, Bernier C, Chouaid C, Descourt R. First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study. Cancer Med. 2020;9(7):2309-2316.
  37. Arpin D, Charpentier M-C, Bernardi M, Monnet I, Boni A, Watkin E, Goubin-Versini I, Lamy R, Gérinière L, Geier M, Forest F, Gervais R, Madrosyk A, Guisier F, Serrand C, Locher C, Decroisette C, Fournel P, Auliac J-B, Jeanfaivre T, Letreut J, Doubre H, François G, Piton N, Chouaid C, Damotte D. PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study. Ther Adv Med Oncol. 2020;12:1758835920937972.
  38. Assié J-B, Corre R, Levra MGiaj, Calvet CYannick, Gaudin A-F, Grumberg V, Jouaneton B, Cotté F-E, Chouaid C. Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study). Ther Adv Med Oncol. 2020;12:1758835920967237.
  39. Landre T, Chouahnia K, Guetz GDes, Duchemann B, Assié J-B, Chouaid C. First-line immune-checkpoint inhibitor plus chemotherapy chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis. Ther Adv Med Oncol. 2020;12:1758835920977137.
  40. Landre T, Guetz GDes, Chouahnia K, Duchemann B, Assié J-B, Chouaid C. First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation. J Cancer Res Clin Oncol. 2020;146(12):3333-3339.
  41. Landre T, Guetz GDes, Chouahnia K, Taleb C, Vergnenègre A, Chouaid C. First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers.. J Cancer Res Clin Oncol. 2020;146(2):441-448.
  42. Belmin J, Donadio C, Jarzebowski W, Genranmayeh K, Valembois L, Lafuente-Lafuente C. The value of B-type natriuretic peptide plasma concentrations in very old people with chronic peripheral oedema. Arch Cardiovasc Dis. 2020;113(5):332-340.
  43. Belmin J, Din NUm, Pariel S, Lafuente-Lafuente C. [Confinement of staff with residents in nursing homes: a solution against COVID-19?]. Geriatr Psychol Neuropsychiatr Vieil. 2020;18(3):238-240.
  44. Saint-Lary O, Gautier S, Le Breton J, Gilberg S, Frappé P, Schuers M, Bourgueil Y, Renard V. How GPs adapted their practices and organisations at the beginning of COVID-19 outbreak: a French national observational survey. BMJ Open. 2020;10(12):e042119.
  45. Hauchecorne M, Pierro M, Brain E, Bringuier M, Soubeyran P, Chakiba C, Mathoulin-Pelissier S, Paillaud E, Geiss R, Besse B, Mourey L, Vincent H, Baldini C. Perspectives on cancer care in older patients in France. Ecancermedicalscience. 2020;14:1103.
  46. Bylicki O, Paleiron N, Assié J-B, Chouaid C. Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date. Onco Targets Ther. 2020;13:5691-5706.
  47. Eicher JC, Audia S, Damy T. [Transthyretin cardiac amyloidosis]. Rev Med Interne. 2020;41(10):673-683.
  48. Guisier F, Dubos-Arvis C, Vinas F, Doubre H, Ricordel C, Ropert S, Janicot H, Bernardi M, Fournel P, Lamy R, Perol M, Dauba J, Gonzales G, Falchero L, Decroisette C, Assouline P, Chouaid C, Bylicki O. Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018. J Thorac Oncol. 2020;15(4):628-636.
  49. Pallet N, Hamdane S, Garinet S, Blons H, Zaanan A, Paillaud E, Taieb J, Laprevote O, Loriot M-A, Narjoz C. A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency. Br J Cancer. 2020;123(5):811-818.
  50. Colaneri M, Seminari E, Piralla A, Zuccaro V, Di Filippo A, Baldanti F, Bruno R, Mondelli MU. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy. J Hosp Infect. 2020;105(3):474-6.
  51. Emsen B, Villafane G, David J-P, Evangelista E, Chalaye J, Lerman L, Authier F-J, Gracies J-M, Itti E. Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes. Medicine (Baltimore). 2020;99(45):e23060.
  52. Chouaid C. [Not Available]. Rev Malad Respir Actual. 2020;12(2):2S378-2S382.
  53. Gendarme S, Chouaid C. Monitoring Subsolid Pulmonary Nodules in High-Risk Patients Is Even More Cost-Effective When Combined With a Stop-Smoking Program. J Thorac Oncol. 2020;15(8):1268-1270.
  54. Chouaid C, Baize N, Monnet I. Second-line therapy for disseminated small-cell lung cancer: optimal management remains to be defined. Transl Lung Cancer Res. 2020;9(5):1732-1735.
  55. Mohty D, Pibarot P, Damy T. Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'. Eur Heart J. 2020;41(29):2815.
  56. Tacher V, Blain M, Hérin E, Vitellius M, Chiaradia M, Oubaya N, Derbel H, Kobeiter H. CBCT-Based Image Guidance for Percutaneous Access: Electromagnetic Navigation Versus 3D Image Fusion with Fluoroscopy Versus Combination of Both Technologies-A Phantom Study. Cardiovasc Intervent Radiol. 2020;43(3):495-504.
  57. Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R. Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis. Eur J Clin Microbiol Infect Dis. 2020;39(1):121-129.
  58. Coquerelle S, Darlington M, Michel M, Durand M, Borget I, Baffert S, Marino P, Perrier L, Durand-Zaleski I. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments. Value Health. 2020;23(7):898-906.
  59. Dabi Y, Gosset M, Bastuji-Garin S, Mitri-Frangieh R, Bendifallah S, Darai E, Paniel BJean, Rouzier R, Haddad B, Touboul C. Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer. J Clin Med. 2020;9(1).
  60. Leissing-Desprez C, Thomas E, Segaux L, Broussier A, Oubaya N, Marie-Nelly N, Laurent M, de Langavant LCleret, Fromantin I, David J-P, Bastuji-Garin S. Understated Cognitive Impairment Assessed with the Clock-Drawing Test in Community-Dwelling Individuals Aged ≥50 Years. J Am Med Dir Assoc. 2020;21(11):1658-1664.
  61. Moscova L, Leblanc F, Cittée J, Le Breton J, Vallot S, Fabre J, Phan T-T, Renard V, Ferrat E. Changes over time in attitudes towards the management of older patients with heart failure by general practitioners: a qualitative study. Fam Pract. 2020;37(1):110-117.
  62. Moscova L, Leblanc F, Cittée J, Le Breton J, Vallot S, Fabre J, Phan T-T, Renard V, Ferrat E. Changes over time in attitudes towards the management of older patients with heart failure by general practitioners: a qualitative study. Fam Pract. 2020;37(1):110-117.
  63. Hild S, Johanet M, Valenza A, Thabaud M, Laforest F, Ferrat E, Rat C. Quality of decision aids developed for women at average risk of breast cancer eligible for mammographic screening: Systematic review and assessment according to the International Patient Decision Aid Standards instrument. Cancer. 2020;126(12):2765-2774.
  64. Phan T, Yana J, Fabre J, Yana L, Renard V, Ferrat E. [At-risk drinking screening by general practitioners: A survey of patients in primary care]. Rev Epidemiol Sante Publique. 2020;68(4):215-225.
  65. Stehlé T, Karoui KEl, Sakka M, Ismail A, Matignon M, Grimbert P, Canoui-Poitrine F, Prié D, Audard V. Creatinine clearance after cimetidine administration in a new short procedure: comparison with plasma and renal clearances of iohexol. Clin Kidney J. 2020;13(4):587-596.
  66. Pamoukdjian F, Aparicio T, Zebachi S, Zelek L, Paillaud E, Canoui-Poitrine F. Comparison of Mobility Indices for Predicting Early Death in Older Patients With Cancer: The Physical Frailty in Elderly Cancer Cohort Study. J Gerontol A Biol Sci Med Sci. 2020;75(1):189-196.
  67. Martinez-Tapia C, Diot T, Oubaya N, Paillaud E, Poisson J, Gisselbrecht M, Morisset L, Caillet P, Baudin A, Pamoukdjian F, Broussier A, Bastuji-Garin S, Laurent M, Canoui-Poitrine F. The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. Am J Clin Nutr. 2020.
  68. Etienne N, Karmochkine M, Slama L, Pavie J, Batisse D, Usubillaga R, Letembet V-A, Brazille P, Canouï E, Slama D, Joumaa H, Canoui-Poitrine F, Segaux L, Weiss L, Viard J-P, Salmon D. HIV infection and COVID-19: risk factors for severe disease. AIDS. 2020;34(12):1771-1774.
  69. Ceron DSalmon, Bartier S, Hautefort C, Nguyen Y, Nevoux J, Hamel A-L, Camhi Y, Canoui-Poitrine F, Verillaud B, Slama D, Haim-Boukobza S, Sourdeau E, Cantin D, Corré A, Bryn A, Etienne N, Rozenberg F, Layese R, Papon J-F, Béquignon E. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect. 2020;81(4):614-620.
  70. de'Angelis N, Notarnicola M, Martínez-Pérez A, Memeo R, Charpy C, Urciuoli I, Maroso F, Sommacale D, Amiot A, Canoui-Poitrine F, Levesque E, Brunetti F. Robotic Versus Laparoscopic Partial Mesorectal Excision for Cancer of the High Rectum: A Single-Center Study with Propensity Score Matching Analysis. World J Surg. 2020;44(11):3923-3935.
  71. Beghdadi N, Reitano E, Cochennec F, Desgranges P, Amiot A, Sobhani I, Mongardon N, Langeron O, Notarnicola M, Mulé S, Luciani A, Canoui-Poitrine F, Laurent A, Sommacale D, Brunetti F, Angelis NDe'. Predictors of mortality following emergency open colectomy for ischemic colitis: a single-center experience. World J Emerg Surg. 2020;15(1):40.
  72. Pamoukdjian F, Laurent M, Martinez-Tapia C, Rolland Y, Paillaud E, Canoui-Poitrine F. Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype. J Clin Med. 2020;9(6).
  73. N Saleh B, Voron T, de'Angelis N, Franco I, Canoui-Poitrine F, Mutter D, Brunetti F, Gagnière J, Memeo R, Pezet D, Monange B, Pereira B, Le Roy B. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: results from the CLIMHET study group. Tech Coloproctol. 2020;24(6):585-592.
  74. Angeli E, Chouahnia K, Canoui-Poitrine F, Duchemann B, Aparicio T, Paillaud E, Zelek L, Bousquet G, Pamoukdjian F. Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE. Aging (Albany NY). 2020;12(5):4230-4246.
  75. Aparicio T, Canoui-Poitrine F, Caillet P, Francois E, Cudennec T, Carola E, Albrand G, Bouvier A-M, Petri C, Couturier B, Phelip J-M, Bengrine-Lefevre L, Paillaud E. Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG). Dig Liver Dis. 2020;52(5):493-505.
  76. Beinse G, Reitter D, Segaux L, Carvahlo-Verlinde M, Rousseau B, Tournigand C, Cudennec T, Laurent M, Boudou-Rouquette P, Paillaud E, Canoui-Poitrine F, Caillet P. Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort. J Geriatr Oncol. 2020;11(4):586-592.
  77. Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, Chosidow O, Mekontso-Dessap A, Wolkenstein P, de Prost N. Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients. Br J Dermatol. 2020;182(4):916-926.
  78. Fromantin I, Canoui-Poitrine F, Engels C. [Meaning, research and knowledge]. Rev Infirm. 2020;69(265):22-24.
  79. Engels C, Boutin E, Boussely F, Bourgeon-Ghittori I, Couturier B, Fromantin I, Lafuente-Lafuente C, Canoui-Poitrine F. Use of Evidence-Based Practice Among Healthcare Professionals After the Implementation of a New Competency-Based Curriculum. Worldviews Evid Based Nurs. 2020;17(6):427-436.
  80. Hue S, Beldi-Ferchiou A, Bendib I, Surenaud M, Fourati S, Frapard T, Rivoal S, Razazi K, Carteaux G, Delfau-Larue M-H, Mekontso-Dessap A, Audureau E, de Prost N. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;202(11):1509-1519.
  81. Zarski J-P, David-Tchouda S, Trocme C, Margier J, Vilotitch A, Hilleret M-N, Cagnot C, Boursier V, Ziol M, Sutton A, Layese R, Audureau E, Roudot-Thoraval F, Nahon P. Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis. Clin Res Hepatol Gastroenterol. 2020;44(4):524-531.
  82. Roumenina LT, Chadebech P, Bodivit G, Vieira-Martins P, Grunenwald A, Boudhabhay I, Poillerat V, Pakdaman S, Kiger L, Jouard A, Audureau E, Pirenne F, Galactéros F, Frémeaux-Bacchi V, Bartolucci P. Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy. Am J Hematol. 2020;95(5):456-464.
  83. Raffetin A, Melica G, Audureau E, Habibi A, Decousser JW, Fourati S, Razazi K, Lepeule R, Guillaud C, Khellaf M, Bartolucci P, Gallien S. Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome. Med Mal Infect. 2020;50(1):49-56.
  84. Caeymaex L, Lebeaux C, Roze JChristophe, Danan C, Reynaud A, Jung C, Audureau E. Study on preventing adverse events in neonates (SEPREVEN): A stepped-wedge randomised controlled trial to reduce adverse event rates in the NICU. Medicine (Baltimore). 2020;99(31):e20912.
  85. Sifaoui I, Oliver L, Tacher V, Fiore A, Lepeule R, Moussafeur A, Huguet R, Teiger E, Audureau E, Derbel H, Luciani A, Kobeiter H, Lim P, Ternacle J, Deux J-F. Diagnostic Performance of Transesophageal Echocardiography and Cardiac Computed Tomography in Infective Endocarditis. J Am Soc Echocardiogr. 2020;33(12):1442-1453.
  86. Bataille P, Amiot A, Claudepierre P, Paris N, Neuraz A, Lerner I, Garcelon N, Rance B, Grisel O, Moreau T, Bernaux M, Audureau E, Sbidian E. Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7 808 patients in France. Aliment Pharmacol Ther. 2020;52(7):1245-1248.
  87. Bachoud-Lévi A-C. Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. Mov Disord. 2020;35(8):1323-1335.
  88. Badrawy MEl, Nofal A, Saba J, Audureau E. A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt. NPJ Prim Care Respir Med. 2020;30(1):31.
  89. Heidet M, Da Cunha T, Brami E, Mermet É, Dru M, Simonnard B, Lecarpentier E, Chollet-Xémard C, Bergeron C, Khalid M, Grunau B, Marty J, Audureau E. EMS Access Constraints And Response Time Delays For Deprived Critically Ill Patients Near Paris, France. Health Aff (Millwood). 2020;39(7):1175-1184.
  90. Hebert N, Rakotoson MGeorgine, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease. Am J Hematol. 2020;95(11):1235-1245.
  91. Laurent M, Oubaya N, David J-P, Engels C, Canoui-Poitrine F, Corsin L, Liuu E, Audureau E, Bastuji-Garin S, Paillaud E. Functional decline in geriatric rehabilitation ward; is it ascribable to hospital acquired infection? A prospective cohort study. BMC Geriatr. 2020;20(1):433.
  92. Rougier E, Mar W, V Valle D, Morel B, Irtan S, Audureau E, Coulomb-L'Hermine A, H le Pointe D, Blondiaux E. Added value of MRI for the diagnosis of adnexal torsion in children and adolescents after inconclusive ultrasound examination. Diagn Interv Imaging. 2020;101(11):747-756.
  93. Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Chazouillères O, Mallat A, Grangé J-D, Attali P, d'Alteroche L, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Pol S, Nahon P. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status. J Hepatol. 2020;73(6):1434-1445.
  94. Rwabihama J-P, Belmin J, Rakotoarisoa DRozier, Hagege M, Audureau E, Benzengli H, Ambime G, Rabus M-T, Bastuji-Garin S, Paillaud E, Oubaya N. Promoting patients' rights at the end of life in a geriatric setting in France: The healthcare professionals' level of knowledge about surrogate decision-makers and advance directives. Patient Educ Couns. 2020;103(7):1390-1398.
  95. Mahévas M, Tran V-T, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel T-A, Lescure F-X, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky J-M, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ. 2020;369:m1844.
  96. Rochette A, Brousseau M, Vachon B, Engels C, Amari F, Thomas A. What occupational therapists' say about their competencies' enactment, maintenance and development in practice? A two-phase mixed methods study. BMC Med Educ. 2020;20(1):191.
  97. Delchier J-C, Bastuji-Garin S, Raymond J, Megraud F, Amiot A, Cambau E, Burucoa C. Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection. Med Mal Infect. 2020;50(6):492-499.
  98. Dawidowicz S, Le Breton J, Moscova L, Renard V, Bercier S, Brixi Z, Audureau E, Clerc P, Bastuji-Garin S, Ferrat E. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†. Fam Pract. 2020;37(1):15-24.

2019

  1. Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst RevCochrane Database Syst RevCochrane Database Syst Rev. 2019;9:Cd005049.
  2. Neuzillet Y, Geiss R, Paillaud E, Mongiat-Artus P. [Optimizing the management of bladder cancer in older patients]. Prog Urol. 2019;29(14):849-864.
  3. Mongiat-Artus P, Paillaud E, Albrand G, Caillet P, Neuzillet Y. [Evaluation of the elderly patient with cancer]. Prog Urol. 2019;29(14):807-827.
  4. Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y. [Onco-urology of the aging patient: Epidemiological and biological aspects]. Prog Urol. 2019;29(14):797-806.
  5. Mongiat-Artus P, Paillaud E, Caillet P, Albrand G, Neuzillet Y. [Geriatric specificities of localized renal cell carcinoma]. Prog Urol. 2019;29(14):865-873.
  6. Mongiat-Artus P, Paillaud E, Caillet P, Albrand G, Neuzillet Y. [Geriatric specificities of prostate cancer]. Prog Urol. 2019;29(14):828-839.
  7. Broussier A, Valembois L, Lafuente-Lafuente C, David J-P, Pariel S. [Gerontological evaluation benefits for very older people with cardiovascular disease]. Presse Med. 2019;48(2):120-126.
  8. Lafuente-Lafuente C, Oasi C, Belmin J. [Treatment with oral anticoagulants in older patients: Should warfarin still be prescribed?]. Presse Med. 2019;48(2):154-164.
  9. Pichon J, Chouaid C, Marc E, Voiriot G. [Respiratory isolation in suspected tuberculosis with negative direct sputum examination]. Rev Mal Respir. 2019;36(3):396-404.
  10. Berthelot E, Nouhaud C, Lafuente-Lafuente C, Assayag P, Hittinger L. [Heart failure in patients over 80 years old]. Presse Med. 2019;48(2):143-153.
  11. Neuzillet Y, Albrand G, Caillet P, Paillaud E, Mongiat-Artus P. [Specificity of the management of metastatic renal cancer in the older patient]. Prog Urol. 2019;29(14):874-895.
  12. Neuzillet Y, Geiss R, Caillet P, Paillaud E, Mongiat-Artus P. [Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients]. Prog Urol. 2019;29(14):840-848.
  13. Vayr F, Savall F, Bigay-Gamé L, Soulat J-M, Chouaid C, Hérin F. Lung cancer survivors and employment: A systematic review. Lung Cancer. 2019;131:31-39.
  14. Paillaud E, Cudennec T, Caillet P, Bellera C, Mathoulin-Pelissier S, Soubeyran P. [Clinical trials and elderly patients with cancer, the Geriatric Core Dataset (G-Code) tool]. Soins Gerontol. 2019;24(137):35-37.
  15. Villemain O, Correia M, Mousseaux E, Baranger J, Zarka S, Podetti I, Soulat G, Damy T, Hagège A, Tanter M, Pernot M, Messas E. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults. JACC Cardiovasc Imaging. 2019;12(7 Pt 1):1135-1145.
  16. Zores F, Iliou M-C, Gellen B, Kubas S, Berthelot E, Guillo P, Bauer F, Lamblin N, Bosser G, Damy T, Cohen-Solal A, Beauvais F. Physical activity for patients with heart failure: Position paper from the heart failure (GICC) and cardiac rehabilitation (GERS-P) Working Groups of the French Society of Cardiology. Arch Cardiovasc Dis. 2019;112(11):723-731.
  17. Zouari HG, S Tin NWing, Wahab A, Damy T, Lefaucheur J-P. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy. Eur J Neurol. 2019;26(1):94-e10.
  18. Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y. [Conclusion]. Prog Urol. 2019;29(14):896-897.
  19. Pradel S, Magne J, Jaccard A, Fadel BM, Boulogne C, Salemi VMaria Cury, Damy T, Aboyans V, Mohty D. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study. Int J Cardiovasc Imaging. 2019;35(5):845-854.
  20. Richard P, Ader F, Roux M, Donal E, Eicher J-C, Aoutil N, Huttin O, Selton-Suty C, Coisne D, Jondeau G, Damy T, Mansencal N, Casalta A-C, Michel N, Haentjens J, Faivre L, Lavoute C, Nguyen K, Tregouët D-A, Habib G, Charron P. Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity. Clin Genet. 2019;95(3):356-367.
  21. Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 2019;139(4):431-443.
  22. Tison A, Quere G, Misery L, Funck-Brentano E, Danlos F-X, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, De Quatrebarbes J, Michel C, Auliac J-B, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study. Arthritis Rheumatol. 2019;71(12):2100-2111.
  23. Mirabel M, Damy T, Donal E, Huttin O, Labombarda F, Eicher J-C, Cervino C, Laurito M, Offredo L, Tafflet M, Jouven X, Giura G, Desnos M, Jeunemaître X, Empana J-P, Charron P, Habib G, Réant P, Hagège A. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY). Int J Cardiol. 2019;275:107-113.
  24. Kissel M, Martel-Lafay I, Lequesne J, Faivre J-C, Le Péchoux C, Stefan D, Barraux V, Loiseau C, Grellard J-M, Danhier S, Lerouge D, Chouaid C, Gervais R, Thariat J. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer. BMC Cancer. 2019;19(1):1237.
  25. Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouche D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P. Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use. J Am Soc Nephrol. 2019;30(7):1206-1219.
  26. Damy T, Kristen AV, Suhr OB, Maurer MS, Planté-Bordeneuve V, Yu C-R, Ong M-L, Coelho T, Rapezzi C. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS). Eur Heart J. 2019;43(5):391-400.
  27. Dang J, Abulizi M, Moktefi A, Karoui KEl, Deux J-F, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Planté-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V. Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis. Mayo Clin Proc. 2019;94(6):961-975.
  28. Delva F, Laurent F, Paris C, Belacel M, Brochard P, Bylicki O, Chouaid C, Clin B, Dewitte J-D, Le Denmat V, Gehanno J-F, Lacourt A, Margery J, Verdun-Esquer C, Mathoulin-Pelissier S, Pairon J-C. LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol. BMJ Open. 2019;9(3):e025026.
  29. Descourt R, Perol M, Rousseau-Bussac G, Planchard D, Mennecier B, Wislez M, Cortot A, Guisier F, Galland L, Do P, Schott R, Dansin E, Arrondeau J, Auliac J-B, Chouaid C. Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study). Lung Cancer. 2019;136:109-114.
  30. Galat A, Guellich A, Bodez D, Lipskaia L, Moutereau S, Bergoend E, Hue S, Ternacle J, Mohty D, Monin J-L, Derumeaux G, Radu C, Damy T. Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement. ESC Heart Fail. 2019;6(4):649-657.
  31. Bourdin A, Fabry-Vendrand C, Ostinelli J, Ait-Yahia M, Darnal E, Bouée S, Laurendeau C, Bureau I, Gourmelen J, Chouaid C. The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database. J Allergy Clin Immunol Pract. 2019;7(5):1477-1487.
  32. Cholet C, Damy T, Legou F, Kobeiter H, Rahmouni A, Deux J-F. Quantification of Myocardial Enhancement on Cine-MRI: Diagnostic Value in Cardiac Amyloidosis. Acad Radiol. 2019;26(6):e98-e107.
  33. Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019;26(1):3-9.
  34. Dalon F, Devouassoux G, Belhassen M, Nachbaur G, Da Silva CCorreia, Sail L, Jacoud F, Chouaid C, Van Ganse E. Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy. Int J Chron Obstruct Pulmon Dis. 2019;14:2905-2915.
  35. Auliac J-B, Do P, Bayle S, Doubre H, Vinas F, Letreut J, Falchero L, Hauss PAlexandre, Thomas P, Chouaid C. Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14. Adv Ther. 2019;36(8):2161-2166.
  36. Auliac JBernard, Perol M, Planchard D, Monnet I, Wislez M, Doubre H, Guisier F, Pichon E, Greillier L, Mastroianni B, Decroisette C, Schott R, Le Moulec S, Arrondeau J, Cortot AB, Gérinière L, Renault A, Daniel C, Falchero L, Chouaid C. Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation. Lung Cancer. 2019;127:96-102.
  37. Auliac J-B, Saboundji K, André M, Madelaine J, Quere G, Masson P, Vergnenègre A, Lamy R, Raymond S, Chiappa A-M, Hauss P-A, Fournel P, Corre R, Chouaid C. Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer. Target Oncol. 2019;14(3):307-314.
  38. Boully C, Vidal J-S, Guibert E, Ghazali FNisrin, Pesce A, Beauplet B, Roger J-D, Carrière I, Timbely B, Idiri H, Constensoux J-P, Durocher A-M, Dubail D, Fargier M, Jeandel C, Berrut G, Hanon O. National survey on the management of heart failure in individuals over 80 years of age in French geriatric care units. BMC Geriatr. 2019;19(1):204.
  39. Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, Gallet R, Teiger E, Côté N, Clavel M-A, Tournoux F, Pibarot P, Damy T. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(21):2638-2651.
  40. Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, García-Pavía P. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019;7(8):709-716.
  41. Hagège A, Réant P, Habib G, Damy T, Barone-Rochette G, Soulat G, Donal E, Germain DP. Fabry disease in cardiology practice: Literature review and expert point of view. Arch Cardiovasc Dis. 2019;112(4):278-287.
  42. Magny E, Donadio C, Maronnat F, Nghiem D, Berthelot E, Belmin J, Lafuente-Lafuente C. [Hypotensions in the elderly: Clinical and therapeutic features]. Presse Med. 2019;48(2):134-142.
  43. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Quarta CCristina, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019;12(9):e006075.
  44. Bonnefoy M, Gilbert T, Bruyère O, Paillaud E, Raynaud-Simon A, Guerin O, Jeandel C, Le Sourd B, Haine M, Ferry M, Rolland Y, Berrut G. [Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review]. Geriatr Psychol Neuropsychiatr Vieil. 2019;17(2):137-143.
  45. Bylicki O, Barazzutti H, Paleiron N, Margery J, Assié J-B, Chouaid C. First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors. BioDrugs. 2019;33(2):159-171.
  46. Bylicki O, Didier M, Rivière F, Margery J, Grassin F, Chouaid C. Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care. BMJ Support Palliat Care. 2019;9(4):413-424.
  47. Couderc A-L, Boulahssass R, Nouguerède E, Gobin N, Guerin O, Villani P, Barlesi F, Paillaud E. Functional status in a geriatric oncology setting: A review. J Geriatr Oncol. 2019;10(6):884-894.
  48. Brain E, Caillet P, de Glas N, Biganzoli L, Cheng K, Dal Lago L, Wildiers H. HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology. J Geriatr Oncol. 2019;10(6):1003-1013.
  49. Flécher E, Guihaire J, Pozzi M, Ouattara A, Baudry G, Berthelot E, Beauvais F, Radu C, Dorent R, Sebbag L, Galli E, Roubille F, Damy T, Verhoye JPhilippe, Leprince P, Obadia J-F, Lebreton G. Extracorporeal membrane oxygenation support in acute circulatory failure: A plea for regulation and better organization. Arch Cardiovasc Dis. 2019;112(6-7):441-449.
  50. Guyard A, Charpy C, Théou-Anton N, Cremades A, Grassin F, Bourgogne A, Leroy K, Pujals A, Copie-Bergman C, Chouaid C, Mansuet-Lupo A. Isolated 5' Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature. Transl Oncol. 2019;12(5):784-787.
  51. Costantini A, Fallet V, Corny J, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Brosseau S, Wislez M, Tredaniel J, Cadranel J. Nivolumab-refractory patients with advanced non-small-cell lung cancer. Lung Cancer. 2019;130:128-134.
  52. Ekman S, Griesinger F, Baas P, Chao D, Chouaid C, O'Donnell JC, Penrod JR, Daumont M, Lacoin L, McKenney A, Khovratovich M, Munro REj, Durand-Zaleski I, Johnsen SPaaske. I-O Optimise: a novel multinational real-world research platform in thoracic malignancies. Future Oncol. 2019;15(14):1551-1563.
  53. Chouaid C, Bensimon L, Clay E, Millier A, Lévy-Bachelot L, Huang M, Levy P. Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France. Lung Cancer. 2019;127:44-52.
  54. Chouaid C, Germain N, de Pouvourville G, Aballéa S, Korchagina D, Baldwin M, Le Lay K, Luciani L, Toumi M, Devillier P. Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Curr Med Res Opin. 2019;35(5):785-792.
  55. Chouaid C, Salaün M, Gounant V, Febvre M, Vergnon J-M, Jouniaux V, Fournier C, Lachkar S, Hermant C, Raspaud C, Quantin X, Quiot J-J, Molard A, Dayen C, Marquette C-H, Lena H, Zalcman G, Thiberville L. Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB). PLoS One. 2019;14(1):e0208992.
  56. Belmin J, Lafuente-Lafuente C, Hittinger L. [Heart failure in the elderly: A challenge for the health system and a model for the management of chronic diseases]. Presse Med. 2019;48(2):118-119.
  57. Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y. [Introduction]. Prog Urol. 2019;29(14):795-796.
  58. Badois N, Bauër P, Chéron M, Hoffmann C, Nicodème M, Choussy O, Lesnik M, Poitrine FCanoui, Fromantin I. Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study. J Wound Care. 2019;28(9):624-628.
  59. Vaux J, Lecarpentier E, Heidet M, Oubaya N, Hubert H, Baert V, Segal N, Mansouri N, Gueugniaud P-Y, Bertrand C, Canoui-Poitrine F. Management and outcomes of cardiac arrests at nursing homes: A French nationwide cohort study. Resuscitation. 2019;140:86-92.
  60. Hervochon R, Teissier N, Blondeau J-R, Remus N, Bassinet L, Canoui-Poitrine F, Van Den Abbeele T, Prulière-Escabasse V. Computed Tomography Description of the Uncinate Process Angulation in Patients With Cystic Fibrosis and Comparison With Primary Ciliary Dyskinesia, Nasal Polyposis, and Controls. Ear Nose Throat J. 2019;98(2):89-93.
  61. Canouï E, Zarrouk V, Canoui-Poitrine F, Desmoulin U, Leflon V, Allaham W, de Lastours V, Guigui P, Fantin B. Surgery is safe and effective when indicated in the acute phase of hematogenous pyogenic vertebral osteomyelitis. Infect Dis (Lond). 2019;51(4):268-276.
  62. Pamoukdjian F, Aparicio T, Canoui-Poitrine F, Duchemann B, Lévy V, Wind P, Ganne N, Sebbane G, Zelek L, Paillaud E. Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) study. Clin Nutr. 2019;38(6):2806-2812.
  63. Leibler C, Matignon M, Moktefi A, Samson C, Zarour A, Malard S, Boutin E, Pilon C, Salomon L, Natella P-A, Durrbach A, Robert T, Canoui-Poitrine F, Grimbert P. Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR). Am J Transplant. 2019;19(3):894-906.
  64. Hurtaud A, Lallier F, Heidet M, Arnoult C, Dramé M, Canoui-Poitrine F. Real-life implementation of guidelines on the hospital-to-home transition for older patients: a cohort study in general practice. Age Ageing. 2019;49(1):46-51.
  65. Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, de'Angelis N, Rabot S, Canoui-Poitrine F, Mestivier D, Pédron T, Khazaie K, Sansonetti PJ. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci U S A. 2019;116(48):24285-24295.
  66. Bartier S, Bodez D, Kharoubi M, Guellich A, Canoui-Poitrine F, Chatelin V, Coste A, Damy T, Béquignon E. Association between hearing loss and hereditary ATTR amyloidosis. Amyloid. 2019;26(4):234-242.
  67. Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard J-F, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux. Am J Hematol. 2019;94(12):1314-1324.
  68. Bartier S, Bodez D, Kharoubi M, Canoui-Poitrine F, Chatelin V, Henrion C, Coste A, Damy T, Béquignon E. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. Amyloid. 2019;26(4):216-224.
  69. Heidet M, Canoui-Poitrine F, Revaux F, Perennou T, Bertin M, Binetruy C, Palazzi J, Tapiero E, Nguyen M, Reuter P-G, Lecarpentier E, Vaux J, Marty J. Factors affecting medical file documentation during telephone triage at an emergency call centre: a cross-sectional study of out-of-hours home visits by general practitioners in France. BMC Health Serv Res. 2019;19(1):531.
  70. Lafuente-Lafuente C, Leitao C, Kilani I, Kacher Z, Engels C, Canoui-Poitrine F, Belmin J. Knowledge and use of evidence-based medicine in daily practice by health professionals: a cross-sectional survey. BMJ Open. 2019;9(3):e025224.
  71. Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst RevCochrane Database Syst RevCochrane Database Syst Rev. 2019;9:CD005049.
  72. Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Goria O, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle-Bladou C, Dao T, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Sutton A, Audureau E, Roudot-Thoraval F, Nahon P. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy. Gastroenterology. 2019;156(4):997-1009.e5.
  73. Gracies J-M, Pradines M, Ghédira M, Loche C-M, Mardale V, Hennegrave C, Gault-Colas C, Audureau E, Hutin E, Baude M, Bayle N. Guided Self-rehabilitation Contract vs conventional therapy in chronic stroke-induced hemiparesis: NEURORESTORE, a multicenter randomized controlled trial. BMC Neurol. 2019;19(1):39.
  74. Lalevée S, Audureau E, Riou A, Colin A, Anquetin M, Barau C, Valeyrie-Allanore L, Delfau-Larue M-H, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Hue S. Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns. Clin Exp Allergy. 2019;49(9):1258-1261.
  75. Baghdoyan S, Bassez G, Audureau E, Peschanski M. [Pharmacological research and pluripotent stem cells: from the innovative experimental paradigm to the successful clinical trial]. Med Sci (Paris). 2019;35(1):26-29.
  76. Audureau E, Davis B, Besson MHélène, Saba J, Ladner J. Willingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians. J Comp Eff Res. 2019;8(5):357-369.
  77. Audureau E, Besson MHélène, Nofal A, Jayasundera R, Saba J, Ladner J. Ability to pay for medication: a clustering analysis of 1404 patients with the Patient Financial Eligibility Tool. J Comp Eff Res. 2019;8(12):969-977.
  78. Ahmed-Yahia S, Decousser J-W, Flouzat-Lachaniette CHenri, Dervin G, Roubineau F, Audureau E, Hourdille A, Royer G, Eymard F, Chevalier X. Is the discopathy associated with Modic changes an infectious process? Results from a prospective monocenter study. PLoS One. 2019;14(8):e0221030.
  79. Bassez G, Audureau E, Peschanski M. Reply: Could weight loss contribute to the improved mobility with metformin in patients with myotonic dystrophy type 1?. Brain. 2019;142(2):e6.
  80. Blondiaux E, Autret G, Dhombres F, Gonzales M, Audureau E, Clément O, Jouannic J-M, Houyel L. Evaluation of septal insertion of atrioventricular valves in fetuses by postmortem 4.7 Tesla cardiac MRI: A feasibility study. Diagn Interv Imaging. 2019;100(2):109-116.
  81. Salmon-Céron D, Nahon P, Layese R, Bourcier V, Sogni P, Bani-Sadr F, Audureau E, Merchadou L, Dabis F, Wittkop L, Roudot-Thoraval F. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients. Hepatology. 2019;70(3):939-954.
  82. Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M. Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study. J Clin Med. 2019;8(5).
  83. Costentin CE, Layese R, Roudot-Thoraval F, Audureau E, Nahon P. Reply. Gastroenterology. 2019;156(1):289-290.
  84. Gouraud C, Paillaud E, Martinez-Tapia C, Segaux L, Reinald N, Laurent M, Corsin L, Hoertel N, Gisselbrecht M, Mercadier E, Boudou-Rouquette P, Chahwakilian A, Bastuji-Garin S, Limosin F, Lemogne C, Canoui-Poitrine F. Depressive Symptom Profiles and Survival in Older Patients with Cancer: Latent Class Analysis of the ELCAPA Cohort Study. Oncologist. 2019;24(7):e458-e466.
  85. Hurtaud A, Aubin M, Ferrat E, Lebreton J, Paillaud E, Audureau E, Bastuji-Garin S, Chouaid C, Boisnault P, Clerc P, Canoui-Poitrine F. Continuity of care in general practice at cancer diagnosis (COOC-GP study): a national cohort study of 2853 patients. Br J Gen Pract. 2019;69(679):e88-e96.
  86. Canoui-Poitrine F, Lièvre A, Dayde F, Lopez-Trabada-Ataz D, Baumgaertner I, Dubreuil O, Brunetti F, Coriat R, Maley K, Pernot S, Tournigand C, Hagege M, Aparicio T, Paillaud E, Bastuji-Garin S. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist. 2019;24(12):e1351-e1359.
  87. Segaux L, Oubaya N, Broussier A, Baude M, Canoui-Poitrine F, Naga H, Laurent M, Leissing-Desprez C, Audureau E, Ferrat E, Chailloleau C, Fromantin I, David J-P, Bastuji-Garin S. Identification of five frailty profiles in community-dwelling individuals aged 50-75: A latent class analysis of the SUCCEED survey data. Maturitas. 2019;127:1-11.
  88. Allaire M, Rekik S, Layese R, Mumana A, Guyot E, Nkontchou G, Bourcier V, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Audureau E, Seror O, Nault J-C. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Dig Liver Dis. 2019;51(1):86-94.
  89. Bouillanne O, Melchior J-C, Faure C, Paul M, Canoui-Poitrine F, Boirie Y, Chevenne D, Forasassi C, Guery E, Herbaud S, Le Corvoisier P, Neveux N, Nivet-Antoine V, Astier A, Raynaud-Simon A, Walrand S, Cynober L, Aussel C. Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: The Ciproage randomized controlled trial. Clin Nutr. 2019;38(2):564-574.
  90. Gelu-Simeon M, Lewin M, Ostos M, Bayan T, Delgado MBeso, Teicher E, Layese R, Roudot-Thoraval F, Fontaine H, Sobesky R, Salmon-Céron D, Samuel D, Seror O, Nahon P, Meyer L, Duclos-Vallée J-C. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver Int. 2019;39(1):136-146.
  91. Brichler S, Nahon P, Zoulim F, Layese R, Bourcier V, Audureau E, Sutton A, Letouze E, Cagnot C, Marcellin P, Guyader D, Roulot D, Pol S, De Lédinghen V, Zarski J-P, Calès P, Tran A, Péron J-M, Mallat A, Riachi G, Grangé J-D, Blanc J-F, Bacq Y, Ouzan D, Bronowicki J-P, Mathurin P, Larrey D, Alric L, Attali P, Serfaty L, Pilette C, Bourlière M, Thabut D, Silvain C, Wartelle C, Zucman D, Christidis C, Roudot-Thoraval F, Ganne-Carrié N. Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort. J Viral Hepat. 2019;26(3):384-396.
  92. Contou D, Canoui-Poitrine F, Coudroy R, Préau S, Cour M, Barbier F, Terzi N, Schnell G, Galbois A, Zafrani L, Zuber B, Ehrmann S, Gelisse E, Colling D, Schmidt M, Jaber S, Conia A, Sonneville R, Colin G, Guérin L, Roux D, Jochmans S, Kentish-Barnes N, Audureau E, Layese R, Alves A, Ouedraogo R, Brun-Buisson C, Dessap AMekontso, de Prost N. Long-term Quality of Life in Adult Patients Surviving Purpura Fulminans: An Exposed-Unexposed Multicenter Cohort Study. Clin Infect Dis. 2019;69(2):332-340.
  93. Clause-Verdreau A-C, Audureau E, Leplège A, Coste J. Contrasted trends in health-related quality of life across gender, age categories and work status in France, 1995-2016: repeated population-based cross-sectional surveys using the SF-36. J Epidemiol Community Health. 2019;73(1):65-72.
  94. Pamoukdjian F, Liuu E, Caillet P, Herbaud S, Gisselbrecht M, Poisson J, Boudou-Rouquette P, Zelek L, Paillaud E. How to Optimize Cancer Treatment in Older Patients: An Overview of Available Geriatric Tools. Am J Clin Oncol. 2019;42(2):109-116.
  95. Petrucciani N, Brunetti F, de'Angelis N. Urinary Tract Infection and Vaginal Purulent Flow in a Patient With Recurrent Sigmoiditis. Gastroenterology. 2019;156(1):e5-e7.
  96. Zehou O, Ferkal S, Brugières P, Barbarot S, Bastuji-Garin S, Combemale P, Valeyrie-Allanore L, Sbidian E, Wolkenstein P. Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial. J Invest Dermatol. 2019;139(3):718-720.
  97. Martinez-Tapia C, Canoui-Poitrine F, Caillet P, Bastuji-Garin S, Tournigand C, Assaf E, Varnier G, Pamoukdjian F, Brain E, Rollot-Trad F, Laurent M, Paillaud E. Preferences for surrogate designation and decision-making process in older versus younger adults with cancer: A comparative cross-sectional study. Patient Educ Couns. 2019;102(3):429-435.
  98. Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, de la Tour RPeffault, Bretagne S, Bastuji-Garin S. Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellula. Biol Blood Marrow Transplant. 2019;25(2):354-361.
  99. Belkacemi Y, Colson-Durand L, Fayolle-Campana M, Pons P, Rialland A, Bastuji-Garin S, Hoang QNguyen, Lerouge D, Jaffré F, Bollet M, Azria D. A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST Survey. Pract Radiat Oncol. 2019;9(2):108-114.
  100. Thuleau A, Gilbert C, Bauër P, Alran S, Fourchotte V, Guillot E, Vincent-Salomon A, Kerihuel J-C, Dugay J, Semetey V, Kriegel I, Fromantin I. A New Transcutaneous Method for Breast Cancer Detection with Dogs. Oncology. 2019;96(2):110-113.

2018

  1. Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, Hamel CEl, Lavergne D, Damy T, Aboyans V, Jaccard A. Author's reply. J Cardiol. 2018;72(4):368.
  2. Van Der Gucht A, Cottereau A-S, Abulizi M, Guellich A, Blanc-Durand P, Israël J-M, Galat A, Planté-Bordeneuve V, Dubois-Randé J-L, Bodez D, Rosso J, Damy T, Itti E. Apical sparing pattern of left ventricular myocardial Tc-HMDP uptake in patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2018;25(6):2072-2079.
  3. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018;379(11):1007-1016.
  4. Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, Hamel CEl, Lavergne D, Damy T, Aboyans V, Jaccard A. Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study. J Cardiol. 2018;71(4):419-427.
  5. Lefaucheur J-P, Zouari HG, Gorram F, Nordine T, Damy T, Planté-Bordeneuve V. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy. Clin Neurophysiol. 2018;129(8):1565-1569.
  6. Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018;39(30):2799-2806.
  7. d'Humières T, Fard D, Damy T, Roubille F, Galat A, Doan H-L, Oliver L, Dubois-Randé J-L, Squara P, Lim P, Ternacle J. Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure. Arch Cardiovasc Dis. 2018;111(10):582-590.
  8. Cantrelle C, Dorent R, Legeai C, Damy T, Bastien O, Tuppin P. Hospitalisation and life support in the year before and during heart transplantation: a French national study. Open Heart. 2018;5(2):e000913.
  9. Carment L, Abdellatif A, Lafuente-Lafuente C, Pariel S, Maier MA, Belmin J, Lindberg PG. Manual Dexterity and Aging: A Pilot Study Disentangling Sensorimotor From Cognitive Decline. Front Neurol. 2018;9:910.
  10. Chevance V, Damy T, Tacher V, Legou F, Ridouani F, Luciani A, Kobeiter H, Rahmouni A, Deux J-F. Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study. Eur Radiol. 2018;28(2):816-823.
  11. Abulizi M, Cottereau A-S, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Planté-Bordeneuve V, Dubois-Randé J-L, Bodez D, Rosso J, Damy T, Itti E. Early-phase myocardial uptake intensity of Tc-HMDP vs Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol. 2018;25(1):217-222.
  12. Pamoukdjian F, Tine S, Aber M, Ferreira A, Sebbane G, Paillaud E. [Not Available]. Soins Gerontol. 2018;23(130):45-46.
  13. McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, Pohjantähti-Maaroos H, Taylor J, Comin-Colet J. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018;20(12):1664-1672.
  14. Berthelot E, Bauer F, Eicher J-C, Flécher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, De Groote P, Damy T. Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues. ESC Heart Fail. 2018;5(5):755-763.
  15. Bulsei J, Darlington M, Durand-Zaleski I, Azizi M. How to perform a cost-effectiveness analysis with surrogate endpoint: renal denervation in patients with resistant hypertension (DENERHTN) trial as an example. Blood Press. 2018;27(2):66-72.
  16. Devillers L, Sicsic J, Delbarre A, Le Bel J, Ferrat E, Lary OSaint. General Practitioner trainers prescribe fewer antibiotics in primary care: Evidence from France. PLoS One. 2018;13(1):e0190522.
  17. Audureau E, Roux F, D Danic L, Bagot M, Cantagrel A, Dernis E, Gouyette N, Hilliquin P, Jullien D, Lioté F, Passeron T, Richard MA, Claudepierre P. Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'. J Eur Acad Dermatol Venereol. 2018;32(11):1950-1953.
  18. Bastard J-P, Fellahi S, Audureau E, Layese R, Roudot-Thoraval F, Cagnot C, Mahuas-Bourcier V, Sutton A, Ziol M, Capeau J, Nahon P. Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis. Eur Cytokine Netw. 2018;29(3):112-120.
  19. Winter A, Féray C, Audureau E, Azoulay D, Antoine C, Daurès J-P, Landais P. Author Correction: A Donor Quality Index for liver transplantation: development, internal and external validation. Sci Rep. 2018;8(1):15109.
  20. de'Angelis N, Abdalla S, Bianchi G, Memeo R, Charpy C, Petrucciani N, Sobhani I, Brunetti F. Robotic Versus Laparoscopic Colorectal Cancer Surgery in Elderly Patients: A Propensity Score Match Analysis. J Laparoendosc Adv Surg Tech A. 2018;28(11):1334-1345.
  21. Nigri G, Petrucciani N, Debs T, Mangogna LMaria, Crovetto A, Moschetta G, Persechino R, Aurello P, Ramacciato G. Treatment options for PNET liver metastases: a systematic review. World J Surg Oncol. 2018;16(1):142.
  22. Nigri G, Petrucciani N, Pinna ADaniele, Ravaioli M, Jovine E, Minni F, Grazi GLuca, Chirletti P, Balzano G, Ferla F, De Carlis L, Tisone G, Napoli N, Boggi U, Ramacciato G. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units. Int J Surg. 2018;55:103-109.
  23. Aparicio T, Bouché O, Francois E, Retornaz F, Barbier E, Taieb J, Kirscher S, Etienne P-L, Faroux R, F Akouz K, F Hajbi E, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Bedenne L, Paillaud E. Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer. Eur J Cancer. 2018;97:16-24.
  24. Fancellu A, Petrucciani N, Melis M, Porcu A, Feo CF, Zorcolo L, Nigri G. Usefulness of Infra-hepatic Inferior Vena Cava Clamping During Liver Resection: a Meta-analysis of Randomized Controlled Trials. J Gastrointest Surg. 2018;22(5):941-951.
  25. Petrucciani N, Debs T, Nigri G, Gugenheim J, Ramacciato G. What Is the Impact of Intraoperative Reresection After a Positive Pancreatic Margin Frozen Section in the Era of Perioperative Therapies?. Ann Surg. 2018;267(3):e55-e56.
  26. Petrucciani N, Martínez-Pérez A, Bianchi G, Memeo R, Brunetti F, Angelis NDe'. The use of laparoscopy for locally advanced rectal cancer. Minerva Chir. 2018;73(1):77-92.
  27. Ramacciato G, Petrucciani N, Nigri G. Open vs Minimally Invasive Approach in Pancreatic Surgery: Where Are We?. J Am Coll Surg. 2018;226(2):203-204.
  28. Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne P-L, Faroux R, F Akouz K, F Hajbi E, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, Francois E, Bedenne L. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results. Ann Oncol. 2018;29(1):133-138.
  29. Petrucciani N, Debs T, Nigri G, Giannini G, Sborlini E, Kassir R, Ben Amor I, Iannelli A, Valabrega S, D'Angelo F, Gugenheim J, Ramacciato G. Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review. HPB (Oxford). 2018;20(1):3-10.
  30. Saboundji K, Auliac J-B, Perol M, François G, Janicot H, Marcq M, Dubos-Arvis C, Renault A, Guisier F, Odier L, Gervais R, Chouaid C. Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors. Target Oncol. 2018;13(4):501-507.
  31. Locher C, Pourel N, Le Caer H, Bérard H, Auliac J-B, Monnet I, Descourt R, Vergnenègre A, Lafay IMartel, Greillier L, Chouaid C. Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06). Lung Cancer. 2018;121:25-29.
  32. Naccache J-M, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, Cadranel J. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10(6):3829-3844.
  33. Garassino MChiara, Cho B-C, Kim J-H, Mazières J, Vansteenkiste J, Lena H, Jaime JCorral, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. Lancet Oncol. 2018;19(4):521-536.
  34. Picchi H, Mateus C, Chouaid C, Besse B, Marabelle A, Michot JM, Champiat S, Voisin AL, Lambotte O. Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment. Clin Microbiol Infect. 2018;24(3):216-218.
  35. Gauvain C, Vauléon E, Chouaid C, Le Rhun E, Jabot L, Scherpereel A, Vinas F, Cortot ABenjamin, Monnet I. Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases. Lung Cancer. 2018;116:62-66.
  36. Babey H, Quere G, Descourt R, Le Calloch R, Lanfranco L, Nousbaum J-B, Cornec D, Tison A, Chouaid C. Immune-checkpoint inhibitors to treat cancers in specific immunocompromised populations: a critical review. Expert Rev Anticancer Ther. 2018;18(10):981-989.
  37. Vergnenègre A, Chouaid C. Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC). Expert Rev Pharmacoecon Outcomes Res. 2018;18(5):519-528.
  38. Bylicki O, Paleiron N, Rousseau-Bussac G, Chouaid C. New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab. Onco Targets Ther. 2018;11:4051-4064.
  39. Bennouna J, Falchero L, Schott R, Bonnetain F, Coudert M, Yahia BBen Hadj, Chouaid C. Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE). Oncology. 2018;94(1):55-64.
  40. la Martire G, Robin C, Oubaya N, Lepeule R, Beckerich F, Leclerc M, Barhoumi W, Toma A, Pautas C, Maury S, Akrout W, Cordonnier-Jourdin C, Fihman V, Venditti M, Cordonnier C. De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis. 2018;37(10):1931-1940.
  41. Barreau D, Bouton C, Renard V, Fournier J-P. Health sciences libraries' subscriptions to journals: expectations of general practice departments and collection-based analysis. J Med Libr Assoc. 2018;106(2):235-243.
  42. Gauthier M, Canoui-Poitrine F, Guery E, Desvaux D, Hue S, Canaud G, Stehlé T, Lang P, Kofman T, Grimbert P, Matignon M. Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey. Nephrol Dial Transplant. 2018;33(4):709-716.
  43. Serris A, Amoura Z, Canoui-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg J-E, Godeau B, Michel M. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults. Am J Hematol. 2018;93(3):424-429.
  44. Lemogne C, Turinici M, Panjo H, Ngo C, Canoui-Poitrine F, Chauvet-Gelinier J-C, Limosin F, Consoli SM, Goldberg M, Zins M, Ringa V. Personality and breast cancer screening in women of the GAZEL cohort study. Cancer Med. 2018;7(2):515-524.
  45. Contou D, Sonneville R, Canoui-Poitrine F, Colin G, Coudroy R, Pène F, Tadié J-M, Cour M, Béduneau G, Marchalot A, Guérin L, Jochmans S, Ehrmann S, Terzi N, Préau S, Barbier F, Schnell G, Roux D, Leroy O, Pichereau C, Gelisse E, Zafrani L, Layese R, Brun-Buisson C, Dessap AMekontso, de Prost N. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. Intensive Care Med. 2018;44(9):1502-1511.
  46. Hanon O, Vidal J-S, Lehmann S, Bombois S, Allinquant B, Tréluyer J-M, Gelé P, Delmaire C, Blanc F, Mangin J-F, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P-H, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella J-L, Duron E, Rigaud A-S, Schraen-Maschke S, Gabelle A. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Alzheimers Dement. 2018;14(7):858-868.
  47. Hentati H, Salloum C, Caillet P, Lahat E, Disabato M, Levesque E, Compagnon P, Lim C, Azoulay D. Risk Factors for Mortality and Morbidity in Elderly Patients Presenting with Digestive Surgical Emergencies. World J Surg. 2018;42(7):1988-1996.
  48. Derbez B. Is there a "right time" for bad news? Kairos in familial communication on hereditary breast and ovarian cancer risk. Soc Sci Med. 2018;202:13-19.
  49. Frasca M, Soubeyran P, Bellera C, Rainfray M, Leffondre K, Mathoulin-Pélissier S. Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer. Eur J Cancer. 2018;90:10-18.
  50. Sobhani I, Itti E, Luciani A, Baumgaertner I, Layese R, André T, Ducreux M, Gornet J-M, Goujon G, Aparicio T, Taieb J, Bachet J-B, Hemery F, Retbi A, Mons M, Flicoteaux R, Rhein B, Baron S, Cherrak I, Rufat P, Le Corvoisier P, de'Angelis N, Natella P-A, Maoulida H, Tournigand C, I Zaleski D, Bastuji-Garin S. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial. Ann Oncol. 2018;29(4):931-937.
  51. Magny E, Le Petitcorps H, Pociumban M, Bouksani-Kacher Z, Pautas É, Belmin J, Bastuji-Garin S, Lafuente-Lafuente C. Predisposing and precipitating factors for delirium in community-dwelling older adults admitted to hospital with this condition: A prospective case series. PLoS One. 2018;13(2):e0193034.
  52. Brenaut E, Bastuji-Garin S. [Notions of epidemiology of value in dermatology]. Ann Dermatol Venereol. 2018;145(2):129-140.
  53. Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim S-W, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim D-W, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB. Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2018;13(4):576-584.
  54. Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouze E, Audureau E, Roudot-Thoraval F. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018;68(4):1245-1259.
  55. Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Roudot-Thoraval F, Audureau E. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Gastroenterology. 2018;155(5):1436-1450.e6.
  56. Heidet M, Amathieu R, Audureau E, Augusto O, de Barmon VNicolazo, Rialland A, Schmitz D, Pierrang F, Marty J, Chollet-Xémard C, Thirion O, Jacob L. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study). BMJ Open. 2018;8(8):e021943.
  57. Bassez G, Audureau E, Hogrel J-Y, Arrouasse R, Baghdoyan S, Bhugaloo H, Gourlay-Chu M-L, Le Corvoisier P, Peschanski M. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain. 2018;141(10):2855-2865.
  58. Heidet M, Mermet É, Vaux J, Jérémie R, Audureau E, Marty J. Simulated EMS response times until patients located in public train stations: A geospatial model to improve on-foot accessibility. Resuscitation. 2018;131:e3-e5.
  59. Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux J-F. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J Cardiovasc Magn Reson. 2018;20(1):58.
  60. Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouze E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study. Gastroenterology. 2018;155(2):431-442.e10.
  61. Winter A, Féray C, Audureau E, Azoulay D, Antoine C, Daurès J-P, Landais P. A Donor Quality Index for liver transplantation: development, internal and external validation. Sci Rep. 2018;8(1):9871.
  62. Boyer L, Bastuji-Garin S, Chouaid C, Housset B, Le Corvoisier P, Derumeaux G, Boczkowski J, Maitre B, Adnot S, Audureau E. Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach. Sci Rep. 2018;8(1):8569.
  63. Audureau E, Simon-Deckers A, Franco-Montoya M-L, Annangi B, Kermanizadeh A, Boczkowski J, Lanone S. Substantial modification of the gene expression profile following exposure of macrophages to welding-related nanoparticles. Sci Rep. 2018;8(1):8554.
  64. Bocahut N, Audureau E, Poignard A, Delambre J, Queinnec S, Lachaniette C-HFlouzat, Allain J. Incidence and impact of implant subsidence after stand-alone lateral lumbar interbody fusion. Orthop Traumatol Surg Res. 2018;104(3):405-410.
  65. Ferrat E, Bastuji-Garin S, Paillaud E, Caillet P, Clerc P, Moscova L, Gouja A, Renard V, Attali C, Le Breton J, Audureau E. Efficacy of nurse-led and general practitioner-led comprehensive geriatric assessment in primary care: protocol of a pragmatic three-arm cluster randomised controlled trial (CEpiA study). BMJ Open. 2018;8(4):e020597.
  66. Cacoub P, Nahon P, Layese R, Blaise L, Desbois AClaire, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CIsnard, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. Am Heart J. 2018;198:4-17.
  67. Teiger E, Thambo J-B, Defaye P, Hermida J-S, Abbey S, Klug D, Juliard J-M, Pasquie J-L, Rioufol G, Lepillier A, Elbaz M, Horvilleur J, Brenot P, Pierre B, Le Corvoisier P. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events. Circ Cardiovasc Interv. 2018;11(3):e005841.
  68. Blondiaux E, Chougar L, Gelot A, Valence S, Audureau E, le Pointe HDucou, Jouannic J-M, Dhombres F, Garel C. Developmental patterns of fetal fat and corresponding signal on T1-weighted magnetic resonance imaging. Pediatr Radiol. 2018;48(3):317-324.
  69. Schlemmer F, Boyer L, Soumagne T, Ridoux A, Chouaid C, Maitre B, Lanone S, Adnot S, Audureau E, Boczkowski J. Beclin1 circulating levels and accelerated aging markers in COPD. Cell Death Dis. 2018;9(2):156.
  70. Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, Zouaoui S, Guyotat J, Le Reste P-J, Faillot T, Litre F, Desse N, Petit A, Emery E, Lechapt-Zalcman E, Peltier J, Duntze J, Dezamis E, Voirin J, Menei P, Caire F, Hieu PDam, Barat J-L, Langlois O, Vignes J-R, Fabbro-Peray P, Riondel A, Sorbets E, Zanello M, Roux A, Carpentier A, Bauchet L, Pallud J. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol. 2018;136(3):565-576.
  71. Audureau E, Guellich A, Guery E, Canoui-Poitrine F, Benedyga V, Duchossoir H, Taieb C, Damy T. Development and Validation of a New Tool to Assess Burden of Dietary Sodium Restriction in Patients with Chronic Heart Failure: The BIRD Questionnaire. Nutrients. 2018;10(10).
  72. Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P. Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial. Lancet Haematol. 2018;5(11):e554-e562.
  73. Le Corvoisier P, Gallet R, Lesault P-F, Audureau E, Paul M, Ternacle J, Ghostine S, Champagne S, Arrouasse R, Bitari D, Mouillet G, Dubois-Randé J-L, Berdeaux A, Ghaleh B, Deux J-F, Teiger E. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial. BMC Cardiovasc Disord. 2018;18(1):193.
  74. Franco I, de'Angelis N, Canoui-Poitrine F, Le Roy B, Courtot L, Voron T, Aprodu R, Salamé E, Saleh NBou, Berger A, Ouaïssi M, Altomare DFrancesco, Pezet D, Mutter D, Brunetti F, Memeo R. Feasibility and Safety of Laparoscopic Right Colectomy in Oldest-Old Patients with Colon Cancer: Results of the CLIMHET Study Group. J Laparoendosc Adv Surg Tech A. 2018;28(11):1326-1333.
  75. Paillaud E, Soubeyran P, Caillet P, Cudennec T, Brain E, Terret C, Etchepare F, Mourey L, Aparicio T, Pamoukdjian F, Audisio RA, Rostoft S, Hurria A, Bellera C, Mathoulin-Pélissier S. Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. Eur J Cancer. 2018;103:61-68.
  76. Bush SH, Lawlor PG, Ryan K, Centeno C, Lucchesi M, Kanji S, Siddiqi N, Morandi A, Davis DHJ, Laurent M, Schofield N, Barallat E, Ripamonti CI. Delirium in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv143-iv165.
  77. Wendum D, Layese R, Ganne-Carrié N, Bourcier V, Merabtene F, Cagnot C, Sauce E, Barget N, Bedossa P, Terris B, Selves J, Bioulac-Sage P, Sturm N, Sattonnet C, Nahon P, Roudot-Thoraval F, Ziol M. Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Hepatology. 2018;68(4):1534-1548.
  78. Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, Schmutz JL, Beneton N, Mahé E, Viguier M, Chosidow O, Canoui-Poitrine F, Sbidian E. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol. 2018;32(11):1920-1929.
  79. de'Angelis N, Petrucciani N, Giannandrea G, Brunetti F. The protocol of low-impact laparoscopic cholecystectomy: the combination of mini-laparoscopy and low-pressure pneumoperitoneum. Updates Surg. 2018;70(4):553-556.
  80. Debs T, Petrucciani N, Kassir R, Sejor E, Karam S, Ben Amor I, Gugenheim J. Complications after laparoscopic sleeve gastrectomy: can we approach a 0% rate using the largest staple height with reinforcement all along the staple line? Short-term results and technical considerations. Surg Obes Relat Dis. 2018;14(12):1804-1810.
  81. Petrucciani N, de'Angelis N, Brunetti F. Robotic Toupet fundoplication following Heller myotomy for achalasia (with video). J Visc Surg. 2018;155(5):427-428.
  82. Auliac JB, Bayle S, Vergnenegre A, Le Caer H, Falchero L, Gervais R, Doubre H, Vinas F, Marin B, Chouaid C. Patients with non-small-cell lung cancer harbouring a mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14. Curr Oncol. 2018;25(5):e398-e402.
  83. Scherpereel A, Durand-Zaleski I, Cotté F-E, Fernandes J, Debieuvre D, Blein C, Gaudin A-F, Tournier C, Vainchtock A, Chauvin P, Souquet P-J, Westeel V, Chouaid C. Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study. BMC Cancer. 2018;18(1):1013.
  84. Lesueur P, Escande A, Thariat J, Vauléon E, Monnet I, Cortot A, Lerouge D, Danhier S, Do P, Dubos-Arvis C, Chouaid C, Gervais R. Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC. Cancer Med. 2018;7(11):5505-5513.
  85. Bigay-Gamé L, Bota S, Greillier L, Monnet I, Madroszyk A, Corre R, Mastroianni B, Falchero L, Mazières J, Colineaux H, Lepage B, Chouaid C. Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France. Oncology. 2018;95(6):337-343.
  86. Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz P-E, Revel M-P, Westeel V, Dixmier A, Trédaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria J-C, Friard S, Stern J-B, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani J-M, Alifano M, Chatellier G, Girard P. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Eur Respir J. 2018;52(4).
  87. Lesueur P, Martel-Laffay I, Escande A, Kissel M, Locher C, Gervais R, Schott R, Vergnenègre A, Chouaid C. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. Expert Rev Anticancer Ther. 2018;18(11):1159-1165.
  88. Chouaid C, Danson S, Andreas S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M-H, Barth J, Hoffmann H, Potter V, Barlesi F, Price M, Chirila C, Hollis K, Sweeney C, Wolowacz S, Kaye JA, Kontoudis I. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer. 2018;124:310-316.
  89. Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M-H, Barth J, Hoffmann H, Potter V, Barlesi F, Chirila C, Hollis K, Sweeney C, Price M, Wolowacz S, Kaye JA, Kontoudis I. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer. 2018;124:298-309.
  90. Costantini A, Corny J, Fallet V, Renet S, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Nguenang M, Jouveshomme S, Wislez M, Trédaniel J, Cadranel J. Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer. ERJ Open Res. 2018;4(2).
  91. Corre R, Gervais R, Guisier F, Tassy L, Vinas F, Lamy R, Fraboulet G, Greillier L, Doubre H, Descourt R, Chouaid C, Auliac J-B. Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study). Oncotarget. 2018;9(9):8253-8262.
  92. Chouaid C, Assié JBaptiste, Andujar P, Blein C, Tournier C, Vainchtock A, Scherpereel A, Monnet I, Pairon JClaude. Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis. Cancer Med. 2018;7(4):1102-1109.
  93. Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazières J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenègre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B. Real-life experience of ceritinib in crizotinib-pretreated advanced non-small cell lung cancer patients. ERJ Open Res. 2018;4(1).
  94. Remy P, Audard V, Natella PAndré, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Sahlia NAit, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Kidney Int. 2018;94(6):1217-1226.
  95. Hersant B, SidAhmed-Mezi M, Belkacemi Y, Darmon F, Bastuji-Garin S, Werkoff G, Bosc R, Niddam J, Hermeziu O, La Padula S, Meningaud JPaul. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. 2018;25(10):1124-1130.
  96. Thuleau A, Dugay J, Dacremont C, Jemmali Z, Elard J, De Ricke Y, Cassoux N, Watson S, Escande M-C, Fromantin I. Volatile Organic Compounds of Malignant Breast Cancer Wounds: Identification and Odors. Wounds. 2018;30(11):337–344.
  97. Kofman T, Pourcine F, Canoui-Poitrine F, Kamar N, Malvezzi P, François H, Boutin E, Audard V, Lang P, Martinez F, Legendre C, Matignon M, Grimbert P. Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study. Transpl Int. 2018;31(4):377-385.
  98. Rwabihama J-P, Audureau E, Laurent M, Rakotoarisoa L, Jegou M, Saddedine S, Krypciak S, Herbaud S, Benzengli H, Segaux L, Guery E, Ambime G, Rabus M-T, Perilliat J-G, David J-P, Paillaud E. Prophylaxis of Venous Thromboembolism in Geriatric Settings: A Cluster-Randomized Multicomponent Interventional Trial. J Am Med Dir Assoc. 2018;19(6):497-503.
  99. Laurent M, Guetz GDes, Bastuji-Garin S, Culine S, Caillet P, Aparicio T, Audureau E, Carvahlo-Verlinde M, Reinald N, Tournigand C, Landre T, LeThuaut A, Paillaud E, Canoui-Poitrine F. Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6. Am J Clin Oncol. 2018;41(1):73-80.
  100. Fonteyne V, Ost P, Bellmunt J, Droz JPierre, Mongiat-Artus P, Inman B, Paillaud E, Saad F, Ploussard G. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur Urol. 2018;73(1):40-50.
  101. Paillaud E, Bastuji-Garin S, Plonquet A, Foucat E, Fournier B, Boutin E, Le Thuaut A, Levy Y, Hue S. Combined Plasma Elevation of CRP, Intestinal-Type Fatty Acid-Binding Protein (I-FABP), and sCD14 Identify Older Patients at High Risk for Health Care-Associated Infections. J Gerontol A Biol Sci Med Sci. 2018;73(2):211-217.
  102. Boutin E, Natella P-A, Schott A-M, Bastuji-Garin S, David J-P, Paillaud E, Rolland Y, Canoui-Poitrine F. Interrelations between body mass index, frailty, and clinical adverse events in older community-dwelling women: The EPIDOS cohort study. Clin Nutr. 2018;37(5):1638-1644.
  103. Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga J-M, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G. High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol. 2018;25(1):120-127.
  104. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin Nutr. 2018;37(4):1101-1113.

2017

  1. Hagege M. [Hepatitis C in prison: an opportunity for healthcare]. Sante Publique. 2017;29(4):563-567.
  2. Engels C. [Generation Y healthcare students’ expectations: hard skills but also soft skills.]. Rech Soins Infirm. 2017;(131):41-51.
  3. Debs T, Petrucciani N, Kassir R, Chassang M, Havet J, Piche T, Ben Amor I, Gugenheim J. Double Perforation of Marginal Ulcers after One Anastomosis Gastric Bypass with a Biliary Peritonitis. Obes Surg. 2017;27(11):2993-2995.
  4. Mege D, Petrucciani N, Maggiori L, Panis Y. Peritoneal perforation is less a complication than an expected event during transanal endoscopic microsurgery: experience from 194 consecutive cases. Tech Coloproctol. 2017;21(9):729-736.
  5. Petrucciani N, Debs T, Nigri G, D'Angelo F, Gugenheim J, Ramacciato G. Borderline resectable pancreatic cancer: an evolving concept. Ann Oncol. 2017;28(9):2315.
  6. Debs T, Petrucciani N, Gugenheim J. Why Would a Patient Complain of Dysphagia and Heartburn After Multiple Bariatric Surgeries?. Gastroenterology. 2017;153(3):653-654.
  7. Aurello P, Petrucciani N', Sirimarco D, Mangogna LMaria, Nigri G, Valabrega S, D'Angelo F, Ramacciato G. Esophagectomy with Esophagocoloplasty for Malignancies: Indications, Technique (with Video), and Results. Systematic Review of the Literature. J Gastrointest Surg. 2017;21(9):1557-1561.
  8. Kassir R, Debs T, Petrucciani N, Tiffet O, Ben Amor I, Gugenheim J. Predictive Value of C-Reactive Protein for Complications Post-Laparoscopic Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(9):2460-2461.
  9. Kassir R, Lointier P, Tiffet O, Debs T, Petrucciani N, Kassir R, Ben Amor I, Gugenheim J. Revision bariatric surgery: What technical choices should be taken depending on the first intervention?. Int J Surg. 2017;44:7-8.
  10. Petrucciani N, Debs T, Kassir R, Ben Amor I, Gugenheim J. Gastric Bypass and Synchronous Cholecystectomy: a Matter of Numbers?. Obes Surg. 2017;27(8):2174-2176.
  11. Petrucciani N, Debs T, Ciampi D, Massalou D, Kassir R, Ben Amor I, Gugenheim J. Rare Cause of Small Bowel Ischemia During Pregnancy After Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(7):1879-1881.
  12. Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it?. World J Gastroenterol. 2017;23(19):3379-3387.
  13. Debs T, Petrucciani N, Kassir R, Vanbiervliet G, Ben Amor I, Staccini AMyx, Sejor E, Gugenheim J. Migration of an Endoscopic Double Pigtail Drain into the Abdominal Wall Placed as a Treatment of a Fistula Post Revisional Bariatric Surgery. Obes Surg. 2017;27(5):1335-1337.
  14. Ben Amor I, Petrucciani N, Kassir R, Munifi AAl, Piche T, Debs T, Gugenheim J. Laparoscopic Conversion of One Anastomosis Gastric Bypass to a Standard Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(5):1398.
  15. Debs T, Petrucciani N, Kassir R, Ouvrier D, Frin AClaire, Ben Amor I, Gugenheim J. Chylous leak after pancreatic resection: A grading system was needed. Surgery. 2017;162(6):1345.
  16. Ramacciato G, Nigri G, Petrucciani N', Pinna ADaniele, Ravaioli M, Jovine E, Minni F, Grazi GLuca, Chirletti P, Tisone G, Ferla F, Napoli N', Boggi U. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. BMC Surg. 2017;17(1):109.
  17. Le Caer H, Borget I, Corre R, Locher C, Raynaud C, Decroisette C, Bérard H, Audigier-Valette C, Dujon C, Auliac JBernard, Crequit J, Monnet I, Vergnenègre A, Chouaid C. Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group. J Thorac Dis. 2017;9(10):3747-3754.
  18. Paris C, Do P, Mastroianni B, Dixmier A, Dumont P, Pichon E, Chouaid C, Coudert B, Foucher P, Fraboulet S, Locatelli-Sanchez M, Baize N, Dansin E, Moreau L, Vincent M, Missy P, Morin F, Moro-Sibilot D, Couraud S. Association between lung cancer somatic mutations and occupational exposure in never-smokers. Eur Respir J. 2017;50(4).
  19. Tordrup D, Chouaid C, Cuijpers P, Dab W, van Dongen JMaria, Espin J, Jönsson B, Léonard C, McDaid D, McKee M, Miguel JPereira, Patel A, Reginster J-Y, Ricciardi W, van Molken MRutten-, Rupel VPrevolnik, Sach T, Sassi F, Waugh N, Bertollini R. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION. Int J Technol Assess Health Care. 2017;33(6):609-619.
  20. Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S. Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France. Clinicoecon Outcomes Res. 2017;9:655-668.
  21. Etienne H, Majewski M, Cochennec F, Segaux L, Becquemin J-P. Emergency Endovascular Interventions for Ruptured Descending Thoracic Aortic Aneurysm. Ann Vasc Surg. 2017;39:160-166.
  22. Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, Castaing D, Cherqui D, Irtan S, Calmus Y, Chazouillères O, Soubrane O, Luciani A, Féray C. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study. Ann Surg. 2017;266(6):1035-1044.
  23. Caillet P, Liuu E, Simon ARaynaud, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C, Ferry M, Rolland Y, Paillaud E. Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clin Nutr. 2017;36(6):1473-1482.
  24. Jourjon R, Morel B, Irtan S, Audureau E, Coulomb-L'Herminé A, Larroquet M, le Pointe HDucou, Blondiaux E. Analysis of Clinical and Ultrasound Determinants of Adnexal Torsion in Children and Adolescents. J Pediatr Adolesc Gynecol. 2017;30(5):582-590.
  25. Gross J, Oubaya N, Eymard F, Hourdille A, Chevalier X, Guignard S. Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case-control study. Scand J Rheumatol. 2017;46(6):507-508.
  26. Ferrat E, Paillaud E, Caillet P, Laurent M, Tournigand C, Lagrange J-L, Droz J-P, Balducci L, Audureau E, Canoui-Poitrine F, Bastuji-Garin S. Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study. J Clin Oncol. 2017;35(7):766-777.
  27. Ernande L, Audureau E, Jellis CL, Bergerot C, Henegar C, Sawaki D, Czibik G, Volpi C, Canoui-Poitrine F, Thibault H, Ternacle J, Moulin P, Marwick TH, Derumeaux G. Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus. J Am Coll Cardiol. 2017;70(14):1704-1716.
  28. Deux J-F, Audard V, Brugières P, Habibi A, Manea E-M, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises. Am J Kidney Dis. 2017;69(1):51-59.
  29. Derbez B, de Pauw A, Stoppa-Lyonnet D, de Montgolfier S. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics. Fam Cancer. 2017;16(3):447-457.
  30. Delva F, Margery J, Laurent F, Petitprez K, Pairon J-C. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. BMC Public Health. 2017;17(1):191.
  31. Chouaid C, Luciani L, LeLay K, Do P, Bennouna J, Perol M, Moro-Sibilot D, Vergnenègre A, de Pouvourville G. Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers. J Thorac Oncol. 2017;12(10):1496-1502.
  32. Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E. Cost analysis of adverse events associated with non-small cell lung cancer management in France. Clinicoecon Outcomes Res. 2017;9:443-449.
  33. Chouaid C, Falchero L, Schott R, Bonnetain F, Taguieva-Pioger N, Bennouna J. [Bevacizumab in combination with first-line treatment for metastatic non-small cell lung cancer in clinical practice. Results of the EOLE study]. Rev Mal Respir. 2017;34(1):36-43.
  34. Chouaid C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, Blein C, Gaudin A-F, Ozan N, Leblanc S, Vainchtock A, Chauvin P, Cotté F-E, Souquet P-J. Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLoS One. 2017;12(8):e0182798.
  35. Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial. Intensive Care Med. 2017;43(11):1613-1625.
  36. Caliez J, Monnet I, Pujals A, Rousseau-Bussac G, Jabot L, Boudjemaa A, Leroy K, Chouaid C. [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement]. Rev Mal Respir. 2017;34(5):576-580.
  37. Cadier B, Bulsei J, Nahon P, Seror O, Laurent A, Rosa I, Layese R, Costentin C, Cagnot C, Durand-Zaleski I, Chevreul K. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. Hepatology. 2017;65(4):1237-1248.
  38. Bylicki O, Paleiron N, Margery J, Guisier F, Vergnenègre A, Robinet G, Auliac J-B, Gervais R, Chouaid C. Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer. Target Oncol. 2017;12(5):563-569.
  39. Boussageon R, Pouchain D, Renard V. Prevention of complications in type 2 diabetes: is drug glucose control evidence based?. Br J Gen Pract. 2017;67(655):85-87.
  40. Blondiaux E, Pidial L, Autret G, Rahmi G, Balvay D, Audureau E, Wilhelm C, Guerin CL, Bruneval P, Silvestre J-S, Menasché P, Clément O. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction. J Tissue Eng Regen Med. 2017;11(12):3417-3427.
  41. Béquignon E, Guellich A, Bartier S, Raynal M, Prulière-Escabasse V, Canoui-Poitrine F, Coste A, Damy T. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study. Amyloid. 2017;24(2):96-100.
  42. Baize N, Monnet I, Greillier L, Quere G, Kerjouan M, Janicot H, Vergnenègre A, Auliac JBernard, Chouaid C. Second-line treatments of small-cell lung cancers. Expert Rev Anticancer Ther. 2017;17(11):1033-1043.
  43. Auliac J-B, Monnet I, Dubos-Arvis C, Chiappa AMarie, Baize N, Bota S, Vergnenègre A, Doubre H, Locher C, Bizieux A, Robinet G, Chouaid C. Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study). Target Oncol. 2017;12(6):833-838.
  44. Audureau E, Hua C, de Prost N, Hemery F, Decousser JW, Bosc R, Lepeule R, Chosidow O, Sbidian E. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12. Br J Dermatol. 2017;177(6):1575-1582.
  45. Winter A, Féray C, Audureau E, Écochard R, Jacquelinet C, Roudot-Thoraval F, Duvoux C, Daurès J-P, Landais P. External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry. Liver Int. 2017;37(8):1229-1238.
  46. Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet J-M, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier A-L, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X. Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis. J Crohns Colitis. 2017;11(8):930-935.
  47. Toumi M, Motrunich A, Millier A, Rémuzat C, Chouaid C, Falissard B, Aballéa S. Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment. J Mark Access Health Policy. 2017;5(1):1344088.
  48. Touma J, Kashi M, Oubaya N, Cochennec F, Allaire E, Marzelle J, Becquemin J-P, Desgranges P. Results of Cryopreserved Arterial Allografts to Treat Infections of Peripheral Bypasses. Ann Vasc Surg. 2017;38:e2.
  49. Ternacle J, Wan F, Sawaki D, Surenaud M, Pini M, Mercedes R, Ernande L, Audureau E, Dubois-Randé J-L, Adnot S, Hue S, Czibik G, Derumeaux G. Short-term high-fat diet compromises myocardial function: a radial strain rate imaging study. Eur Heart J Cardiovasc Imaging. 2017;18(11):1283-1291.
  50. Taipale K, Winfree KB, Boye M, Basson M, Sleilaty G, Eaton J, Evans R, Chouaid C. A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France. Clinicoecon Outcomes Res. 2017;9:505-518.
  51. Stücker I, Martin D, Neri M, Laurent-Puig P, Blons H, Antoine M, Guiochon-Mantel A, Brailly-Tabard S, Canonico M, Wislez M, Trédaniel J. Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank. BMC Public Health. 2017;17(1):324.
  52. Soreze Y, Audureau E, Decobert F, Jaby O, Blary S, Danan C, Durrmeyer X. Reduced Sufentanil Doses are Effective for Postoperative Analgesia After Ductal Closure in Extremely Premature Infants: A 10 Years Retrospective Cohort Study. Clin J Pain. 2017;33(12):1109-1116.
  53. Rahmi G, Vinet M-A, Perrod G, Saurin J-C, Samaha E, Ponchon T, Canard J-M, Edery J, Maoulida H, Chatellier G, Durand-Zaleski I, Cellier C. Efficacy of double-balloon enteroscopy for small-bowel polypectomy: clinical and economic evaluation. Therap Adv Gastroenterol. 2017;10(6):465-472.
  54. Pouessel D, Bastuji-Garin S, Houédé N, Vordos D, Loriot Y, Chevreau C, Sevin E, Beuzeboc P, de la Taille A, Le Thuaut A, Allory Y, Culine S. Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort. Clin Genitourin Cancer. 2017;15(1):e45-e52.
  55. Plichart M, Orvoën G, Jourdain P, Quinquis L, Coste J, Escande M, Friocourt P, Paillaud E, Chedhomme F-X, Labourée F, Boully C, Benetos A, Domerego J-J, Komajda M, Hanon O. Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study. Eur J Heart Fail. 2017;19(4):540-548.
  56. Paul E, Franco-Montoya M-L, Paineau E, Angeletti B, Vibhushan S, Ridoux A, Tiendrebeogo A, Salome M, Hesse B, Vantelon D, Rose J, Canoui-Poitrine F, Boczkowski J, Lanone S, Delacourt C, Pairon J-C. Pulmonary exposure to metallic nanomaterials during pregnancy irreversibly impairs lung development of the offspring. Nanotoxicology. 2017;11(4):484-495.
  57. Parpaleix A, Boyer L, Wiedemann A, Lacabaratz C, Margarit L, Enouf V, Le Corvoisier P, Lino A, Covali-Noroc A, Housset B, Chouaid C, Maitre B, Levy Y, Lelièvre J-D, Adnot S. Impaired humoral and cellular immune responses to influenza vaccination in chronic obstructive pulmonary disease patients. J Allergy Clin Immunol. 2017;140(6):1754-1757.e6.
  58. Pamoukdjian F, Lévy V, Sebbane G, Boubaya M, Landre T, Bloch-Queyrat C, Paillaud E, Zelek L. Slow Gait Speed Is an Independent Predictor of Early Death in Older Cancer Outpatients: Results from a Prospective Cohort Study. J Nutr Health Aging. 2017;21(2):202-206.
  59. Pamoukdjian F, Canoui-Poitrine F, Longelin-Lombard C, Aparicio T, Ganne N, Wind P, Martinez-Tapia C, Audureau E, Sebbane G, Zelek L, Paillaud E. Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study. Oncotarget. 2017;8(31):50393-50402.
  60. Pamoukdjian F, Aparicio T, Zelek L, Boubaya M, Caillet P, François V, de Decker L, Lévy V, Sebbane G, Paillaud E. Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort study. J Geriatr Oncol. 2017;8(3):190-195.
  61. Paillaud E, Canoui-Poitrine F, Varnier G, Anfasi-Ebadi N, Guery E, Saint-Jean O, Gisselbrecht M, Aparicio T, Bastuji-Garin S, Laurent M, Caillet P. Preferences about information and decision-making among older patients with and without cancer. Age Ageing. 2017;46(4):665-671.
  62. Oubaya N, Dramé M, Novella J-L, Quignard E, Cunin C, Jolly D, Mahmoudi R. Screening for frailty in community-dwelling elderly subjects: Predictive validity of the modified SEGA instrument. Arch Gerontol Geriatr. 2017;73:177-181.
  63. Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, Miglioresi L, Vitale A, Vennarecci G, Ambrosio CD, Burra P, Di Benedetto F, Fagiuoli S, Colasanti M, Ettorre GMaria, Andreoli A, Cillo U, Laurent A, Katsahian S, Audureau E, Roudot-Thoraval F, Duvoux C. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. J Hepatol. 2017;66(3):552-559.
  64. Natella P-A, Le Corvoisier P, Paillaud E, Renaud B, Mahé I, Bergmann J-F, Perchet H, Mottier D, Montagne O, Bastuji-Garin S. Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study. BMC Geriatr. 2017;17(1):34.
  65. Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Goria O, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Trinchet J-C, Moreau R, Roudot-Thoraval F. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut. 2017;66(2):330-341.
  66. Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Leroy V, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. Gastroenterology. 2017;152(1):142-156.e2.
  67. Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study. Transpl Int. 2017;30(3):277-287.
  68. Matignon M, Pilon C, Commereuc M, Grondin C, Leibler C, Kofman T, Audard V, Cohen J, Canoui-Poitrine F, Grimbert P. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study. PLoS One. 2017;12(6):e0178572.
  69. Martinez-Tapia C, Paillaud E, Liuu E, Tournigand C, Ibrahim R, Fossey-Diaz V, Culine S, Canoui-Poitrine F, Audureau E. Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer. Eur J Cancer. 2017;83:211-219.
  70. Laurent M, Brureau L, Demery MEl, Fléchon A, Le Thuaut A, Carvahlo-Verlinde M, Bastuji-Garin S, Paillaud E, Canoui-Poitrine F, Culine S. Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study. Urol Oncol. 2017;35(1):34.e9-34.e16.
  71. Ladner J, Rodrigues M, Davis B, Besson M-H, Audureau E, Saba J. Societal impact of dengue outbreaks: Stakeholder perceptions and related implications. A qualitative study in Brazil, 2015. PLoS Negl Trop Dis. 2017;11(3):e0005366.
  72. Ladner J, Davis B, Audureau E, Saba J. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries. Malar J. 2017;16(1):353.

2016

  1. Petrucciani N', Nigri G, Debs T, Giannini G, Sborlini E, Antolino L, Aurello P, D'Angelo F, Gugenheim J, Ramacciato G. Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: Does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology. 2016;16(6):1037-1043.
  2. Blondiaux J, Naji S, Audureau E, Colard T. Cementochronology and sex: A reappraisal of sex-associated differences in survival in past French societies. Int J Paleopathol. 2016;15:152-163.
  3. Duguet AM, Masmoudi T, Duchier J, Rwabihama J-P, Maatoug S. Access to Care in France for Elderly Immigrants from North Africa: Influence of Socio-cultural Factors (the MATC Survey). Eur J Health Law. 2016;23(5):470-80.
  4. Cabaret O, Bonnal C, Canoui-Poitrine F, Emirian A, Bizouard G, Levesque E, Maitre B, Fihman V, Decousser J-W, Botterel F. Concomitant presence of Aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease?. J Med Microbiol. 2016;65(5):414-419.
  5. Bressy G, Brun V, Ferrier A, Dujardin D, Oubaya N, Morel N, Fontanin N, Ohl X. Lack of stability at more than 12 months of follow-up after anterior cruciate ligament reconstruction using all-inside quadruple-stranded semitendinosus graft with adjustable cortical button fixation in both femoral and tibial sides. Orthop Traumatol Surg Res. 2016;102(7):867-872.
  6. Boyer L, Audureau E, Margarit L, Marcos E, Bizard E, Le Corvoisier P, Macquin-Mavier I, Derumeaux G, Damy T, Drouot X, Covali-Noroc A, Boczkowski J, Bastuji-Garin S, Adnot S. Telomere Shortening in Middle-Aged Men with Sleep-disordered Breathing. Ann Am Thorac Soc. 2016;13(7):1136-43.
  7. Blondiaux E, Laurent M, Audureau E, Boudjemaa S, Sileo C, Lenoir M, Dainese L, Garel C, Coulomb A, le Pointe HDucou. Factors influencing the diagnostic yield and accuracy of image-guided percutaneous needle biopsy of pediatric tumors: single-center audit of a 26-year experience. Pediatr Radiol. 2016;46(3):372-82.
  8. Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MGeorgine, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galactéros F, Audard V. Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease. J Am Soc Nephrol. 2016;27(6):1847-53.
  9. Balkau B, Halimi S, Blickle J-F, Vergès B, Avignon A, Attali C, Chartier I, Amelineau E. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study. Ann Endocrinol (Paris). 2016;77(6):649-657.
  10. Auliac JB, Fournier C, C Valette A, Perol M, Bizieux A, Vinas F, C van Ho DPhan, S Ouchlif B, Corre R, Le Garff G, Fournel P, Baize N, Lamy R, Vergnenegre A, Arpin D, Marin B, Chouaid C, Gervais R. Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study. Target Oncol. 2016;11(2):167-74.
  11. Audureau E, Pouchot J, Coste J. Gender-Related Differential Effects of Obesity on Health-Related Quality of Life via Obesity-Related Comorbidities: A Mediation Analysis of a French Nationwide Survey. Circ Cardiovasc Qual Outcomes. 2016;9(3):246-56.
  12. Atsou K, Créquit P, Chouaid C, Hejblum G. Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France. PLoS One. 2016;11(6):e0156514.
  13. Aparicio T, Pamoukdjian F, Quero L, Manfredi S, Wind P, Paillaud E. Colorectal cancer care in elderly patients: Unsolved issues. Dig Liver Dis. 2016;48(10):1112-8.
  14. Aparicio T, Francois E, Cristol-Dalstein L, Carola E, Maillard E, Paillaud E, Retornaz F, Faroux R, André T, Bedenne L, Seitz J-F. PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial. Dig Liver Dis. 2016;48(2):206-7.
  15. Dweik BAl, Redjoul R, Bastuji-Garin S, Beckerich F, Robin C, Pautas C, Toma A, Cabanne L, Maury S, Cordonnier C. Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration. Am J Hematol. 2016;91(4):E276-8.
  16. Lim C, Audureau E, Salloum C, Levesque E, Lahat E, Merle JClaude, Compagnon P, Dhonneur G, Féray C, Azoulay D. Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value. HPB (Oxford). 2016;18(6):540-8.
  17. Le Breton J, Ferrat E, Attali C, Bercier S, Le Corvoisier P, Brixi Z, Veerabudun K, Renard V, Bastuji-Garin S. Effect of reminders mailed to general practitioners on colorectal cancer screening adherence: a cluster-randomized trial. Eur J Cancer Prev. 2016;25(5):380-7.
  18. Lazzati A, Audureau E, Hemery F, Schneck A-S, Gugenheim J, Azoulay D, Iannelli A. Reduction in early mortality outcomes after bariatric surgery in France between 2007 and 2012: A nationwide study of 133,000 obese patients. Surgery. 2016;159(2):467-74.
  19. Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, Van Ganse E. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respir Med. 2016;117:33-9.
  20. Ladner J, Besson M-H, Audureau E, Rodrigues M, Saba J. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014. BMC Health Serv Res. 2016;16(1):575.
  21. Krypciak S, Liuu E, Minard A, Obraztsova A, Paillaud E. [Orthostatic hypotension in elderly: a case-control study]. Soins Gerontol. 2016;(117):37-43.
  22. Kempf E, Caillet P, Rousseau B, Le Thuaut A, Bastuji-Garin S, Liuu E, Lagrange J-L, Tournigand C, Paillaud E, Canoui-Poitrine F. What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA-08 Cohort Study. J Am Geriatr Soc. 2016;64(6):1360-2.
  23. Kanagaratnam L, Dramé M, Trenque T, Oubaya N, Nazeyrollas P, Novella J-L, Jolly D, Mahmoudi R. Adverse drug reactions in elderly patients with cognitive disorders: A systematic review. Maturitas. 2016;85:56-63.
  24. Hureaux J, Couturier O, Lacœuille F, Bouchet F, Chouaid C, Saulnier P, Urban T. [Can positron emission tomography assessment of response to treatment help to individualize use of erlotinib in non-small cell lung cancer?]. Rev Mal Respir. 2016;33(9):817-823.
  25. Hélage S, Revel MP, Chabi ML, Audureau E, Ferretti G, Laurent F, Alifano M, Mansuet-Lupo A, Buy JN, Vadrot D. Solitary fibrous tumor of the pleura: Can computed tomography features help predict malignancy? A series of 56 patients with histopathological correlates. Diagn Interv Imaging. 2016;97(3):347-53.
  26. Hanaire H, Attali C, Lecointre B, Fraysse M, Gouet D, Babel M-R, Charbonnel B, Sarkozy F, Gourmelen J, Detournay B. [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]. Sante Publique. 2016;28(6):781-789.
  27. Haddad B, Winer N, Chitrit Y, Houfflin-Debarge V, Chauleur C, Bages K, Tsatsaris V, Benachi A, Bretelle F, Gris J-C, Bastuji-Garin S. Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial. Obstet Gynecol. 2016;128(5):1053-1063.
  28. Gellen B, Canoui-Poitrine F, Boyer L, Drouot X, Le Thuaut A, Bodez D, Covali-Noroc A, D'ortho MPia, Guendouz S, Rappeneau S, Kharoubi M, Dubois-Randé J-L, Hittinger L, Adnot S, Bastuji-Garin S, Damy T. Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?. Int J Cardiol. 2016;203:1022-8.
  29. Ganne-Carrié N, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Trinchet J-C, Nahon P, Roudot-Thoraval F. Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). Hepatology. 2016;64(4):1136-47.
  30. Galat A, Guellich A, Bodez D, Slama M, Dijos M, Zeitoun DMessika, Milleron O, Attias D, Dubois-Randé J-L, Mohty D, Audureau E, Teiger E, Rosso J, Monin J-L, Damy T. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?. Eur Heart J. 2016;37(47):3525-3531.
  31. Freyer G, Scotte F, Borget I, Bruyas A, Vainchtock A, Chouaid C. [Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database]. Bull Cancer. 2016;103(6):552-60.
  32. Fournel P, Vergnenègre A, Robinet G, Lena H, Gervais R, Le Caer H, Souquet P-J, Chavaillon J-M, Bozonnat M-C, Daurès J-P, Chouaid C, Martel-Lafay I. Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01. Eur J Cancer. 2016;52:181-7.
  33. Ferrat E, Le Breton J, Guéry E, Adeline F, Audureau E, Montagne O, Roudot-Thoraval F, Attali C, Le Corvoisier P, Renard V. Effects 4.5 years after an interactive GP educational seminar on antibiotic therapy for respiratory tract infections: a randomized controlled trial. Fam Pract. 2016;33(2):192-9.
  34. Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange J-L, Canoui-Poitrine F, Caillet P, Bastuji-Garin S. Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort. J Gerontol A Biol Sci Med Sci. 2016;71(12):1653-1660.
  35. Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FCanoui, Conti M, Rakotoson MGeorgine, Habibi A, Khorgami S, Vingert B, Maitre B, Galactéros F, Pirenne F, Bartolucci P. Dense red blood cell and oxygen desaturation in sickle-cell disease. Am J Hematol. 2016;91(10):1008-13.
  36. David J-P, Ferrat E, Parisot J, Naga H, Lakroun S, Menasria F, Saddedine S, Natella P-A, Paillaud E, Fromantin I, Bastuji-Garin S. White Matter Lesions: Prevalence and Clinical Phenotype in Asymptomatic Individuals Aged ≥50 Years. Dement Geriatr Cogn Disord. 2016;42(3-4):159-168.
  37. Damy T, Costes B, Hagège AA, Donal E, Eicher J-C, Slama M, Guellich A, Rappeneau S, Gueffet J-P, Logeart D, Planté-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Randé J-L, Goossens M, Canoui-Poitrine F, Buxbaum JN. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J. 2016;37(23):1826-34.
  38. Créquit P, Ruppert A-M, Rozensztajn N, Gounant V, Vieira T, Poulot V, Antoine M, Chouaid C, Wislez M, Cadranel J, Lavole A. EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients. Lung Cancer. 2016;96:74-7.
  39. Corre R, Lena H, Vergnenègre A, Chouaid C. Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al. J Clin Oncol. 2016;34(33):4050-4051.
  40. Corre R, Greillier L, Le Caer H, Audigier-Valette C, Baize N, Bérard H, Falchero L, Monnet I, Dansin E, Vergnenègre A, Marcq M, Decroisette C, Auliac J-B, Bota S, Lamy R, Massuti B, Dujon C, Perol M, Daurès J-P, Descourt R, Lena H, Plassot C, Chouaid C. Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. J Clin Oncol. 2016;34(13):1476-83.
  41. Chouaid C, Borget I, Braun E, Bazil M-L, Schaetz D, Rémuzat C, Toumi M. French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends. Target Oncol. 2016;11(4):515-34.
  42. Chaput U, Vienne A, Audureau E, Bauret P, Bichard P, Coumaros D, Napoléon B, Ponchon T, Duchmann J-C, Laugier R, Lamouliatte H, Védrenne B, Gaudric M, Chaussade S, Robin F, Leblanc S, Prat F. Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures. United European Gastroenterol J. 2016;4(3):403-12.
  43. Carsin-Vu A, Oubaya N, Mulé S, Janvier A, Delemer B, Soyer P, Hoeffel C. MDCT Linear and Volumetric Analysis of Adrenal Glands: Normative Data and Multiparametric Assessment. Eur Radiol. 2016;26(8):2494-501.
  44. Canoui-Poitrine F, Reinald N, Laurent M, Guery E, Caillet P, David J-P, Tournigand C, Lagrange J-L, Bastuji-Garin S, Lemogne C, Paillaud E. Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study. Psychooncology. 2016;25(1):104-11.
  45. Yiou R, Bütow Z, Parisot J, Lingombet O, Augustin D, de la Taille A, Salomon L, Audureau E. Update on 2-year outcomes of the TOMS™ transobturator male sling for the treatment of male stress urinary incontinence. Neurourol Urodyn. 2016;35(1):44-7.
  46. Vinas F, Ben Hassen I, Jabot L, Monnet I, Chouaid C. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J. 2016;10(3):267-71.
  47. Vergnenègre A, Massuti B, de Marinis F, Carcereny E, Felip E, Do P, Sanchez JMiguel, Paz-Arez L, Chouaid C, Rosell R. Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC. J Thorac Oncol. 2016;11(6):801-7.
  48. Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, Radu C, Guendouz S, Couetil J-P, Benhaiem N, Hittinger L, Dubois-Randé J-L, Planté-Bordeneuve V, Mohty D, Deux J-F, Damy T. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016;9(2):126-38.
  49. Tardieu É, Mahmoudi R, Novella J-L, Oubaya N, Blanchard F, Jolly D, Dramé M. [External validation of the short emergency geriatric assessment (SEGA) instrument on the SAFES cohort]. Geriatr Psychol Neuropsychiatr Vieil. 2016;14(1):49-55.
  50. Soyez F, Ninot G, Herkert A, S Huyn P, Prosper M, Chinet T, Housset B, Chouaid C, Roche N. [Validation of an evaluation questionnaire for COPD acute exacerbations (Exascore)]. Rev Mal Respir. 2016;33(1):17-24.
  51. Schuler M, Yang JC-H, Park K, Kim J-H, Bennouna J, Chen Y-M, Chouaid C, De Marinis F, Feng J-F, Grossi F, Kim D-W, Liu X, Lu S, Strausz J, Vinnyk Y, Wiewrodt R, Zhou C, Wang B, Chand VK, Planchard D. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial. Ann Oncol. 2016;27(3):417-23.
  52. Schneck A-S, Lazzati A, Audureau E, Hemery F, Gugenheim J, Azoulay D, Iannelli A. One or two steps for laparoscopic conversion of failed adjustable gastric banding to sleeve gastrectomy: a nationwide French study on 3357 morbidly obese patients. Surg Obes Relat Dis. 2016;12(4):840-848.
  53. Renault A, Patkaï J, Dassieu G, Ayoubi MEl, Canoui-Poitrine F, Durrmeyer X. Hydrocortisone use in ventilated extremely preterm infants decreased bronchopulmonary dysplasia with no effects on neurodevelopment after two years. Acta Paediatr. 2016;105(9):1047-55.
  54. Quoix E, Lena H, Losonczy G, Forget F, Chouaid C, Papai Z, Gervais R, Ottensmeier C, Szczesna A, Kazarnowicz A, Beck JT, Westeel V, Felip E, Debieuvre D, Madroszyk A, Adam J, Lacoste G, Tavernaro A, Bastien B, Halluard C, Palanché T, Limacher J-M. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial. Lancet Oncol. 2016;17(2):212-223.
  55. Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaid C. Targeted therapy for localized non-small-cell lung cancer: a review. Onco Targets Ther. 2016;9:4099-104.
  56. Nielsen L, Canoui-Poitrine F, Jais J-P, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V. Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients. Br J Haematol. 2016;174(1):148-52.
  57. Muller N, Amiot A, Le Thuaut A, Bastuji-Garin S, Deforges L, Delchier J-C. Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains. Clin Res Hepatol Gastroenterol. 2016;40(4):517-24.
  58. Martinez-Tapia C, Canoui-Poitrine F, Bastuji-Garin S, Soubeyran P, Mathoulin-Pelissier S, Tournigand C, Paillaud E, Laurent M, Audureau E. Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version. Oncologist. 2016;21(2):188-95.
  59. Louvel G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste P-J, Hieu PDam, Faillot T, Litre F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes J-R, Barat J-L, Langlois O, Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J. Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients. Radiother Oncol. 2016;118(1):9-15.
  60. Liuu E, Caillet P, Curé H, Anfasi N, De Decker L, Pamoukdjian F, Canoui-Poitrine F, Soubeyran P, Paillaud E. [Comprehensive geriatric assessment (CGA) in elderly with cancer: For whom?]. Rev Med Interne. 2016;37(7):480-8.

2015

  1. Cittée J, Sauteron B, Brossier S, Ferrat E, Attali C, Chouaid C, Housset B. [In Process Citation]. Sante Publique. 2015;1 Suppl:177-87.
  2. Bazire L, Fromantin I, Diallo A, de la Lande B, Pernin V, Dendale R, Fourquet A, Savignoni A, Kirova YM. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. Radiother Oncol. 2015;117(2):229-33.
  3. Gandré C, Prigent A, Kemel M-L, Leboyer M, Chevreul K. Evolution of public and non-profit funding for mental health research in France between 2007 and 2011. Eur Neuropsychopharmacol. 2015;25(12):2339-48.
  4. Gallet R, Meyer G, Ternacle J, Biendel C, Brunet A, Meneveau N, Rosario R, Couturaud F, Sebbane M, Lamblin N, Bouvaist H, Coste P, Maitre B, Bastuji-Garin S, Dubois-Randé J-L, Lim P. Diuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study. BMJ Open. 2015;5(5):e007466.
  5. Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, Lagrange J-L, Canoui-Poitrine F, Bastuji-Garin S. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. J Gerontol A Biol Sci Med Sci. 2015;70(9):1148-55.
  6. Esteban H, Blondiaux E, Audureau E, Sileo C, Moutard ML, Gelot A, Jouannic JM, H le Pointe D, Garel C. Prenatal features of isolated subependymal pseudocysts associated with adverse pregnancy outcome. Ultrasound Obstet Gynecol. 2015;46(6):678-87.
  7. Durand-Zaleski I, Rabetrano H, Devonec M, Mandron E, Soulie M, De la Taille A, Benoit G, Mottet N, Gasman D, Dore B, Zerbib M, Vaessen C, Irani J, Lebret T, Colombel M, Lechevallier E, Bastuji-Garin S, Allory Y, Abbou C, Rischmann P, Salomon L. [Not Available]. Prog Urol. 2015;25(13):742.
  8. Couraud S, Souquet P-J, Paris C, Do P, Doubre H, Pichon E, Dixmier A, Monnet I, Etienne-Mastroianni B, Vincent M, Trédaniel J, Perrichon M, Foucher P, Coudert B, Moro-Sibilot D, Dansin E, Labonne S, Missy P, Morin F, Blanché H, Zalcman G. BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers. Eur Respir J. 2015;45(5):1403-14.
  9. Couraud S, Debieuvre D, Moreau L, Dumont P, Margery J, Quoix E, Duvert B, Cellerin L, Baize N, Taviot B, Coudurier M, Cadranel J, Missy P, Morin F, Mornex J-F, Zalcman G, Souquet P-J. No impact of passive smoke on the somatic profile of lung cancers in never-smokers. Eur Respir J. 2015;45(5):1415-25.
  10. Coolen N, Morand P, Martin C, Hubert D, Kanaan R, Chapron J, Honoré I, Dusser D, Audureau E, Veziris N, Burgel P-R. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. J Cyst Fibros. 2015;14(5):594-9.
  11. Clerc P, Duhot D, Le Breton J. [Restructuring of ambulatory care in France: proposals for the management of hypertensive patients]. Sante Publique. 2015;27(1 Suppl):S209-17.
  12. Cittée J, Sauteron B, Brossier S, Ferrat E, Attali C, Chouaid C, Housset B. [COPD patient care pathways: points of view of hospital personnel]. Sante Publique. 2015;27(1 Suppl):S177-87.
  13. Chouaid C, Rémuzat C, Caban A, Toumi M. Is Oncology Drug Financial Toxicity A Specific Us Issue?. Value Health. 2015;18(7):A573.
  14. Chouaid C, Crequit P, Borget I, Vergnenègre A. Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review. Clinicoecon Outcomes Res. 2015;7:9-15.
  15. Chouaid C, Borget I, Braun E, Bazil M, Schaetz D, Rémuzat C, Toumi M. French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends. Value Health. 2015;18(7):A489.
  16. Boyer L, Chouaid C, Bastuji-Garin S, Marcos E, Margarit L, Le Corvoisier P, Vervoitte L, Hamidou L, Frih L, Audureau E, Covali-Noroc A, Andujar P, Saakashvili Z, Lino A, Ghaleh B, Hue S, Derumeaux G, Housset B, Dubois-Randé J-L, Boczkowski J, Maitre B, Adnot S. Aging-related systemic manifestations in COPD patients and cigarette smokers. PLoS One. 2015;10(3):e0121539.
  17. Boulanger-Scemama E, Querques G, About F, Puche N, Srour M, Mane V, Massamba N, Canoui-Poitrine F, Souied EH. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting. J Fr Ophtalmol. 2015;38(7):620-7.
  18. Bonnefoy M, Berrut G, Lesourd B, Ferry M, Gilbert T, Guérin O, Hanon O, Jeandel C, Paillaud E, Raynaud-Simon A, Ruault G, Rolland Y. Frailty and nutrition: searching for evidence. J Nutr Health Aging. 2015;19(3):250-7.
  19. Besse B, Le Moulec S, Mazières J, Senellart H, Barlesi F, Chouaid C, Dansin E, Bérard H, Falchero L, Gervais R, Robinet G, Ruppert A-M, Schott R, Lena H, Clément-Duchêne C, Quantin X, Souquet PJean, Trédaniel J, Moro-Sibilot D, Perol M, Madroszyk A-C, Soria J-C. Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study. Clin Cancer Res. 2015;21(8):1896-903.
  20. Barlesi F, Chouaid C, Crequit J, Le Caer H, Pujol J-L, Legodec J, Vergnenègre A, Le Treut J, Fabre-Guillevin E, Loundou A, Auquier P, Simeoni M-C, Thomas PA. A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective. Interact Cardiovasc Thorac Surg. 2015;20(6):783-90.
  21. Rakotoson MGeorgine, Di Liberto G, Audureau E, Habibi A, Fauroux C, Khorgami S, Hulin A, Loric S, Noizat-Pirenne F, Galactéros F, Bartolucci P. Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea. Orphanet J Rare Dis. 2015;10:57.
  22. Paz-Ares L, Mezger J, Ciuleanu TE, Fischer JR, von Pawel J, Provencio M, Kazarnowicz A, Losonczy G, de Castro G, Szczesna A, Crino L, Reck M, Ramlau R, Ulsperger E, Schumann C, Miziara JElias A, Lessa ÁE, Dediu M, Bálint B, Depenbrock H, Soldatenkova V, Kurek R, Hirsch FR, Thatcher N, Socinski MA. Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study. Lancet Oncol. 2015;16(3):328-37.
  23. Parisot J, Penso-Assathiany D, Farcet Y, Raynaud E, Consigny S, Feton-Danou N, Bastuji-Garin S. [Outpatient expectations in dermatology consultations: A pilot study]. Ann Dermatol Venereol. 2015;142(11):639-45.
  24. Parisot J, Damy T, Gellen B, Covali-Noroc A, Bodez D, Rappeneau S, Guellich A, Adnot S, Bastuji-Garin S, Hittinger L, d'Ortho M-P, Boyer L, Canoui-Poitrine F. Sleep-disordered breathing in chronic heart failure: development and validation of a clinical screening score. Sleep Med. 2015;16(9):1094-101.
  25. Pamoukdjian F, Paillaud E, Zelek L, Laurent M, Lévy V, Landre T, Sebbane G. Measurement of gait speed in older adults to identify complications associated with frailty: A systematic review. J Geriatr Oncol. 2015;6(6):484-96.
  26. Pallud J, Audureau E, Noel G, Corns R, Lechapt-Zalcman E, Duntze J, Pavlov V, Guyotat J, Hieu PDam, Le Reste P-J, Faillot T, Litre C-F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes J-R, Barat J-L, Langlois O, Dezamis E, Parraga E, Zanello M, Nader E, Lefranc M, Bauchet L, Devaux B, Menei P, Metellus P. Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort. Neuro Oncol. 2015;17(12):1609-19.
  27. Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S, Wechsler J, de Feraudy S, Duong T-A, Delfau-Larue M-H, Chosidow O, Wolkenstein P, Roujeau J-C. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. Br J Dermatol. 2015;173(1):50-8.
  28. Moro-Sibilot D, Audigier-Valette C, Merle P, Quoix E, Souquet P-J, Barlesi F, Chouaid C, Molinier O, Bennouna J, Lavole A, Mazières J, Toffart A-C, Langlais A, Morin F, Zalcman G. Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study). Lung Cancer. 2015;89(2):139-45.
  29. Matignon M, Aissat A, Canoui-Poitrine F, Grondin C, Pilon C, Desvaux D, Saadoun D, Barathon Q, Garrido M, Audard V, Remy P, Lang P, Cohen J, Grimbert P. Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection. Am J Transplant. 2015;15(10):2718-25.
  30. Letrilliart L, Pouchain D, Le Reste J-Y, Renard V. [Letter on the editorial: "Early diagnosis of Alzheimer's disease: Are we too close to the tree to see the forest?"]. Presse Med. 2015;44(5):577-8.
  31. Le Corvoisier P, Bastuji-Garin S, Renaud B, Mahé I, Bergmann J-F, Perchet H, Paillaud E, Mottier D, Montagne O. Functional status and co-morbidities are associated with in-hospital mortality among older patients with acute decompensated heart failure: a multicentre prospective cohort study. Age Ageing. 2015;44(2):225-31.
  32. Laurent M, Bastuji-Garin S, Plonquet A, Bories PN, Le Thuaut A, Audureau E, Lang PO, Nakib S, Liuu E, Canoui-Poitrine F, Paillaud E. Interrelations of immunological parameters, nutrition, and healthcare-associated infections: prospective study in elderly in-patients. Clin Nutr. 2015;34(1):79-85.
  33. Laurendeau C, Chouaid C, Roche N, Terrioux P, Gourmelen J, Detournay B. [Management and costs of chronic pulmonary obstructive disease in France in 2011]. Rev Mal Respir. 2015;32(7):682-91.
  34. Launay N, Silvera S, Tenenbaum F, Groussin L, Tissier F, Audureau E, Vignaux O, Dousset B, Bertagna X, Legmann P. Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses. Int J Endocrinol. 2015;2015:213875.
  35. Ladner J, Besson M-H, Rodrigues M, Saba J, Audureau E. Performance of HIV Prevention of Mother-To-Child Transmission Programs in Sub-Saharan Africa: Longitudinal Assessment of 64 Nevirapine-Based Programs Implemented in 25 Countries, 2000-2011. PLoS One. 2015;10(6):e0130103.
  36. Krypciak S, Liuu E, Vincenot M, Landelle C, Lesprit P, Cariot M-A, Mézière A, Taillandier-Hériche E, Leroux J-L, Canoui-Poitrine F, Paillaud E. [Improvement of pneumococcal immunization coverage in older patients]. Rev Med Interne. 2015;36(4):243-7.
  37. Hurabielle C, Ingen-Housz-Oro S, Ortonne N, Cornillet-Lefèbvre P, Merah A, D'Incan M, Joly P, Franck N, Estève E, Maubec E, Grange F, Machet L, Laroche L, Barete S, Dalac S, Mortier L, Michel C, Quereux G, Saiag P, Ram-Wolff C, Lenormand B, Wechsler J, Bastuji-Garin S, Bagot M, Delfau-Larue MH. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group. Br J Dermatol. 2015;173(4):1015-23.
  38. Hocine A, Belmokhtar K, Bauley K, Jaisson S, Gaha K, Oubaya N, Lesaffre F, Lavaud S, Halin P, Gillery P, Rieu P, Touré F. Serum and Tissue Accumulation of Advanced Glycation End-Products Correlates with Vascular Changes. Perit Dial Int. 2015;35(5):592-4.
  39. Gervais R, Le Caer H, Monnet I, Falchero L, Baize N, Olivero G, Thomas P, Bérard H, Auliac JBernard, Chouaid C. Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501. Clin Lung Cancer. 2015;16(2):100-5.
  40. Yiou R, Loche C-M, Lingombet O, Abbou C, Salomon L, de la Taille A, Audureau E. Evaluation of urinary symptoms in patients with post-prostatectomy urinary incontinence treated with the male sling TOMS. Neurourol Urodyn. 2015;34(1):12-7.
  41. Yiou R, Bütow Z, Parisot J, Binhas M, Lingombet O, Augustin D, de la Taille A, Audureau E. Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year?. Sex Med. 2015;3(1):42-8.
  42. Yiou R, Bütow Z, Baron T, Salomon L, Audureau E. Adjustable continence therapy (ProACT™) after male sling failure for patients with post-radical prostatectomy urinary incontinence: a prospective study with one-year follow-up. World J Urol. 2015;33(9):1331-6.
  43. Yiou R, Audureau E, Loche C-M, Dussaud M, Lingombet O, Binhas M. Comprehensive evaluation of embarrassment and pain associated with invasive urodynamics. Neurourol Urodyn. 2015;34(2):156-60.
  44. Walzer S, Chouaid C, Lister J, Gultyaev D, Vergnenègre A, de Marinis F, Meng J, Carpeno Jde Castro, Crott R, Kleman M, Ngoh C. Simulation and comparison of progression-free survival among patients with non-squamous non-small-cell lung cancer receiving sequential therapy. Expert Rev Anticancer Ther. 2015;15(1):121-8.
  45. Toumi M, Rémuzat C, E Hammi E, Millier A, Aballéa S, Chouaid C, Falissard B. Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France. Value Health. 2015;18(7):A521.
  46. Toffart A-C, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit J-F. Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units. Intensive Care Med. 2015;41(1):164-5.
  47. Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2015;16(7):763-74.
  48. Sesé L, Didier M, Rousseau-Bussac G, Crequit P, Masanes MJ, Chouaid C. [Chemotherapy at the end of life for patients with lung cancer. A practice analysis]. Rev Mal Respir. 2015;32(3):256-61.
  49. Schmid-Bindert G, Engel-Riedel W, Reck M, Schuette W, Stöhlmacher J, Fischer JR, Mazières J, Chouaid C, Wolf M, Vinolas N, Soldatenkova V, Ripoche V, Nguyen T, Visseren-Grul C. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer. Lung Cancer. 2015;90(3):397-404.
  50. Scherpereel A, Fernandes J, Cotté F, Blein C, Debieuvre D, Durand-Zaleski I, Gaudin A, Ozan N, Saitta B, Souquet P, Vainchtock A, Westeel V, Chouaid C. Access to Innovative Drugs in Patients with Metastatic Lung Cancer in French Public Hospitals (the Territoire Study). Value Health. 2015;18(7):A341.
  51. Salomon L, Bastuji-Garin S, Soulie M, Devonec M, Boutin E, Mandron E, Benoit G, Rischmann P, Mottet N, Gasman D, Irani J, De la Taille A, Zerbib M, Vaesen C, Dore B, Lebret T, Colombel M, Lechevallier E, Gregoire L, Allory Y, Abbou C. [Not Available]. Prog Urol. 2015;25(13):793.
  52. Salomon L, Bastuji-Garin S, Mazerolles C, Devonec M, Soulie M, Benoit G, Rischmann P, Decaussin-Petrucci M, Mottet N, Gasman D, Fromont-Hankard G, Irani J, De la Taille A, Zerbib M, Ferlicot S, Comperat E, Vaesen C, Beuvon F, Lebret T, Boutin E, Mege-Lechevallier F, Dore B, Radulescu C, Paoletti M, Shar A, Colombel M, Lechevallier E. [Not Available]. Prog Urol. 2015;25(13):792-3.
  53. Rwabihama J-P, Rabus M-T, Perilliat J-G. [Evolution of patients' rights at the end of life]. Presse Med. 2015;44(4 Pt 1):392-400.
  54. Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet P-J, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015;16(3):257-65.
  55. Revel M-P, Fitton I, Audureau E, Benzakoun J, Lederlin M, Chabi M-L, Rousset P. Breast dose reduction options during thoracic CT: influence of breast thickness. AJR Am J Roentgenol. 2015;204(4):W421-8.
  56. Raynaud C, Greillier L, Mazieres J, Monnet I, Mastroianni B, Robinet G, Fraboulet G, Dixmier A, Berard H, Lamy R, Letreut J, Lena H, Oliviero G, Botta S, Vergnenegre A, Borget I, Chouaid C. Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study). BMC Cancer. 2015;15:857.

2014

  1. Pradier C, Sakarovitch C, Le Duff F, Layese R, Metelkina A, Anthony S, Tifratene K, Robert P. The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database. PLoS One. 2014;9(8):e103630.
  2. Fromantin I, Watson S, Baffie A, Rivat A, Falcou M-C, Kriegel I, Ingenior Yde Rycke. A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. Ostomy Wound Manage. 2014;60(6):38-48.
  3. Ghebriou D, Avenin D, Caillet P, Mongiat-Artus P, Durdux C, Massard C, Culine S. [FRancilian Oncogeriatric Group (FROG)'s focus on management of elderly patients with bladder cancer]. Bull Cancer. 2014;101(9):841-55.
  4. Gauvain C, Crequit P, Rousseau-Bussac G, Ganoun A, Baud M, Chouaid C. [Adjuvant chemotherapy of non-small cell lung cancer: Tolerance of combined cisplatin-pemetrexed therapy]. Rev Mal Respir. 2014;31(9):817-21.
  5. Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res. 2014;27(1):134-9.
  6. Coste J, Quinquis L, D'Almeida S, Audureau E. Smoking and health-related quality of life in the general population. Independent relationships and large differences according to patterns and quantity of smoking and to gender. PLoS One. 2014;9(3):e91562.
  7. Chouaid C, Dujon C, Do P, Monnet I, Madroszyk A, Le Caer H, Auliac JBernard, Bérard H, Thomas P, Lena H, Robinet G, Baize N, Bizieux-Thaminy A, Fraboulet G, Locher C, Le Treut J, Hominal S, Vergnenègre A. Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01). Lung Cancer. 2014;86(2):170-3.
  8. Chouaid C, Borget I, Vergnenègre A. Targeted therapies in non-small-cell lung cancer management: no cost-effective strategies?. J Clin Oncol. 2014;32(31):3577.
  9. Chauvin A, Le Thuaut A, Belhassan M, Le Baleur Y, Mesli F, Bastuji-Garin S, Delchier JCharles, Amiot A. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study. Dig Liver Dis. 2014;46(8):695-700.
  10. Canoui-Poitrine F, Veerabudun K, Larmignat P, Letournel M, Bastuji-Garin S, Richalet J-P. Risk prediction score for severe high altitude illness: a cohort study. PLoS One. 2014;9(7):e100642.
  11. Canoui-Poitrine F, Poulain C, Molto A, Le Thuaut A, Lafon C, Farrenq V, Ferkal S, Le Corvoisier P, Ghaleh B, Bastuji-Garin S, Fautrel B, Dougados M, Claudepierre P. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort. Arthritis Care Res (Hoboken). 2014;66(9):1395-402.
  12. Caillet P, Mongiat-Artus P, Liuu E, Dutendas S, Paillaud E. [Kidney and bladder cancers in the elderly]. Soins Gerontol. 2014;(109):38-42.
  13. Caillet P, Laurent M, Bastuji-Garin S, Liuu E, Culine S, Lagrange J-L, Canoui-Poitrine F, Paillaud E. Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment. Clin Interv Aging. 2014;9:1645-60.
  14. Bütow Z, Audureau E, Salomon L, De la Taille A, Yiou R. [Not Available]. Prog Urol. 2014;24(13):890.
  15. Brugel L, Laurent M, Caillet P, Radenne A, Durand-Zaleski I, Martin M, Baron M, de Kermadec H, Bastuji-Garin S, Canoui-Poitrine F, Paillaud E. Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR). BMC Cancer. 2014;14:427.
  16. Bories P-N, Laurent M, Liuu E, Denjean L, Popovici T, Paillaud E. Interleukin-10 promoter (-1082) polymorphism in association with repeated hospital-acquired infections in elderly patients. Aging Clin Exp Res. 2014;26(1):25-31.
  17. Borget I, Perol M, Pérol D, Lavole A, Greillier L, Do P, Westeel V, Crequit J, Lena H, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Chabaud S, Vergnenègre A, Zalcman G, Chouaid C. Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study. BMC Cancer. 2014;14:953.
  18. Berrut G, Dibon C, Hanon O, Gavazzi G, Chassagne P, de Decker L. [Care of elderly subject with iron deficiency anaemia: evaluation of geriatric practice]. Geriatr Psychol Neuropsychiatr Vieil. 2014;12 Suppl 2:17-24.
  19. Belkacemi Y, Bigorie V, Pan Q, Bouaita R, Pigneur F, Itti E, Badaoui H, Assaf E, Caillet P, Calitchi E, Bosc R. Breast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement. Ann Surg Oncol. 2014;21(12):3758-65.
  20. Barlesi F, Scherpereel A, Gorbunova V, Gervais R, Vikström A, Chouaid C, Chella A, Kim JH, Ahn MJ, Reck M, Pazzola A, Kim HT, Aerts JG, Morando C, Loundou A, Groen HJM, Rittmeyer A. Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial. Ann Oncol. 2014;25(5):1044-52.
  21. Auliac JB, Chouaid C, Greillier L, Monnet I, Le Caer H, Falchero L, Corre R, Descourt R, Bota S, Berard H, Schott R, Bizieux A, Fournel P, Labrunie A, Marin B, Vergnenegre A. Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study. Lung Cancer. 2014;85(3):415-9.
  22. Amiot A, Mansour H, Baumgaertner I, Delchier J-C, Tournigand C, Furet J-P, Carrau J-P, Canoui-Poitrine F, Sobhani I. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening. PLoS One. 2014;9(7):e99233.
  23. Rousseau-Bussac G, Crequit P, Alifano M, Chouaid C. [Management of malignant pericardial effusion in lung cancer]. Rev Mal Respir. 2014;31(8):746-53.
  24. Richalet J-P, Canoui-Poitrine F. Pro: hypoxic cardiopulmonary exercise testing identifies subjects at risk for severe high altitude illnesses. High Alt Med Biol. 2014;15(3):315-7.
  25. Richalet J-P, Canoui-Poitrine F. Rebuttal to the con statement. High Alt Med Biol. 2014;15(3):321.
  26. Postel-Vinay N, Hanon O, Clerson P, Brown JM, Ménard J, Paillaud E, Alonso E, Pasquier F, Pariel S, Belliard S, Péré J-J, Belmin J. Validation of the Test Your Memory (F-TYM Test) in a French memory clinic population. Clin Neuropsychol. 2014;28(6):994-1007.
  27. Ploussard G, Albrand G, Rozet F, Lang H, Paillaud E, Mongiat-Artus P. Challenging treatment decision-making in older urologic cancer patients. World J Urol. 2014;32(2):299-308.
  28. Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Adib-Conquy M, Cavaillon J-M. CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis. J Immunol. 2014;192(5):2449-59.
  29. Parisot J, Yiou R, Salomon L, de la Taille A, Lingombet O, Audureau E. Erection hardness score for the evaluation of erectile dysfunction: further psychometric assessment in patients treated by intracavernous prostaglandins injections after radical prostatectomy. J Sex Med. 2014;11(8):2109-18.
  30. Pallud J, Audureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, Mandonnet E, Dezamis E, Psimaras D, Guyotat J, Peruzzi P, Page P, Gal B, Parraga E, Baron M-H, Vlaicu M, Guillevin R, Devaux B, Duffau H, Taillandier L, Capelle L, Huberfeld G. Epileptic seizures in diffuse low-grade gliomas in adults. Brain. 2014;137(Pt 2):449-62.
  31. Paillaud E, Liuu E, Laurent M, Le Thuaut A, Vincent H, Raynaud-Simon A, Bastuji-Garin S, Tournigand C, Caillet P, Canoui-Poitrine F. Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumour site and metastatic status. The ELCAPA-05 cohort study. Clin Nutr. 2014;33(2):330-5.
  32. Oubaya N, Mahmoudi R, Jolly D, Zulfiqar AA, Quignard E, Cunin C, Nazeyrollas P, Novella JL, Dramé M. Screening for frailty in elderly subjects living at home: validation of the Modified Short Emergency Geriatric Assessment (SEGAm) instrument. J Nutr Health Aging. 2014;18(8):757-64.
  33. Moran T, Wei J, Cobo M, Qian X, Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, R Peñas deLas, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, ALHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez JJ, Camps C, Liu B, Rosell R, Colinet B, De Grève J, Germonpre P, Chen H, Chen X, Du J, Gao Y, Hu J, Hu W, Kong W, Li L, Li R, Li X, Liu B, Liu J, Lu H, Qian X, Ren W, Song Y, Wang L, Wei J, Wen L, Wu Q, Xiao X, Xu X, Yan J, Yang J, Yang M, Yang Y, Yin J, You C, Yu L, Yue X, Zhang F, Zhang J, Zhou Y, Zhu L, Zou Z, Baize N, Bombaron P, Chouaid C, Dansin E, Fournel P, Fraboulet G, Gervais R, Hominal S, Kahlout S, Lecaer H, Lena H, Letreut J, Locher C, Molinier O, Monnet I, Oliviero G, Robinet G, Schoot R, Thomas P, Vergnenegre A, Berchem G, Rauh S, H Husaini A, Aparisi F, Arriola E, Ballesteros I, Barneto I, Bernabé R, Blasco A, Bosch-Barrera J, Bover I, V de Juan C, Camps C, Carcereny E, Catot S, Cobo M, R Peñas deLas, Domine M, Felip E, García-Campelo MR, García-Girón C, García-Gómez R, Garcia-Sevila R, Garde J, Gasco A, Gil J, González-Larriba JL, Hernando-Polo S, Jantus E, Insa A, Isla D, Jiménez B, Lianes P, López-López R, López-Martín A, Lopez-Vivanco G, Macias JA, Majem M, Marti-Ciriquian JL, Massuti B, Montoyo R, Morales-Espinosa D, Moran T, Moreno MA, Pallares C, Parera M, Pérez-Carrión R, Porta R, Provencio M, Reguart N, Rosell R, Rosillo F, Sala MA, Sanchez JM, Sullivan I, Terrasa J, Trigo JM, Valdivia J, Viñolas N, Viteri S, Botia-Castillo M, Mate JL, Perez-Cano M, Ramirez JL, Sanchez-Rodriguez B, Taron M, Tierno-Garcia M, Mijangos E, Ocaña J, Pereira E, Shao J, Sun X, O'Brate R. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol. 2014;25(11):2147-2155.
  34. Mézière A, Audureau E, Vairelles S, Krypciak S, Dicko M, Monié M, Giraudier S. B12 deficiency increases with age in hospitalized patients: a study on 14,904 samples. J Gerontol A Biol Sci Med Sci. 2014;69(12):1576-85.
  35. Marty R, Roze S, Tisseau A, Borget I, Chouaid C. Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation: Reflection On A General Modeling Framework And Key Methodological Points. Value Health. 2014;17(7):A565.
  36. Loustau V, Debouverie O, Canoui-Poitrine F, Baili L, Khellaf M, Touboul C, Languille L, Loustau M, Bierling P, Haddad B, Godeau B, Pourrat O, Michel M. Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol. 2014;166(6):929-35.
  37. Liuu E, Canoui-Poitrine F, Tournigand C, Laurent M, Caillet P, Le Thuaut A, Vincent H, Culine S, Audureau E, Bastuji-Garin S, Paillaud E. Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 study. J Geriatr Oncol. 2014;5(1):11-9.
  38. Lerouge D, Rivière A, Dansin E, Chouaid C, Dujon C, Schott R, Lavole A, Le Pennec V, Fabre E, Crequit J, Martin F, Dehette S, Fournel P, Precheur-Agulhon B, Lartigau E, Zalcman G. A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer. BMC Cancer. 2014;14:231.
  39. Lecomte F, Huet S, Audureau E, Guyerdet V, Pourriat J-L, Claessens Y-E. Patients in pain that refuse acetaminophen at triage. Am J Emerg Med. 2014;32(4):388-9.
  40. Laurent M, Paillaud E, Tournigand C, Caillet P, Le Thuaut A, Lagrange J-L, Beauchet O, Vincent H, Carvahlo-Verlinde M, Culine S, Bastuji-Garin S, Canoui-Poitrine F. Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study. Oncologist. 2014;19(3):275-82.
  41. Ladner J, Besson M-H, Rodrigues M, Audureau E, Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health. 2014;14:670.
  42. Grimaldi D, Canoui-Poitrine F, Croisille L, Lee K, Roudot-Thoraval F, Languille L, Khellaf M, Michel M, Godeau B, Bierling P. Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding. Ann Hematol. 2014;93(2):309-15.
  43. Valipour A, Herth FJF, Burghuber OC, Criner G, Vergnon J-M, Goldin J, Sciurba F, Ernst A. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387-96.
  44. Simon D, Detournay B, Eschwege E, Bouée S, Bringer J, Attali C, Dejager S. Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study. Diabetes Ther. 2014;5(1):207-24.

2013

  1. Ségéral O, Hagege M. [Hepatitis C in French prisons]. Soins. 2013;(780):43-5.
  2. Lafuente-Lafuente C, Paillaud E, Belmin J. [Prescribing drugs in the elderly: improvements are necessary]. Presse Med. 2013;42(2):168-70.
  3. E Colombo S, Hoffman I. Acute high-altitude illnesses. N Engl J Med. 2013;369(17):1665-6.
  4. Caillet P, Souberbielle JC, Jaglal SB, Reymondier A, Van Ganse E, Chapurlat R, Schott AM. Vitamin D supplementation in a healthy, middle-aged population: actual practices based on data from a French comprehensive regional health-care database. Eur J Clin Nutr. 2013;67(11):1133-7.
  5. Bernard E, Saint-Lary O, Haboubi L, Le Breton J. [Cervical cancer screening: women's knowledge and participation]. Sante Publique. 2013;25(3):255-62.
  6. Fromantin I, Seyer D, Watson S, Rollot F, Elard J, Escande MChristine, De Rycke Y, Kriegel I, Garde VLarreta. Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51(10):3368-73.
  7. Bastuji-Garin S, Sbidian E, Gaudy-Marqueste C, Ferrat E, Roujeau J-C, Richard M-A, Canoui-Poitrine F. Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis. PLoS One. 2013;8(8):e64733.
  8. Audureau E, Rican S, Coste J. Worsening trends and increasing disparities in health-related quality of life: evidence from two French population-based cross-sectional surveys, 1995-2003. Qual Life Res. 2013;22(1):13-26.
  9. Audureau E, Rican S, Coste J. From deindustrialization to individual health-related quality of life: multilevel evidence of contextual predictors, mediators and modulators across French regions, 2003. Health Place. 2013;22:140-52.
  10. Audureau E, Kahn JG, Besson M-H, Saba J, Ladner J. Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health. 2013;13:286.
  11. Amigues I, Schott A-M, Amine M, Gelas-Dore B, Veerabudun K, Paillaud E, Beauchet O, Rolland Y, Poitrine FCanouï, Bonnefoy M. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study. J Am Med Dir Assoc. 2013;14(5):352-7.
  12. Ferrat E, Le Breton J, Djassibel M, Veerabudun K, Brixi Z, Attali C, Renard V. Understanding barriers to organized breast cancer screening in France: women's perceptions, attitudes, and knowledge. Fam Pract. 2013;30(4):445-51.
  13. Fauque P, Audureau E, Leandri R, Delaroche L, Assouline S, Epelboin S, Jouannet P, Patrat C. Is the nuclear status of an embryo an independent factor to predict its ability to develop to term?. Fertil Steril. 2013;99(5):1299-1304.e3.
  14. Doz M, Chouaid C, Com-Ruelle L, Calvo E, Brosa M, Robert J, Decuypère L, Pribil C, Huerta A, Detournay B. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13:15.
  15. Dicko M, Caillet P, Lafuente-Lafuente C, Paillaud E. [Iatrogenic agitation in elderly patient: prevalence, aetiologies and management]. Presse Med. 2013;42(2):181-6.
  16. Decroisette C, Galerneau L-M, Hominal S, Chouaid C. [Epidemiology, management and cost of bone metastases from lung cancer]. Rev Mal Respir. 2013;30(4):309-15.
  17. Coste J, Quinquis L, Audureau E, Pouchot J. Non response, incomplete and inconsistent responses to self-administered health-related quality of life measures in the general population: patterns, determinants and impact on the validity of estimates - a population-based study in France using the MOS S. Health Qual Life Outcomes. 2013;11:44.
  18. Chouaid C, Le Caer H, Corre R, Crequit J, Locher C, Falchero L, Dujon C, Bérard H, Monnet I, Vergnenègre A. Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505). Clin Lung Cancer. 2013;14(2):103-7.
  19. Chouaid C, Agulnik J, Goker E, Herder GJM, Lester JF, Vansteenkiste J, Finnern HW, Lungershausen J, Eriksson J, Kim K, Mitchell PLR. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting. J Thorac Oncol. 2013;8(8):997-1003.
  20. Chouaid C. [Supportive care in thoracic oncology: a new series in the Revue]. Rev Mal Respir. 2013;30(2):97-8.
  21. Chaput U, Heresbach D, Audureau E, Vanbiervliet G, Gaudric M, Bichard P, Bauret P, Coumaros D, Ponchon T, Fumex F, Bensoussan E, Lamouliatte H, Chryssostalis A, Robin F, Prat F. Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study. United European Gastroenterol J. 2013;1(2):93-102.
  22. Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, Pouget F, Wolkenstein P, Bastuji-Garin S. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506-11.
  23. Cambot M, Mazurier C, Canoui-Poitrine F, Hebert N, Picot J, Clay D, Picard V, Ripoche P, Douay L, Dubart-Kupperschmitt A, Cartron J-P. In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders. Am J Hematol. 2013;88(5):343-9.
  24. Bylicki O, Ferlay C, Chouaid C, Lavole A, Barlesi F, Dubos C, Westeel V, Crequit J, Corre R, Vergnenègre A, Monnet I, Le Caer H, Fournel P, Vaylet F, Falchero L, Poudenx M, Linard P, Pérol D, Zalcman G, Perol M. Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study. J Thorac Oncol. 2013;8(7):906-14.
  25. Bourgault M, Grimbert P, Verret C, Pourrat J, Herody M, Halimi JMichel, Karras A, Amoura Z, Jourde-Chiche N, Izzedine H, François H, Boffa J-J, Hummel A, Bernadet-Monrozies P, Fouque D, Canoui-Poitrine F, Lang P, Daugas E, Audard V. Acute renal infarction: a case series. Clin J Am Soc Nephrol. 2013;8(3):392-8.
  26. Bonnet-Zamponi D, d'Arailh L, Konrat C, Delpierre S, Lieberherr D, Lemaire A, Tubach F, Lacaille S, Legrain S. Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the Optimization of Medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc. 2013;61(1):113-21.
  27. Blondiaux E, Pidial L, Vilar J, Autret G, Balvay D, Audureau E, Bruneval P, Bel A, Cuenod C-A, Silvestre J-S, Clément O. Evaluation of rat heart microvasculature with high-spatial-resolution susceptibility-weighted MR imaging. Radiology. 2013;269(1):277-82.
  28. Blachier M, Coutanceau B, Dougados M, Saraux A, Bastuji-Garin S, Ferkal S, Le Corvoisier P, Farrenq V, Poulain C, Ghaleh B, Canoui-Poitrine F, Claudepierre P. Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort. Ann Rheum Dis. 2013;72(6):979-85.
  29. Blachier M, Canoui-Poitrine F, Dougados M, LeThuaut A, Fautrel B, Ferkal S, Le Corvoisier P, Farrenq V, Poulain C, Ghaleh B, Bastuji-Garin S, Claudepierre P. Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort. Rheumatology (Oxford). 2013;52(9):1686-93.
  30. Belkacemi Y, Allab-Pan Q, Bigorie V, Khodari W, Beaussart P, Totobenazara J-L, Mège J-P, Caillet P, Pigneur F, Dao T-H, Salmon R, Calitchi E, Bosc R. The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area. Ann Oncol. 2013;24(8):2023-8.
  31. Baud M, Strano S, Dechartres A, Jouni R, Triponez F, Chouaid C, Forgez P, Damotte D, Roche N, Régnard J-F, Alifano M. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis. J Thorac Cardiovasc Surg. 2013;145(5):1305-11.
  32. Nassar D, Sbidian E, Bastuji-Garin S, Martin L, Dupuy A. Typology of the primary outcome construction in dermatology: a systematic review of published randomized controlled trials. J Invest Dermatol. 2013;133(2):371-6.
  33. Mézière A, Paillaud E, Plaud B. [Anesthesia in the elderly]. Presse Med. 2013;42(2):197-201.
  34. Mézière A, Paillaud E, Belmin J, Pariel S, Herbaud S, Canoui-Poitrine F, Le Thuaut A, Marty J, Plaud B. Delirium in older people after proximal femoral fracture repair: role of a preoperative screening cognitive test. Ann Fr Anesth Reanim. 2013;32(9):e91-6.
  35. Mézière A, Blachier M, Thomas S, Verny M, Herbaud S, Bouillanne O, Henry O, David J-P, Le Thuaut A, Canoui-Poitrine F, Paillaud E. Neuropsychiatric symptoms in elderly inpatients: a multicenter cross-sectional study. Dement Geriatr Cogn Dis Extra. 2013;3(1):123-30.
  36. Mazières J, Peters S, Lepage B, Cortot AB, Barlesi F, Beau-Faller M, Besse B, Blons H, Mansuet-Lupo A, Urban T, Moro-Sibilot D, Dansin E, Chouaid C, Wislez M, Diebold J, Felip E, Rouquette I, Milia JD, Gautschi O. Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. J Clin Oncol. 2013;31(16):1997-2003.
  37. Leveziel N, Caillaux V, Bastuji-Garin S, Zmuda M, Souied EH. Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularization. Am J Ophthalmol. 2013;155(5):913-9.
  38. Lester JF, Agulnik J, Akerborg O, Chouaid C, De Geer A, Finnern HW, Herder GJM, Lungershausen J, Mitchell PLR, Vansteenkiste J, Ziske C, Goker E. What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study. Lung Cancer. 2013;82(1):128-35.
  39. Le Treut J, Sault MC, Lena H, Souquet PJ, Vergnenegre A, Le Caer H, Berard H, Boffa S, Monnet I, Damotte D, Chouaid C. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Ann Oncol. 2013;24(6):1548-52.
  40. Le Corvoisier P, Renard V, Roudot-Thoraval F, Cazalens T, Veerabudun K, Canoui-Poitrine F, Montagne O, Attali C. Long-term effects of an educational seminar on antibiotic prescribing by GPs: a randomised controlled trial. Br J Gen Pract. 2013;63(612):e455-64.
  41. Lafuente-Lafuente C, Baudry E, Paillaud E, Piette F. [Clinical pharmacology and aging]. Presse Med. 2013;42(2):171-80.
  42. Ladner J, Tekinturhan E, Tavolacci M-P, Audureau E, Saba J. Increasing access to care for chronic myeloid leukemia patients: assessment of a scaling-up program. J Health Care Poor Underserved. 2013;24(4):1486-97.
  43. Ladner J, Besson M-H, Rodrigues M, Sams K, Audureau E, Saba J. Prevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000-2011. BMC Public Health. 2013;13:470.
  44. La Combe B, Gaillard S, Bennis S, Chouaid C. [Management of spinal metastases of lung cancer]. Rev Mal Respir. 2013;30(6):480-9.
  45. Krypciak S, Mézière A, Belmin J, Herbaud S, Paillaud E. [Which vaccination and cardiovascular prevention in elderly?]. Presse Med. 2013;42(2):202-8.
  46. Jouveshomme S, Canoui-Poitrine F, Le Thuaut A, Bastuji-Garin S. Results of platinum-based chemotherapy in unselected performance status (PS) 2 patients with advanced non-small cell lung cancer: a cohort study. Med Oncol. 2013;30(2):544.
  47. Guedj M, Saad A, Audureau E, Gatinel D. Photorefractive keratectomy in patients with suspected keratoconus: five-year follow-up. J Cataract Refract Surg. 2013;39(1):66-73.
  48. Grandfils N, Detournay B, Attali C, Joly D, Simon D, Vergès B, Toussi M, Briand Y, Delaitre O. Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in france: a cross-sectional study. Int J Endocrinol. 2013;2013:640632.
  49. Gellen B, Lesault P-F, Canoui-Poitrine F, Champagne S, Mouillet G, Pongas D, Le Thuaut A, Jakljevic T, Boudiche S, de la Vega M, Maalej A, Veugeois A, Dubois-Randé J-L, Teiger E. Feasibility limits of transradial primary percutaneous coronary intervention in acute myocardial infarction in the real life (TRAP-AMI). Int J Cardiol. 2013;168(2):1056-61.
  50. Gellen B, Canoui-Poitrine F, Lesault P-F, Le Thuaut A, Lim P, Gueret P, Guendouz S, Pongas D, Teiger E, Dubois-Randé J-L, Hittinger L, Damy T. Usefulness of tissue Doppler imaging for assessing left ventricular filling pressure in patients with stable severe systolic heart failure. Am J Cardiol. 2013;112(10):1619-24.
  51. Ferrat E, Le Breton J, Veerabudun K, Bercier S, Brixi Z, Khoshnood B, Paillaud E, Attali C, Bastuji-Garin S. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer. 2013;109(6):1437-44.
  52. Zehou O, Bularca S, Bastuji-Garin S, Ortonne N, Valeyrie-Allanore L, Wolkenstein P, Duong TA. Neurofibromatosis 1 phenotype associated to malignant peripheral nerve sheath tumours: a case-control study. J Eur Acad Dermatol Venereol. 2013;27(8):1044-7.
  53. Vergnenègre A, Hominal S, Tchalla AEdem, Bérard H, Monnet I, Fraboulet G, Baize N, Audigier-Valette C, Robinet G, Oliviero G, Le Caer H, Thomas P, Gérinière L, Mastroianni B, Chouaid C. Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study). Lung Cancer. 2013;82(2):353-7.
  54. Vergnenegre A, Borget I, Chouaid C. Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents. Clinicoecon Outcomes Res. 2013;5:137-41.
  55. Vergnenègre A, Borget I, Chouaid C. Treatment of lung cancer: will financial issues become a criterion of choice?. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):273-5.
  56. Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, Ortonne N, Bagot M, Roujeau J-C, Revuz JE, Wechsler J, Wolkenstein P. Prognostic value of histologic features of toxic epidermal necrolysis. J Am Acad Dermatol. 2013;68(2):e29-35.
  57. Tilleul J, Querques G, Canoui-Poitrine F, Leveziel N, Souied EH. Assessment of a spectral domain OCT segmentation software in a retrospective cohort study of exudative AMD patients. Ophthalmologica. 2013;229(2):80-5.
  58. Thibault V, Gaudy-Graffin C, Colson P, Gozlan J, Schnepf N, Trimoulet P, Pallier C, Saune K, Branger M, Coste M, Thoraval FRoudot. Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study. Virol J. 2013;10:87.
  59. Tekinturhan E, Audureau E, Tavolacci M-P, Garcia-Gonzalez P, Ladner J, Saba J. Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program. BMC Health Serv Res. 2013;13:304.
  60. Scagliotti GV, Felip E, Besse B, von Pawel J, Mellemgaard A, Reck M, Bosquee L, Chouaid C, Lianes-Barragán P, Paul EM, Ruiz-Soto R, Sigal E, Ottesen LH, Lechevalier T. An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer. J Thorac Oncol. 2013;8(12):1529-37.
  61. Saba J, Audureau E, Bizé M, Koloshuk B, Ladner J. Development and validation of a multilateral index to determine economic status in developing countries: the Patient Financial Eligibility Tool (PFET). Popul Health Manag. 2013;16(2):82-9.
  62. Rousset P, Chaillot P-F, Audureau E, Rey-Salmon C, Becour B, Fitton I, Vadrot D, Revel M-P. Detection of residual packets in cocaine body packers: low accuracy of abdominal radiography-a prospective study. Eur Radiol. 2013;23(8):2146-55.
  63. Rittmeyer A, Gorbunova V, Vikström A, Scherpereel A, Kim J-H, Ahn M-J, Chella A, Chouaid C, Campbell AK, Barlesi F. Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089). J Thorac Oncol. 2013;8(11):1409-16.
  64. Richalet J-P, Canoui-Poitrine F, Canoui-Poitrine F, Larmignat P. Acute high-altitude illnesses. N Engl J Med. 2013;369(17):1664-5.
  65. Ramalingam S, Crawford J, Chang A, Manegold C, Perez-Soler R, Douillard J-Y, Thatcher N, Barlesi F, Owonikoko T, Wang Y, Pultar P, Zhu J, Malik R, Giaccone G. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial). Ann Oncol. 2013;24(11):2875-80.
  66. Prat L, Chouaid C, Kettaneh A, Fardet L. Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: case report and literature review. Lung Cancer. 2013;79(1):91-3.
  67. Pouchain D, Lièvre M, Huas D, Lebeau J-P, Renard V, Bruckert E, Girerd X, Boutitie F. Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice. Trials. 2013;14:318.
  68. Perol M, Pérol D, Chouaid C. Reply to N. Singh et al. J Clin Oncol. 2013;31(9):1251-2.
  69. Pautas C, Sbidian E, Hicheri Y, Bastuji-Garin S, Bretagne S, Corbel C, Gregoire L, Maury S, Merabet L, Cordonnier C, Cambau E. A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter. J Antimicrob Chemother. 2013;68(4):943-6.
  70. Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, Bauchet L, Peruzzi P, Frénay M, Colin P, Guillevin R, Bernier V, Baron M-H, Guyotat J, Duffau H, Taillandier L, Capelle L. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol. 2013;15(5):595-606.
  71. Paleiron N, André M, Grassin F, Chouaid C, Venissac N, Margery J, Couturaud F, Noël-Savina E, Tromeur C, Vinsonneau U, Vedrine L, Leroyer C, Nowak E, Berard H, Thomas P, Brouchet L, Bagan P, Fournel P, Mottier D, Robinet G. [Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]. Rev Mal Respir. 2013;30(3):231-7.

2012

  1. Lekpa FKemta, Farrenq V, Canoui-Poitrine F, Paul M, Chevalier X, Bruckert R, Bastuji-Garin S, Claudepierre P. Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition. Joint Bone Spine. 2012;79(1):47-50.
  2. Lhuissier FJ, Canoui-Poitrine F, Richalet J-P. Ageing and cardiorespiratory response to hypoxia. J Physiol. 2012;590(21):5461-74.
  3. Cochat P, Hulton S-A, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729-36.
  4. Thomas L, Canoui-Poitrine F, Gottenberg J-E, Economu-Dubosc A, Medkour F, Chevalier X, Bastuji-Garin S, Le Louët H, Farrenq V, Claudepierre P. Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry. J Rheumatol. 2012;39(5):893-8.
  5. Mechtouff L, Canoui-Poitrine F, Schott A-M, Nighoghossian N, Trouillas P, Termoz A, Porthault-Chatard S, David J-S, Chasles V, Derex L. Lack of association between air pollutant exposure and short-term risk of ischaemic stroke in Lyon, France. Int J Stroke. 2012;7(8):669-74.
  6. Querques G, Canoui-Poitrine F, Coscas F, Massamba N, Querques L, Mimoun G, Bandello F, Souied EH. Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(3):1264-70.
  7. Canoui-Poitrine F, F Lekpa K, Farrenq V, Boissinot V, Hacquard-Bouder C, Comet D, Bastuji-Garin S, Thibout E, Claudepierre P. Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey. Arthritis Care Res (Hoboken). 2012;64(6):919-24.
  8. Confavreux CB, Canoui-Poitrine F, Schott A-M, Ambrosi V, Tainturier V, Chapurlat RD. Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database. Eur J Endocrinol. 2012;166(4):735-41.
  9. Richalet J-P, Larmignat P, Poitrine E, Letournel M, Canoui-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(2):192-8.
  10. Pallud J, Dezamis E, Audureau E, Devaux B, Souillard-Scemama R, Sanai N, Page P, Beuvon F, Koziak M, Oppenheim C, Dhermain F, Schlienger M, Meder J-F, Roux F-X, Varlet P. Neuronal immunoexpression and a distinct subtype of adult primary supratentorial glioblastoma with a better prognosis. J Neurosurg. 2012;117(3):476-85.
  11. Burgel P-R, Baixench M-T, Amsellem M, Audureau E, Chapron J, Kanaan R, Honoré I, Dupouy-Camet J, Dusser D, Klaassen CH, Meis JF, Hubert D, Paugam A. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother. 2012;56(2):869-74.
  12. Hardouin J-B, Audureau E, Leplège A, Coste J. Spatio-temporal Rasch analysis of quality of life outcomes in the French general population: measurement invariance and group comparisons. BMC Med Res Methodol. 2012;12:182.
  13. Ettou S, Audureau E, Humbrecht C, Benet B, Jammes H, Clozel T, Bardet V, Lacombe C, Dreyfus F, Mayeux P, Solary E, Fontenay M. Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML. Leukemia. 2012;26(10):2297-9.
  14. Arzt H, Fromantin I, Ribinik P, Barrois B, Colin D, Michel J-M, Passadori Y. Which medical device and/or which local treatment are to be used, as of 2012, in patients with infected pressure sore? Developing French guidelines for clinical practice. Ann Phys Rehabil Med. 2012;55(7):498-507.

2011

  1. Goubard A, Marzouk M, Canoui-Poitrine F, Launay S, Le Thuaut A, Legrand P. Performance of the Iris iQ(R)200 Elite analyser in the cell counting of serous effusion fluids and cerebrospinal drainage fluids. J Clin Pathol. 2011;64(12):1123-7.
  2. Canoui-Poitrine F, Bastuji-Garin S, Alonso E, Darcel G, Verstichel P, Caillet P, Paillaud E. Risk and prognostic factors of status epilepticus in the elderly: a case-control study. Epilepsia. 2011;52(10):1849-56.
  3. Kofman T, Grimbert P, Canoui-Poitrine F, Zuber J, Garrigue V, Mousson C, Frimat L, Kamar N, Couvrat G, Bouvier N, Albano L, Le Thuaut A, Pillebout E, Choukroun G, Couzi L, Peltier J, Mariat C, Delahousse M, Buchler M, Le Pogamp P, Bridoux F, Pouteil-Noble C, Lang P, Audard V. Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study. Am J Transplant. 2011;11(11):2423-31.
  4. Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, Bastuji-Garin S, Culine S, Paillaud E. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636-42.
  5. R Hassani TJoutei, Le Tien V, Canoui-Poitrine F, Atmani K, Querques G, Sterkers M, Massamba N, Coscas G, Soubrane G, Bastuji-Garin S, Souied EH. [SPA-2: semiology for phenotyping AMD: atrophic AMD]. J Fr Ophtalmol. 2011;34(2):83-90.
  6. Querques G, Querques L, Rafaeli O, Canoui-Poitrine F, Bandello F, Souied EH. Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab. Invest Ophthalmol Vis Sci. 2011;52(9):7012-8.
  7. Salameh C, Canoui-Poitrine F, Cortet M, Lafon A, Rudigoz R-C, Huissoud C. [Does persistent occiput posterior position increase the risk of severe perineal laceration?]. Gynecol Obstet Fertil. 2011;39(10):545-8.
  8. Canoui-Poitrine F, Luc G, Mallat Z, Machez E, Bingham A, Ferrieres J, Ruidavets J-B, Montaye M, Yarnell J, Haas B, Arveiler D, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P, Empana J-P. Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology. 2011;77(12):1165-73.
  9. Chaput U, Alberto SFolgado, Terris B, Beuvon F, Audureau E, Coriat R, Roche H, Gaudric M, Prat F, Chaussade S. Risk factors for advanced adenomas amongst small and diminutive colorectal polyps: a prospective monocenter study. Dig Liver Dis. 2011;43(8):609-12.
  10. Cottu PH, Fourchotte V, Vincent-Salomon A, Kriegel I, Fromantin I. Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy. J Wound Care. 2011;20(9):403-4, 406, 408 passim.

2010

  1. Canoui-Poitrine F, Luc G, Bard J-M, Ferrieres J, Yarnell J, Arveiler D, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P, Empana J-P. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis. 2010;30(3):252-9.
  2. Empana J-P, Jouven X, Canoui-Poitrine F, Luc G, Tafflet M, Haas B, Arveiler D, Ferrieres J, Ruidavets J-B, Montaye M, Yarnell J, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P. C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study. Arterioscler Thromb Vasc Biol. 2010;30(10):2047-52.
  3. Canoui-Poitrine F, Jaglal S, Chapurlat R, Tainturier V, Colin C, Schott AM. Has reimbursement of bone mineral density testing and anti-osteoporotic treatments improved management of osteoporosis in France?. Bone. 2010;47(4):790-4.
  4. Chabroux S, Canoui-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, Thivolet C. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab. 2010;36(2):152-7.
  5. Huissoud C, Dupont C, Canoui-Poitrine F, Touzet S, Dubernard G, Rudigoz R-C. Decision-to-delivery interval for emergency caesareans in the Aurore perinatal network. Eur J Obstet Gynecol Reprod Biol. 2010;149(2):159-64.
  6. Audureau E, Merle V, Kerleau K, Dollois B, Baugé-Rousseau M, Théry S, Tavolacci M-P, Dubreuil N, Thillard D, Gasparin-Grisel S, Mathieu M, Augé C, Czernichow P. [Information for patients about hospital infections in psychiatry: An assessment of healthcare professionals' knowledge, opinion and attitude]. Encephale. 2010;36(2):132-8.
  7. Rwabihama J-P, Girre C, Duguet A-M. Ethics committees for biomedical research in some African emerging countries: which establishment for which independence? A comparison with the USA and Canada. J Med Ethics. 2010;36(4):243-9.

2009

  1. Canoui-Poitrine F, Luc G, Juhan-Vague I, Morange P-E, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets J-B, Haas B, Evans A, Ducimetiere P, Empana J-P. Respective contribution of conventional risk factors and antihypertensive treatment to stable angina pectoris and acute coronary syndrome as the first presentation of coronary heart disease: the PRIME Study. Eur J Cardiovasc Prev Rehabil. 2009;16(5):550-5.
  2. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219(2):148-54.
  3. Canoui-Poitrine F, Jeanblanc G, Alberti C, Armoogum P, Cebrian A, Carrié D, Henry P, Teiger E, Slama M, Spaulding C, Durand-Zaleski I. Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial. Appl Health Econ Health Policy. 2009;7(1):19-29.
  4. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61(1):51-7.
  5. Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F, Viallette C, Revuz J. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment. Dermatology. 2009;218(2):134-5.
  6. Audureau E, Deneux-Tharaux C, Lefèvre P, Brucato S, Morello R, Dreyfus M, Bouvier-Colle M-H. Practices for prevention, diagnosis and management of postpartum haemorrhage: impact of a regional multifaceted intervention. BJOG. 2009;116(10):1325-33.

2008

  1. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JClaude, Bonnelye G, Grob JJacques, Bastuji-Garin S. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596-601.
  2. Empana J-P, Canoui-Poitrine F, Luc G, Juhan-Vague I, Morange P, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets J-B, Haas B, Evans A, Ducimetiere P. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study. Eur Heart J. 2008;29(16):1966-74.

2007

  1. Audureau E, Karmaly M, Daigurande C, Paris C, Evreux E, Thielly P, Pfister C. [Bladder cancer and occupation: a descriptive analysis in Haute Normandie in 2003]. Prog Urol. 2007;17(2):213-8.

2006

  1. Canoui-Poitrine F, Cadot E, Spira A. Excess deaths during the August 2003 heat wave in Paris, France. Rev Epidemiol Sante Publique. 2006;54(2):127-35.
  2. Rwabihama J-P, Aubourg R, Oliary J, Mouly S, Champion K, Leverge R, Bergmann J-F. [Use and misuse of intravenous drug administration in a department of internal medicine]. Presse Med. 2006;35(10 Pt 1):1453-60.

2005

  1. Holstein J, Canoui-Poitrine F, Neumann A, Lepage E, Spira A. Were less disabled patients the most affected by 2003 heat wave in nursing homes in Paris, France?. J Public Health (Oxf). 2005;27(4):359-65.